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II Abstract 
 
Campylobacter jejuni is a prominent food-borne pathogen and causative agent 
of Campylobacteriosis infection. This infection arises primarily from the 
consumption of foodstuffs/beverages previously contaminated with this 
microorganism. Despite current food control measures currently employed, this 
pathogen remains problematic despite its fastidious nature. To help control the 
spread of Campylobacter many hurdles are used in the food industry, including 
natural products such as modified atmosphere and salt. Other natural 
antimicrobials are shown to possess antibacterial activity.  
Chitosan, a natural antimicrobial, has promising uses in food production. 
However, little is known about the transcriptional differences of C. jejuni upon 
chitosan exposure. Molecular responses may allow for generation of adaptive 
responses in an attempt to combat such a stressor, possibly altering phenotypic 
and virulence potential. The aims of this study were to establish the adaptive 
response of C. jejuni to low molecular weight chitosan by assessing the 
phenotypic and molecular differences arising from the chitosan challenge. 
By exposing C. jejuni NTCT11168 to suboptimal levels of chitosan, based on MIC 
determination on a model system, an adaptive strain of C. jejuni has been 
developed. This newly developed isolate, referred to as the ‘adapted’ C. jejuni 
NCTC11168 was found to have enhanced antimicrobial tolerance to chitosan, 
with a 3.83 fold increase in MIC relative to the parental wild-type C. jejuni 
NCTC11168 cells (0.012% - 0.046% (w/v) respectively). Antimicrobial activity of 
chitosan was found to be pH dependant. Differences in motility were also 
apparent between the ‘adapted’ and wild-type strains. Consistent increases in 
motility were noted in the ‘adapted’ cells, especially in relation to wild-type after 
24, 48 and 72 hours (p<0.05). Biofilm formation was also enhanced especially in 
the ‘adapted’ isolate relative to the wild-type NCTC11168 cells. This was 
indicated by significant increases, most notably after 3 days formation (p<0.05). 
Microarray analysis revealed significant alterations in transcriptional levels in 
response to chitosan exposure. Protein-encoding genes, believed to be 
associated with energy metabolism, solute/ion uptake/acquisition and efflux 
systems, were found to be differentially regulated when grown in the presence of 
low molecular weight chitosan (p<0.05). Overlapping between initial 
comparisons revealed several genes, which were differentially regulated. Most 
notably, PEB3 (major antigenic peptide), Cj0017c (disulphide bond formation) 
and Cj0294 (thiamine biosynthesis) genes were found to be up regulated in 
‘adapted’ C. jejuni cells when compared to the wild-type (p<0.05). Whilst 
significant down regulation was found in the protein-coding genes, Cj0025c 
(putative sodium:dicarboxylate symporter) and Cj1608 (two-component 
regulator). 
These results indicate that regulation of these genes may contribute to enhanced 
phenotypic responses observed in the ‘adapted’ isolate of C. jejuni NCTC11168. 
These findings are likely to account for increased growth and survival of 
‘adapted’ C. jejuni NCTC11168 when challenged to this antimicrobial, when 
compared to the wild-type. The findings in this study provide useful information 
as to how C. jejuni NCTC11168 can develop an adaptive tolerance response to 
chitosan and that alterations in transcriptional aspects may facilitate this, 
contributing to an enhanced phenotypic response and virulence potential. 
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RAPD Random Amplified Polymorphic DNA 
ReA Reactive Arthritis  
RNA Ribonucleic acid 
ROS Reactive oxygen species 
TCRs Two-component regulators 
UV Ultra Violet  
V Volts 
v/v Volume/volume 
VBNC Viable but non-culturable 
Wt Wild-type 
w/v  Weight/volume 
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Chapter 1 - Introduction 
 
 
 
Campylobacter species, particularly C. jejuni account for the most commonly 
reported bacterial cause of food-borne gastroenteritis, worldwide (Moore et al., 
2006). Infections resulting from this pathogen can cause symptoms such as 
abdominal pain, diarrhoea, haemorrhagic colitis and in rare cases Guillain-Barré 
syndrome (Papaconstantinou and Thomas, 2007). The majority of sporadic cases 
of human campylobacteriosis arise through the consumption of undercooked/raw 
poultry meat (Moore et al., 2006).  
 
Owing to a chronic overuse of antibiotics in both human medicine and animal 
husbandry, an increase in the incidence of resistance to antibiotics has become 
evident of the years (Iovine, 2013). As a result of this issue, there has been a 
shift towards more alternative antimicrobials. In this respect, there is a 
preference for naturally occurring agents/derivatives which allow for a suitable 
decontamination (Burt, 2004; Chouliara et al., 2007). For food safety assurance, 
consumers frequently demand food products which contain natural alternatives 
to the traditional chemical additives, which still permit increases in food quality 
and shelf-life (Piskernik et al., 2011). 
 
Chitosan, a naturally derived form of deacetylated chitin, has been seen to 
illustrate antimicrobial activity in a number of bacterial species (Wu et al., 
2006). Due to the natural origin and Generally Recognised as Safe (GRAS) 
status of this biopolymer, it could be a desirable alternative to chemical 
decontaminants and food packaging or coatings (FDA, 2001). Much in the same 
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way that exposure to antibiotics and biocides can lead to enhanced resistance 
properties, having been previously documented in C. jejuni (Miflin et al., 2006; 
Mavri and Mozina, 2012), there may be a potential for C. jejuni to develop an 
increased tolerance towards chitosan and become stress hardened.  
 
Limited gene expression analysis has been conducted following exposure of 
microorganisms to chitosan. For C. jejuni to illustrate an adaptive tolerance 
response, differences in molecular responses are likely to be present. Thus it 
seems appropriate to explore both the transcriptional response of C. jejuni to 
chitosan exposure and assess the impact of this in terms of altered phenotypic 
responses from an aspect of virulence.  
 
Overall, the works undertaken in this study provide data highlighting the 
antimicrobial activity of low molecular weight chitosan against several C. jejuni 
strains/isolates. In addition the data allow for an assessment of C. jejuni 
NCTC11168 to adapt to sub-lethal low molecular weight chitosan and to 
subsequently explore the associated phenotypic and transcriptional differences 
resultant from challenge to this antimicrobial.  
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Chapter 2 - Literature Review 
 
 
2.1 Campylobacter jejuni  
 
2.1.1 Taxonomy, physiology and pathogenesis 
 
Campylobacter jejuni is a Gram negative, non-spore forming, helical shaped, 
motile microorganism, belonging to the genus Campylobacter.  Along with 
bacteria species from Arcobacter and Sulfurospirillum genera, Campylobacter 
spp. are designated under the family Campylobacteraceae (De Boer et al., 
2013). C. jejuni is referred to as fastidious, requiring microaerobic conditions in 
order to grow optimally. An oxygen concentration of 3-15% and carbon dioxide 
concentration of 3-5% is accepted as being optimal for this growth (Ketley, 
1997). C. jejuni has the ability to grow at temperatures ranging from 30-47oC, 
with optimal growth at a temperature of 42oC (Stintzi, 2003). With respect to 
pH, C. jejuni is said to grow optimally at a range of 6.5-7.5, with an inhibition in 
growth observed at pH 4.9 or less (Doyle and Roman, 1981). 
 
C. jejuni has been identified as the most common bacterial pathogen causing 
gastroenteritis and post infectious irritable bowel syndrome (PI-IBS) in humans 
(Zilbauer et al., 2008; Sung et al., 2013). These symptoms of gastroenteritis, 
sometimes labelled as Campylobacter enteritis or Campylobacteriosis include 
abdominal cramping/pain, nausea, fever, muscle pain and acute diarrhoea (CDC, 
2011; Alazzam et al., 2011).  
  
Despite the well-documented pathogenesis of C. jejuni with respect to humans, 
birds and other animals; it is the microaerophilic and chemo-organotropic nature 
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which dictates the need for complex media when isolating and re-cultivating 
from environmental and clinical sources (Corry et al., 1995).  Mechanisms 
involving the virulence and resistance to various environmental stresses remain 
either unknown or not fully understood. This is likely due to the relative fragility 
of this micro-organism (Garénaux et al., 2008; Alazzam et al., 2011; Corry et 
al., 1995). Therefore, gaining knowledge with respect to factors such as stress 
resistance, adaptation and virulence of C. jejuni are paramount for developing a 
greater understanding of this microorganism.  
 
2.1.2 Epidemiology 
 
Campylobacter infection with respect to humans is known to occur more often in 
summer months compared to winter in temperate climates. Approximately 
double the number of cases of Campylobacter infection occurs during summer 
when compared to winter (Butzler, 2004).  
 
A similar trend is seen in the degree of flock colonisation of chickens. In many 
European countries, the amount of flock colonisation with Campylobacter 
appears to be seasonally dependant, with higher rates during in summer in 
contrast to autumn (EFSA, 2010).  
 
The rate of notification of campylobacteriosis from archived census data from 
1991 and 1996 for general population and aboriginal populations respectively in 
Western Australia revealed higher rates in spring months. Males were seen to 
have a higher rate of 89 cases of campylobacteriosis per 10,000 compared to 
that of females (78 per 10,000). The aboriginal population were typical of higher 
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incidence, as oppose to the general population, with young children and younger 
adults being particularly affected (Banmali et al., 2006).  
 
True incidence of gastroenteritis resulting from Campylobacter spp. is not well 
known, with particular respect to low-income countries. In the case of high-
income countries, the number of cases ranges from 44 and 93 per 10,000 
individuals (WHO, 2013). Statistics suggest yearly increases in reported cases of 
around 30% in Scotland and 14% in England and Wales, according to data 
obtained in 2009. This number is likely to be markedly higher (450,000) with 
10% of all cases being hospitalised (Strachan and Forbes, 2010). However, this 
number is likely to be greater due to under reporting (Thomas et al., 2006).  
 
Zoonotic transfer via the faecal-oral route can lead to colonisation of the 
intestinal mucosa of host animals and humans alike (Jones, 2001; Newell et al., 
2001). The environmental niche of choice is believed to be avian intestinal tracts 
(Newel and Fearnley, 2003). The main reservoir can involve either the domestic 
or wild animal populations. It has been recognised that poultry are seen to play 
a pivotal role when infection is concerned, with particular emphasis on 
contaminated poultry which are often a staple part of many diets worldwide 
(Butzler, 2004; Mullner et al., 2009; Stafford et al., 2008). 
 
The main route of infection as identified in outbreak reports and case-control 
studies have uncovered other risk factors that can be involved. Examples 
includes the transmission of Campylobacter by means of flies as a vector which 
has led to the assumption that Campylobacter is readily transferred from 
organism to foodstuffs (Nichols et al., 2005; Ekdahl et al., 2005). However, it is 
often that contaminated foodstuffs are usually the culprit for human infection. 
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The handling of poultry is believed to be the focal route of infection with respect 
to developed countries (Gormely et al., 2008). When assessing Campylobacter 
infections in Ireland, the most pressing risk factor appeared to be consumption 
of chicken. Other factors to consider include other foodstuffs, such as lettuce and 
“fast food” as well as contact with sheep, bowel problems, hiatus hernia, peptic 
ulcers and consumption of bird pecked milk (Danis et al., 2009; Moore and 
Rooney, 2010). A case-control study in Sweden revealed an increase in 
campylobacteriosis infection concerning key risk behaviours including the 
consumption of unpasteurised milk, boned pork, barbecuing, hen/chicken 
breeding and farming (Studahl and Andersson, 2000). The above reiterate the 
potential risks associated with actions such as undercooking foodstuffs alongside 
other risk factors which may lead to an increased risk of the C. jejuni persistence 
in communities.  
 
 
2.1.3 Historical aspects of Campylobacter 
 
Although Campylobacter species were not acknowledged as being pathogenic to 
humans until the 1970s, they were likely to have been observed prior to this by 
the German paediatrician, Theodor Escherich. A spiral bacteria present in the 
colons of infants who had died from enteric disease, which was referred to as 
“cholera infatum”. He then attempted to culture these microorganisms from the 
stool samples, and was unsuccessful. This was likely to be due to the fastidious 
nature of campylobacters (Escherich, 1886). 
 
Additionally, campylobacters have been associated with veterinary disease. 
During 1909, two veterinary surgeons, McFadyean and Stockman repeatedly 
isolated unknown isolates originating from aborted ewe foetuses, resembling 
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vibrio characteristics with respect to morphology. They also presumed that the 
resultant infection was caused by entry into the mouth as opposed to other 
possible routes such as the genital tract (McFadyean and Stockman, 1913). 
Later in 1919, Smith isolated a bacterial species whilst investigating bovine 
abortions and was defined as Spirillum. Further work was undertaken, resulting 
in the species being termed “Vibrio fetus”, owing to the morphological aspect 
and the isolation from a foetal origin (Smith, 1919; Smith and Taylor, 1919). 
Additionally, an organism termed Vibrio jejuni associated with winter dysentery 
in calves by Jones et al. (1931), was found to be very similar to an organism 
reported dysentery (Doyle (1944). 
Following on from these microorganisms being established as veterinary 
pathogens, the first definitive human case was not identified until 1938, cases 
originating from a milk-borne originating enteritis outbreak. The species “V. 
jejuni” was identified in 10% of cases documented (Levy, 1946). Later in 1959, 
Florent categorised two distinct types of V. fetus according to their biochemical 
and pathogenic individualities, called V. fetus venerealis and V. fetus intestinalis 
(Florent, 1959). 
 
Eventually, the genus Vibrio changed to Campylobacter, encompassing these 
species which were observed to be different than those in the Vibro genus. C. 
fetus and C. bubulus were two species which were immediately placed in the 
Campylobacter genus, based upon their microaerobic needs and also the low 
DNA base composition (Sebald and Véron, 1963). After this, there were many 
isolates confirmed as belonging to the Campylobacter genus, also aided by the 
development of a filtration technique facilitating the isolation of Campylobacter 
species from faecal samples (Dekeyser et al., 1972). This was also assisted with 
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development of selective isolation media particular to Campylobacter species as 
well as equipment and methodology advances tailored for the microaerobic 
requirements necessary for isolation (Skirrow, 1977).  
 
 
2.1.4 Complications of Campylobacter infection 
 
Manifestations of infection related complications arise if Campylobacter spp. 
disseminates from the gastrointestinal tract. Infections local to this including 
appendicitis, pancreatitis and cholecystitis can occur with haemorrhaging (Allos, 
2001). Rarer still, other complications, namely meningitis, endocarditis, 
osteomyelitis and bacteraemia can occur as a result of Campylobacter infection, 
with the latter generally seen in around 1% of cases. These issues are naturally 
more prevalent in individuals who are at either end of the age spectrum or those 
of whom are immunocompromised (Allos, 2001).  
 
Guillain-Barré syndrome (GBS), a leading case of acute flaccid paralysis can also 
occur as a result of post-infectious complications, and in the minority of cases 
can prove to be fatal (Moore et al., 2005). Compared to other complications 
associated with C. jejuni infection, GBS is understood to be the most abundant 
serious issue. There are between 0.6 and 4 cases per 100,000 population per 
annum worldwide (Hughes and Rees, 1997). More recent and vigilant European 
population-based studies revealed an incidence of 1.2-1.9 cases per 100,000 
individuals (Hughes and Cornblath, 2005). A review conducted by Poropatich et 
al. (2010) of previously published findings of GBS rates in patients before and 
during Campylobacter infections indicated that approximately 31% of GBS cases 
arose from Campylobacter species. 
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 Following the eradication of the poliovirus, GBS has become the most 
widespread cause of paralysis at a neuromuscular level (Nachamkin et al., 
1998). This autoimmune disorder affects the peripheral nervous system and is 
characterised by atypical sensations involving numbness, tingling and weakening 
in muscles. The disease is self-limiting and generally individuals are observed as 
recovering completely (Nachamkin et al., 1998). However, approximately 15-
20% of those affected appear to succumb to permanent neurological defects 
which are deemed severe, post recovery from the initial infection (Nachamkin et 
al., 1998). 
 
Miller Fisher Syndrome (MFS) is a variant of GBS which is characterised by loss 
in coordination, tendon reflexes and paralysis of muscles in the eye. Similarly to 
GBS, MFS is perceived to be a molecular mimicry of C. jejuni glycoconjugates 
and host cell gangliosides (Ang et al., 2001; Ang et al., 2002). MFS is thought to 
account for approximately 5% of all GBS cases worldwide (McGrogan et al., 
2009). As is often the case, within various regions/continents the proportion of 
cases attributable to MFS may be greater or smaller than predicted. A study 
assessing children admitted to two Hong Kong hospitals over a from 1976-2008, 
revealed 9% of GBS cases as MFS (Ma et al., 2010).In contrast, a paediatric 
sample from Argentina showed only 3 of the 179 (1.6%) of GBS cases were 
characteristic of MFS (Buompadre et al., 2006). 
 
Reactive Arthritis (ReA) can also arise from C. jejuni and other microorganisms 
(e.g. Salmonella spp.) which are concerned with infections found primarily in the 
gut or urogenital tract (Hannu et al., 2002).  This spondyloarthropathic disorder 
results in tissue and joint inflammation following infection (Townes, 2010). A 
mean incidence of ReA has been reported to be 9, 12 and 12 per 1000 
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worldwide for Campylobacter, Salmonella and Shigella, respectively (Ajene et 
al., 2013).  
 
The acute cases of gastroenteritis which result from Campylobacter infection can 
occur from an infectious dose ranging from as little as 500-800 bacteria cells 
(Robinson, 1981; Black et al., 1988). The associated diarrhoea that 
Campylobacter causes is known to last for up to two weeks after initial infection, 
however in the vast majority of cases; the symptoms diminish after one week 
post infection (Young et al., 2007). 
 
Prognosis is generally good with Campylobacter enteritis and in the absence of 
chemotherapy; faeces are still deemed Campylobacter positive from around 2-7 
weeks after the illness. Patients with acute Campylobacteriosis, or have 
presented persistent fever, bloody diarrhoea, greater than 8 bowel movements 
per day or have over 7 days of persistent diarrhoea, will necessitate undergoing 
antibiotic therapy (Butzler, 2004).    
 
Also, patients who are immunocompromised (I.e. HIV-positive individuals) 
and/or pregnant should receive antibiotic treatment following Campylobacter 
infection (Allos, 2001). In terms of antibiotics available, erythromycin is the drug 
of choice due to its effectiveness, low cost of manufacture and also the low 
toxicity when administered correctly (Butzler, 1992; Skirrow, 1977; Crushell et 
al., 2004; Salazar-Lindo et al., 1986).  
 
The potential clinical manifestations of diseases which can arise from C. jejuni 
infections highlight the importance of reducing this problematic microorganism. 
Although the incidences of these complications are low, the developments of 
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novel alternative strategies are needed in order to decrease the likelihood of 
these resultant diseases.   
 
2.2 Survival mechanisms 
 
2.2.1 Biofilm Formation 
 
The formation of bacterial biofilms is one survival mechanism employed in the 
presence of environmental stresses. Campylobacter spp. are able to form 
biofilms in three different forms whilst in liquid culture. There is an initial 
attachment to a given surface, an unattached aggregate and also pellicle 
formation. It is important to mention that all three types of biofilms seem to 
resemble one another when observed under scanning electron microscopy 
(Joshua et al., 2006). Past studies have reported that, when Campylobacter 
strains form biofilms, a decrease in antimicrobial susceptibility is present (Joshua 
et al., 2006; Kalmokoff et al., 2006). As biofilms often facilitate numerous 
microorganisms, such as Campylobacter species to survival in harsh 
environments which are not normally favourable and/or tolerable, this 
mechanism is invaluable towards persistence and subsequent colonisation of 
intestinal tract in both avian and animal hosts leading to further issues (Siringan 
et al., 2011). 
 
Biofilm development of C. jejuni NCTC 11168 in microaerobic (5% oxygen, 10% 
carbon dioxide) and aerobic conditions (20% oxygen) after three days was 
assessed in wild-type and mutant variants of C. jejuni (Reuter et al., 2010). 
Biofilm formation by non-motile variants was found to be lower than that of the 
motile flagellated strain. Interestingly, under aerobic conditions a greater 
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development of biofilm was observed as opposed to strains under microaerobic 
conditions, customarily allowing for luxurious growth of C. jejuni (Reuter et al., 
2010). Also, once the biofilms had formed, dissemination of viable planktonic C. 
jejuni cells was identified in the culture supernatant which was non-dependent 
upon the concentration of oxygen. This implies a passive release of cells into 
suspension instead of a mechanism regulated by changes from a desired 
microaerobic to an aerobic environment. Thus, it appears that C. jejuni biofilms 
facilitate the release of cells and can be thought of as reservoir when exposed to 
unfavourable conditions, and therefore is an important mechanism of survival 
(Reuter et al., 2010). 
 
Moreover, protection of C. jejuni via formation of flocs has been documented in a 
study investigating the survival of flocs and planktonic cells in a range of strains. 
Essentially, cells incorporated in the biofilms were seen to survive for twice as 
long as free planktonic cells; of 24 and 12 days, respectively. This highlights the 
persistence of C. jejuni during a biofilm state may contribute to an enhanced 
degree of pathogenesis (Joshua et al., 2006). 
 
It is thought that the ability of Campylobacter spp. to persist as a biofilm 
reservoir may lead to initial contamination in poultry. A study involving the use 
of C. jejuni cultured cells which were adherent to agar (biofilm model) was 
compared with that of C. jejuni cultured in broth (planktonic model) given to 1 
day old broiler chicks, (after which cecal contents were analysed post 12 days.). 
3-4 log cfu/ml-1 increases were observed from the initial starting inoculum (105 
cfu/ml-1), as opposed to the chicks receiving the broth cultured C. jejuni.  This 
implies that the phenotype may allow for differences in colonisation and 
therefore the virulence of C. jejuni (Hanning et al., 2009). 
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Another study by Hanning et al. (2008) investigated whether survival of C. jejuni 
outside the host was increased when pre-formed biofilms were formed. C. jejuni 
was inoculated into four biofilms and incubated at three temperatures prior to 
testing these encapsulated cells against planktonic cells cultured in a broth 
medium. Overall, the survival of C. jejuni after integration with biofilms 
appeared to have an increased survival capacity as oppose to those cells 
cultured in broths. This may be been due to the differences in temperatures 
when incubating the samples. Thus, to some extent it was found that pre-
integration to biofilms may allow for C. jejuni to survive for a longer period of 
time, highlighting once more that biofilms may be the precursor to transmission 
and prevalence of this pathogen (Hanning et al., 2008). 
 
2.2.2 Resistance to Bile Salts 
 
 There are several virulence factors associated with the induction of 
gastroenteritis and therefore the pathogenicity (Deun et al., 2007). It is thought 
that resistance to bile salts is an important factor which can enable C. jejuni to 
become more virulent (Malik-Kale et al., 2008). A study conducted by Lin et al. 
(2003) investigated the multidrug efflux pump in C. jejuni. This pump 
contributes to the resistance of C. jejuni against various antimicrobial 
challenges. Activation of the cmeABC operon which encodes the proteins 
involved in the efflux pump was seen to increase the resistance of C. jejuni to 
various bile salts. Additionally, with regards to the sections of chicken intestine, 
a correlation was observed between the overall bile concentration and 
Campylobacter. Conversely, cmeABC knock-out mutants failed to colonise the 
intestinal tract of the chickens inoculated with Campylobacter. 
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2.2.3 Cellular Invasion and Adherence  
 
Invasion of C. jejuni into the epithelial cells within the intestine must also be 
considered when concerning pathogenesis (Deun et al., 2007). A study by Hu et 
al. (2008) aimed to determine the degree of interaction and also the 
translocation across differentiated Caco-2 cells. Both adherence and invasion 
was greater with in the case of INT407 cells with two thirds of these cells being 
subject to invasion over a two hour time period. However, in the case of Caco-2 
only, 11-17% of host cells were found to have been invaded over the same 
period of time. 
 
Nevertheless, when a supposed global posttranscriptional regulator; csrA was 
mutated in C. jejuni 81-176 strain and compared to the wild-type which 
possessed this gene, various differences were observed between the two strains. 
An example of this was that the csrA mutant less able to deal with and survive 
oxidative stress, whereas the wild-type strain appeared to have less 
susceptibility. To add to this, CsrA presence allowed for an increase in both 
adherence to and invasion of INT407 intestinal epithelial cells. This re-iterates 
the importance of such regulatory genes in the ability of C. jejuni to be 
pathogenic (Fields and Thompson, 2008). 
 
Cell attachment and invasion have also been seen to be inhibited by various 
compounds. For example, a study investigating the invasion and adherence of C. 
jejuni upon Caco-2 cells at numerous concentrations of sugars and other 
chemicals was undertaken. At concentrations of 0.3 and 0.5 M of sugars 
including D-glucose, D-mannose and D-fucose, an inhibition in cell attachment 
and invasion was observed, conversely, when L-sugars were tested this 
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inhibition was not observed indicative of specificity. Additionally, an inhibition of 
cell attachment was observed at 4oC which was similar to a marginally decreased 
cell invasion and attachment in cells with a lack of potassium. This indicates that 
the degree of invasion and attachment are dependent upon resources which C. 
jejuni and other bacteria species alike utilise in order to increase pathogenicity 
(Russell et al., 1994). 
 
 
2.2.4 Invasive and non-invasive Campylobacter 
 
With adhesion and subsequent invasion of epithelial cells being the most 
imperative pathogenic mechanisms of Campylobacter diarrhea, isolates which do 
not occupy these virulence factors lack the ability to cause disease. A study 
assessment of the molecular characterization of invasive and non-invasive 
Campylobacter isolates from children with diarrhea and symptom free using 
random amplified polymorphic DNA techniques (RAPD) revelaed a distinct band 
of 1.6kb of DNA which was more prevalent in invasive isolates (63%) compared 
to that of non-invasive isolates (16%). This band was named the invasion-
associated marker (IAM), and with specific primers, a 518bp fragment of the 
IAM locus was amplified. The degree of amplification was again higher in the 
invasive coupled with the non-invasive isolates, typical of 85% and 20%, 
respectively (Carvalho et al., 2001). 
 
 
2.2.5 Survival at an intracellular level 
 
After colonising the mucosal layer of the intestines, Campylobacter species can 
gain entry to the intestinal epithelial cells and use this as a survival mechanism. 
Inflammation and subsequent diarrhoea present upon infection (Park et al., 
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2002). Once inside intracellular compartments, the degree of persistence is 
increased which thought to be attributable to the changing  physiological 
processes Although C. jejuni can survive in the epithelial cells of the intestine, 
subsequent recovery was required involving specific oxygen-limited culturing 
conditions (Watson and Galán, 2008). 
 
Generally it has been observed that C. jejuni loses viability after a 24 hour 
period after invasion into intestinal epithelial cells (Day et al., 2000). C. jejuni 
also enter macrophages through the action of upon being phagocytosed. In vitro 
invasion and survival of C. jejuni within mononuclear phagocytes can be 
observed under microscopy, with C. jejuni cells undergoing transformation into 
the coccoid form, as opposed to the more uniform spiral shape. Human 
monocytes were seen to demonstrate a greater efficiency of C. jejuni ingestion 
when compared to the murine equivalent monocytes. C. jejuni cells were seen to 
survive for up to seven days in mononuclear phagocytes (Kiehlbauch et al., 
1985). 
 
 
2.2.6 Responses to Environmental Stressors 
 
With the limited ability for C. jejuni to grow in various environmental conditions, 
there is a necessity for the exploitation of specific nutritional requirements. 
Intermediates of the tricarboxylic acid cycle appear to be an alternate energy 
source, as opposed to carbohydrates which C. jejuni cannot metabolise (Stahl et 
al., 2012). This leads to the hypothesis that C. jejuni, unlike many Gram 
negative bacteria, are very sensitive to environmental stresses, as  it seems to 
lack appropriate responses, notably the global regulator gene RpoS which 
oversees the adaptation to environmental challenges (Parkhill et al., 2000).  
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As a result of this, the utilisation of amino acids is paramount in order for C. 
jejuni to thrive within the host gastrointestinal tract. Campylobacter spp. also 
have the ability to exert adaptive responses to increases in acidity by the 
transformation to a viable but non-culturable (VBNC) cell morphology (Murphy et 
al., 2003; Chaveerach et al., 2003). With the vast majority of Campylobacter 
spp. being deemed microaerophilic, they are over sensitive to aerobic 
environments and as such have various regulators i.e. the transcription regulator 
Cj1556, in order to overcome such stresses (Gundogdu et al., 2011; Dasti et al., 
2010). 
 
Heat shock proteins are a co-regulated group of proteins which allow for 
numerous organisms to overcome exposure to the physiological stress of an 
increase in temperature, deviating from the optimum range of 37-42°C (Konkel 
et al., 1998).  Genes which encode GroESL and DnaJ can be synthesised 
following exposure to extremes in temperature (amongst the 24 proteins which 
have been previously characterised) (Konkel et al., 1998; Thies et al., 1999). 
Mutants deficient in certain heat shock proteins are more susceptible to 
increases in temperature outside the optimal growth conditions. Overall growth 
of C. jejuni was seen to be diminished at 46°C and was not able to be isolated 
from infected chickens (Dasti et al., 2010). Expression of proteins driven by the 
RacRS regulon, a two-component heat shock regulatory system appeared to 
dictate the quantity of expression at 37oC and 42oC (Bras et al., 1999). Also, it is 
thought that the majority of bacteria also utilise osmo-regulatory mechanisms, 
although these systems have not yet been found in Campylobacter species 
(Parkhill et al., 2000). 
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2.3 Virulence factors 
 
2.3.1 Motility and Chemotaxis  
 
In order for an organism to be motile and present a chemotactic response to and 
from a stimulus, flagella are required. C. jejuni is no exception, possessing a 
polar flagellum composed of O-linked glycosylated flagellin (Thibault et al., 
2001). This facilitates the attachment of C. jejuni cells onto epithelial cells within 
the intestine which is crucial to the colonisation and subsequent pathogenesis 
(Dasti et al., 2010; Wassenaar et al., 1993).  
 
Basic flagella structure consists of a minimum of three parts, the rotary motor 
integrated into the cell wall matrix, a hook and helical propeller at outer most 
region (Minamino et al., 2008). The colonisation is dependent upon the presence 
of flagellin, comprising of both flaA and flaB subunits, which are subject to 
antigenic and phase variation alike (Wassenaar et al., 1993; Caldwell et al., 
1985; Harris et al., 1987 Nachamkin et al., 1993). 
 
Defects of O-linked glycosylation can lead to a total suppression in motility 
function, which thus decreases the likelihood of host cell adherence and 
subsequent invasion of the epithelial cells (Dasti et al., 2010). Non flagellated 
mutants have shown to be unable to colonise the intestinal cells, whilst the wild-
type C. jejuni cells were seen to colonise this environment (Guerry et al., 1992; 
Yao et al., 1994).  
 
A study using three chemotactic mutants which were previously assessed in 
terms of motility utilising semi-solid medium were not found to exert any 
32 
 
chemotactic responses to known chemo-repellents and chemo-attractants 
compared to the wild-type C. jejuni. All mutants generated were motile and thus 
had intact flagella. According to video tracking, the mutants did not appear to 
undergo the classic tumbling which the wild-type strain expressed. Suckling mice 
were orally given approximately 105 CFUs of the mutant strains and 102 CFUs of 
the wild-type strain separately. After 48 hours, the wild-type strains were seen 
to colonise the intestinal tract, whereas mutant strains lacked the ability to do 
so. Thus, the chemotactic movement was assumed to be partially responsible for 
the degree of colonisation, accounting for the virulence of the particular strain 
(Takata et al., 1992).  
 
Whilst motility appears to a key aspect for colonisation, invasion and adherence, 
the degree of viability of Campylobacter jejuni can also vary. Black et al. (1988) 
fed 111 human volunteers a mixture of motile and non-motile variants of 
Campylobacter jejuni. Also in recovering isolates from the stool samples 
provided by the human subjects, only the motile forms were recovered. This 
implied that motility was an important factor which is required for colonisation of 
intestines. Interestingly, a study using C. jejuni 8116 and A3249 strains were 
shown to possess two-way transitions between aflagellated and flagellated 
phenotypes, with an increase in the ability of the C. jejuni to successfully 
passage through rabbit intestine in the latter case (Caldwell, et al. 1985). 
 
 
2.3.2 Quorum sensing/cell signalling  
 
Numerous bacteria are able to communicate via small signalling molecules, 
coined autoinducers (AI). Bacteria are able to regulate gene expression which 
33 
 
can ultimately affect their degree of virulence and constituting to adaptation as 
well as their colonisation potential (Gölz et al., 2012).  
 
In order to produce a type of AI (AI-2), C. jejuni NCTC 11168 has been found to 
possess a gene which encodes an ortholog of luxS. When a luxS mutant was 
tested in comparison to C. jejuni expressing this gene, the latter strain was seen 
to have a higher degree of motility indicative of the diameter of haloes in 
semisolid agar medium. However the growth rate, Caco-2 invasion and oxidative 
stress susceptibility remained consistent between strains. This suggests that 
motility may be governed by quorum sensing, typical of the cellular 
communication (Elvers and Park, 2002).  
 
Similar results were observed in a study investigating if C. jejuni biofilms are 
facilitated when quorum sensing is present. This experiment also used the luxS 
mutant, which was deficient AI-2 production. Here, a reduction in biofilm 
formation was observed at both 48 and 72 hours when comparing the luxS 
mutant strain to that of the wild-type. Interestingly, when confirming this 
finding, with an addition of culture supernatant fluid (CSF) to luxS mutant 
cultures, collected from wild-type cultures which had quorum sensing molecules 
present, an increase in biofilm formation of the luxS mutant was observed. Once 
more, growth was found to be the same as that of the wild-type and was not 
responsible for these data (Reeser et al., 2007).  
 
Given that C. jejuni contains a homologue of the luxS gene, which has seen to 
be responsible for the AI-2 production, a study was investigated if AI-2 acted as 
a signal in quorum sensing and thus alters gene expression of C. jejuni. AI-2 
was seen to be produced by the strain NCTC 11168 when cultured in Mueller 
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Hinton broth, opposed to none in to a more defined medium (Modified Eagles 
Medium, or MEM-α). Motility assays incubated at 37oC revealed a decrease in 
swarming with respect to the luxS mutant compared to the NCTC 11168 strain. 
In addition, analysis of microarray comparing wild-type and luxS mutants 
indicated that mRNA transcription was dependent upon the broth medium used 
to cultivate the initial samples. Also, exogenously produced AI-2 was not 
reported to cause differences in expression between the luxS and wild-type 
strain (Holmes et al., 2009). Although this decreased swarming on Mueller 
Hinton soft agar was also observed in another study, using C. jejuni 81-176 luxS 
null mutant (Delta luxS), in comparison to the wild-type strain, at 42°C indicated 
that there was no difference (He et al., 2008). 
 
 
2.3.3 Toxin production  
 
When discussing C. jejuni mediated enteritis, it is typically thought that toxins 
play a major role in this pathogenesis, and the various toxic activities have been 
described   (Dasti et al., 2010). 
 
The production and subsequent secretion of cytolethal distending toxin (CDT) is 
important for virulence of a pathogen and a number of species of Campylobacter 
(e.g. C. jejuni, C. coli, C. fetus) are known to produce this toxin (Mooney et al., 
2001; Konkel et al., 2001) which was first observed in a study by Johnson and 
Loir, (1988). In this study, various cell-lines such as Vero, HeLA, Hep-2, Caco-2 
were found to be susceptible as a result of swelling and elongation to 
approximately five times relative to the normal size was observed. Ultimately, 
the exposed cells underwent disintegration (Johnson and Loir, 1988; Whitehouse 
et al., 1998; Lin et al., 2003). Despite CDT being an important virulence factor 
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for C. jejuni, other cells for instance mouse Y-1 adrenal cells do not exhibit 
distension when exposed to this toxin from C. jejuni (Johnson and Lior, 1988; 
Dasti et al., 2010). 
 
2.4 Antimicrobial resistance 
 
 
Resistance to various components perceived be resultant from efflux 
mechanisms or plasmid transfer, have been previously documented (Padungton 
and Kaneene, 2003; Alfredson and Korolik, 2007). 
 
Multidrug efflux pumps, CmeABC and CmeDEF are present in C. jejuni and are 
thought to be paramount in allowing resistance to be established to a variety of 
antimicrobial agents (Lin et al., 2002). CmeABC is known to be more widespread 
in both C. jejuni and C. coli alike, with the CmeDEF being less prolific due to 
reduced gene expression levels regarding the CmeDEF genes (Payot et al., 
2006). Nevertheless, these efflux pumps are said to interact with CmeABC, 
conferring resistance to antimicrobials and toxic agents. The CmeDEF efflux 
pump is perceived to function as a secondary efflux mechanism (Akiba et al., 
2006). 
 
Insertional mutagenesis of the gene CmeB was seen to decrease the tolerance 
towards antibiotics including flouroquinolones, erythromycin, chloramphenicol, 
ampicillin and tetracycline (Lin et al., 2002; Pumbwe and Piddock, 2002). 
Inactivation of other presumed efflux pumps, for example RND and CmeDEF, 
were not seen to inhibit resistance to erythromycin, chloramphenicol, ampicillin, 
tetracycline and ciprofloxacin (Ge et al., 2005; Pumbwe et al., 2005). However, 
a study by Akiba et al. (2006) showed resistance to the antibiotics ciprofloxacin 
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and tetracycline with respect to the interaction between the CmeABC and 
CmeDEF protein operons in various strains. Thus, an inhibition in efflux pumps 
described in C. jejuni may have promising benefits in curbing antibiotic 
resistance (Quinn et al., 2007). 
 
Often, fluoroquinolones such as ciprofloxacin are used in the treatment of a 
patient with symptoms of Campylobacter infection. Despite being effective, 
fluoroquinolone resistance has been observed in many regions of Europe 
(Piddock, 1995), South America (Fernandez, 2001), North America (McDermott 
et al., 2002) and Asia (Murphy et al., 1996). 
 
Resistance to quinolones was investigated in Campylobacter isolates obtained 
from individuals during a six year time period. The 4953 isolates were tested for 
resistance to nalidixic acid along with the resistant and sensitive isolates also 
being tested for ciprofloxacin resistance. The number of isolates resistant to 
quinolone was found to be 10.2% in 1998 (in comparison to 1.3% in 1992). The 
increase in resistance of the isolates obtained over the period of 1996-1997 was 
partially attributable to foreign travel and also the individuals’ use of quinolone 
before stool sample collection. Despite these factors thought to play a role in the 
increase in resistant population of Campylobacter isolates, the use of quinolone 
was found to account for a 15% of these cases from 1996-1998, in which the 
increase in quinolone resistance was also observed in domestic originating 
samples (Smith et al., 1999). With travel and prior quinolone use being 
important considerations in the resistance observed, the use of fluoroquinolones 
in the poultry processing was assumed to have a fundamental role in the 
increased likelihood of the resistant isolates from human origin. 
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2.5 C. jejuni Genetics 
 
The concept of bioinformatics, first coined in 1978, involves the study of 
biological systems utilising computer-based processes (Hogeweg, 1978; 
Hogeweg and Searls, 2011).  The primary use of bioinformatics has been for 
studying the genetic content within organisms of interest. Essentially, the 
development of in silico models which show degrees of complementation for in 
vitro and in vivo experimentation is the proposed outcome of bioinformatics as a 
whole (Cohen, 2004). With the rising number of completed microbial genome 
sequences, there is a necessity for the exploitation of the vast quantities of data 
generated through bioinformatics (Paine and Flower, 2002). 
 
The primary use of bioinformatics lead to the genome sequencing of C. jejuni 
NCTC 11168 has exposed limited mechanisms by which enable the organism to 
become diverse from a genetic perspective. C. jejuni NCTC 11168, unlike the 
vast majority of pathogenic strains which have previously been sequenced 
contain a very small amount of repeat sequences, transposons or presence of 
phage associated sequences (Parkhill et al., 2000; Dorrel et al., 2001). 
 
C. jejuni NCTC 11168 was the first Campylobacter species to be sequenced, 
encompassing a circular chromosome containing 1,641,481 base pairs (bp) 
encompassing a more recent estimation of 1,642 coding sequences in 
comparison to the previously value 1,654 originally stated in the first annotation 
of this organisms genome (Gundogdu et al., 2007; Parkhill et al., 2000). Other 
strains of Campylobacter have also been successfully sequenced including C. 
jejuni RM1221 (Fouts et al., 2005) and C. jejuni 81-176 (Hofreuter et al., 2006). 
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Campylobacter species are recognised as having AT-rich content within their 
genome along with a low GC content of approximately 32.5%, dependent on 
species (Taylor et al., 1992; Taylor et al., 1983). The genomic content of C. 
jejuni NCTC 11168 is very dense in relation to other species which have been 
sequenced. It has been deduced that 94.3% of this genome is believed to 
encode proteins. Additionally, the hypervariable sequences can render a high 
frequency of gene expression changes, thus allowing phase variation of genes 
responsible for biosynthesis and modification of structural surfaces (Parkhill et 
al., 2000). 
 
 
2.6 Chitosan  
 
2.6.1 Antimicrobial activity  
 
 With an ever increasing requirement for novel antimicrobials, there are a 
number of alternatives which may be used in order to meet desired antimicrobial 
strategies. In recent years, various biomolecules including chitosan have been 
undergoing integration within the food industry. As there have been numerous 
outbreaks of bacterial contamination in food products, there is a need for control 
of pathogens in order to address concerns from a public health perspective. The 
biodegradability and non-toxic properties which chitosan presents, allow for 
appropriate use with respect to the food, pharmaceutical, cosmetics and 
agricultural industries whether alone or in conjunction with other natural 
antimicrobials. (Dutta et al., 2012, Kim et al., 2005; Mohire and Yadav, 2010; 
Suman et al., 2011; Gaspar et al., 201; Kong et al., 2010). 
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Chitosan is a collective term for natural biopolymers derived from a deacetylated 
precursor; chitin.  This biopolymer was first proposed by Allan and Hardwiger 
(1979) as having a broad antimicrobial activity against a variety of bacterial and 
fungal species alike, which has led to great scientific interest over recent years 
(Xu et al., 2007; Kong et al., 2010). Additionally, these biopolymers are 
integrated into various commercial settings and are of great potential mainly 
because they are considered GRAS, according to the Food and Drug Association 
(FDA, 2001). 
 
The aminopolysaccharide chitin is a naturally abundant in nature, being a 
primary component of an arthropod skeletal structure.  Chitin is a copolymer of 
β-(1-4)-linked N-acetyl-D-glucosamine and D-glucosamine and is difficult to 
dissolve. However, the deacetylated form, chitosan can be dissolved in various 
dilute organic acids (e.g. acetic, formic) forming a fluid of a non-Newtonian and 
shear-thinning nature (Thanh et al, 2007). Moreover, chitosan is the second-
most ubiquitous polysaccharide on earth, and is often classed as a derivative of 
cellulose (the most ubiquitous) despite chitosan being absent from organisms 
which produce cellulose (Dutta et al., 2004). Structurally, is it identical to 
cellulose except the acetamide (-NHCOCH3) on the C-2 position (Figure 2.1).  
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Figure 2.1: The structural similarities of cellulose and chitin, chitosan and cellulose (Allan et al., 
1977).   
 
 
Chitosan is mass produced commercially in many parts of the world including the 
United States, Poland, India, Norway, Russia and Japan (Singla and Chawla, 
2001). Leading on from this, there is an estimated 109 - 10
10 tons of chitosan 
produced per annum (Peter, 1997). Regardless of the encouraging applications 
of these biopolymers, there is a limited understanding as to the mode of action 
of chitosans relating to their antimicrobial nature. It has been argued that the 
mode of action is due to the cationic (possession of positively charged NH3 
groups) nature, interacting with the negatively charged bacterial cell surface, 
amounting to a disturbance of microbial activities (Raafat et al., 2008; Helander 
et al., 2001; Je and Kim, 2006; Zakrzewska et al., 2005). It had also been 
suggested that characteristics, for instance, water binding capacity, chelation of 
trace metals and the interaction with DNA may also be involved with the 
antimicrobial mode of action (Raafat et al., 2008; Rabea et al., 2003). 
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The antimicrobial efficiency of chitosan biopolymers and their constituent 
components may be subject to intrinsic and extrinsic factors, notably molecular 
weight (MW), degree of deacetylation (DD), presence or absence of cations, pKa, 
pH and the microorganism exposed (Kong et al., 2010). Generally, it is assumed 
that chitosan exhibits a higher antibacterial activity towards Gram positive 
bacteria compared to Gram negative species (Jia et al., 2001).  
 
The utilisation of chitosan in a solid state involves beads, fibres, films and 
hydrogels which are predominantly aimed towards biomedical perspective use 
(Kong et al., 2008; Kong et al., 2010). The effects of chitosan in a solid-state 
have received little attention, including determining the mode of action in this 
form (Kong et al., 2010).  
 
2.6.2 Molecular weight 
 
The molecular weight (Mw) of chitosan has been shown to influence its 
antimicrobial efficiency in some studies. For example, an increased antimicrobial 
efficacy of chitosan was observed with increasing Mw ranging from <5 kDa to 
305 kDa against S. aureus. However, the opposite was seen in the case of E. 
coli, with an apparent decrease in activity with an increase in Mw (Zheng and 
Zhu, 2003). 
Another study tested three chitosans with different Mw which were applied to 
cotton fabrics. When comparing the antibacterial activity those with a Mw of 
100kDa and 210kDa were seen to inhibit S. aureus growth at 0.5% (w/v), 
whereas with the lower Mw chitosan (1.8kDa), the concentration needed was 
greater (1.0% (w/v)) for the same level of growth inhibition. A similar trend was 
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observed when applying these chitosans to E. coli, with a greater concentration 
needed for the inhibition (0.3% (w/v)) for the 100kDa and 210kDa chitosan, as 
opposed to a 0.5% (w/v) concentration required for the 1.8kDa chitosan. These 
findings indicated an increase in bacterial growth inhibition with an increase in 
Mw (Shin et al., 2001). 
 
Another experiment involving six different types of chitosan including six 
oligomers, of different Mws were tested against a variety of Gram positive and 
Gram negative bacteria. All species illustrated growth inhibition, which appeared 
to be Mw and species dependant. According to the MIC values, in the case of the 
Gram negative bacteria, chitosan with a greater Mw (470 kDa) was seen to have 
a greater antimicrobial effect, in contrast to chitosan of 1106 kDa. In contrast, 
1106kDa was seen to be inhibit Lactobacillus plantarum, Lactobacillus bulgaricus 
and Lactobacillus brevis to a greater extent (MIC 0.05-0.08% (w/v)), compared 
to a smaller Mw of 470 kDa, with an MIC value of 0.01% (w/v) or over required 
for inhibition. Interestingly, this trend was not observed with the extremes in 
chitosan Mws. Generally, when comparing the MIC values regarding chitosan of 
1671 kDa and 28 kDa Mw, values were found to be identical, for instance the 
values the Gram negative species, Pseudomonas fluorescens having an MIC of 
0.1% (w/v). This was also the case with the Gram positive species, Listeria 
monocytogenes (No et al., 2002). 
 
In addition, an antibacterial study on E. coli was carried out with chitosans of 
different Mws (5.5×104 to 15.5×104 Da) with a similar degree of acetylation 
(80%±0.29).  Antimicrobial action was observed at concentrations greater than 
200ppm (0.02% (w/v)), and growth below this. The antimicrobial activity 
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appeared to be relative to the Mw, as previously described. Here, the lower the 
Mw, the higher the antimicrobial effect against E. coli. Additionally, the activity 
of chitosan was also found to be Mw dependant at lower concentrations ranging 
from 50 to 100 ppm. At the median Mw (9.0×104 Da) bacterial reduction was 
not apparent. Also, when introduced earlier with respect to growth stages, a 
greater activity of chitosan was observed. The mode of action of chitosan against 
this particular microorganism was deduced as flocculation (Liu et al., 2006). 
 
In a study assessing the antimicrobial efficiency of three different chitosans, 
each with different Mws against three Gram positive and six Gram negative 
species of bacteria; the Gram negative species were found to be less susceptible 
and thus indicative of a lower antimicrobial activity of the chitosans. However, 
the most sensitive Gram negative species was found to be Campylobacter spp., 
independent of chitosan Mw. Additionally, the MIC of the chitosans against the 
Campylobacter spp. varied from 0.005-0.05% (w/v), indicating a high sensitivity 
towards these biopolymers. The physical effects to the bacterial cells upon 
exposure of chitosan were indicative of a loss in the membrane integrity. This 
study highlights the promising antimicrobial effects of the chitosan towards 
Campylobacter spp. as well as the other species (Ganan et al., 2009). 
 
The findings presented above highlight ambiguous results when comparing the 
antimicrobial activity based on Mw. Also, these effects appear to be heavily 
dependent on species. No dissimilarities in antimicrobial activity when comparing 
a Gram positive and Gram negative species have also been observed, with E. coli 
and Bacillus subtilis having equal sensitivities regardless of the Mw of chitosan 
used (Tikhonov et al., 2006).  
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2.6.3 Degree of deacetylation (DD) 
 
In an investigation using chitosan as a membrane purposely for separation 
engineering was undertaken, the antimicrobial activity was assessed via MIC 
values. When comparing the two organisms S. aureus and E. coli, the MIC 
values were approximately 200 and 40 (mg-chitosan/ml-bacterial suspension), 
respectively. Here, a greater antimicrobial activity of chitosan towards Gram 
positive was observed. Furthermore, this inhibition was recognised as 
bactericidal in both species, with this activity being reliant upon differences in 
membrane surface area and shape. Importantly, the DD seemed to alter the 
amount of growth, with the higher DD being indicative of greater inhibition. This 
highlights the dominant role of DD in the overall activity of chitosan biopolymers 
and useful applications which may arise when considering chitosan membranes 
(Takahashia et al., 2008). 
 
2.6.4 pH 
 
The antimicrobial activity of chitosan has been shown to vary with regards to the 
pH. The effect of lowering pH is considered to act synergistically with chitosan. 
This therefore challenges microorganisms with two hurdles, the antimicrobial 
effect of chitosan and acid stress (Aider, 2010; Rhoades and Roller, 2000). 
 
Water-solubility of chitosan is important when considering antimicrobial 
activities. Due to its poor solubility above pH 6.5, antimicrobial effects are 
thought to only be observed with an acidic medium/environment (Li et al., 
2002). Hence, the antimicrobial activity is inversely affected by an increase in 
pH, with an antimicrobial efficacy being greater at lower pH values (Qi et al., 
2004).  
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According to some findings, the reduction or complete loss of antimicrobial 
activity at pH 7 can potentially be the result of decreased solubility of the 
chitosan during preparation and also a greater abundance of amino groups that 
are positively uncharged (Aiedeh and Taha, 2001; Papineau et al., 1991; 
Sudarshan et al., 1992).  
 
2.6.5 Mode of action as an antimicrobial  
 
Antimicrobial mechanisms of chitosan have been postulated to involve the 
interaction between the substance and bacterial cells outer cellular components, 
the cytoplasmic membrane and the cytoplasmic constituents (Raafat et al., 
2009). 
 
Interactions between the positively charged chitosan molecules and the 
negatively charged microbial cell membranes are thought to contribute to leaks 
with respect to various intracellular contents (Rabea et al., 2003). At lower 
concentrations (<0.2 mg/ml), chitosan is perceived to bind to the negatively 
charged surface of the cell membrane, causing agglutination. Contrary to this, 
higher concentrations may give rise to a larger number of positive charges which 
may cause an overall net charge which is positive, thus keeping them suspended 
into solution (Rabea et al., 2003). 
Chitosan is also considered as a chelating agent whereby trace metals are bound 
and subsequently inhibit aflatoxin production in Apergillus spp. and also the 
microbial growth via the limitation of nutrient availability (Cuero et al., 1991). It 
is also postulated that chitosan can also interact with DNA. This is then thought 
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to interfere with successive mRNA synthesis and thus protein production 
(Sudarshan et al., 1992). 
2.6.6 Applications of Chitosan 
 
2.6.6.1 Chitosan films 
 
Chitosan coatings are proven not only to be edible but also low cost, non-toxic, 
non-polluting, aesthetically acceptable, providing a barrier to gasses and 
illustrate biocompatibility (Vásconez et al., 2009). As a result of these desirable 
characteristics/properties, chitosan films have been produced with particular 
application in the food industry and their ability to be utilised as food coatings 
for instance can allow for extended shelf life of numerous food related products 
(Aider et al., 2010). 
 
Antimicrobial packaging is one aspect of the process of active packaging. Active 
packaging serves as providing attributes aside from the more conventional 
remedial barrier properties used.  Ingredients are added in the packaging 
system such as functional polymers (Flores et al., 1997; Han and Rooney, 
2002). 
 
The use of antimicrobial packaging provides this inhibition or killing of spoilage 
and/or pathogenic microorganisms, which present problems both from a public 
health and a financial standpoint. In comparison to the traditional food 
packaging outcomes including extending shelf life, maintenance of quality and 
safety assurance, antimicrobial packaging primarily focuses upon controlling 
microbial load on foodstuffs. Generally these microorganisms are detrimental to 
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the above goals, as foodstuffs which have a naturally prolonged shelf life do not 
often require an antimicrobial packaging system (Han, 2000).  
 
Antimicrobial action of edible films composed of chitosan and incorporated garlic 
oil was investigated against a number of food pathogens (E. coli, S. 
aureus, Salmonella typhimurium, Listeria monocytogenes and Bacillus cereus). 
To provide a comparison to the above test conditions the conventional food 
preservatives potassium sorbate and nisin were also tested. Integration of garlic 
oil from as low as 100 μl/g, potassium sorbate at 100 mg/g or nisin at 
51,000 IU/g of chitosan was seen to be active against all of the species tested 
except E. coli. At the concentrations the films were classed as being acceptable 
with respect to visual, mechanical and physical properties. Also, the garlic oil 
incorporation did not appear to alter either the physical or mechanical properties 
of the chitosan films, since it did not interact with chitosan in the film, as 
measured by Fourier Transform Infrared spectroscopy (FTIR) (Pranoto et al., 
2005). 
 
The use of chitosan alongside other antimicrobials has resulted in synergistic 
effects in some cases which can be more appropriate for use in some 
applications. For instance, the antimicrobial effectiveness of the combination of 
chitosan and essential oil (EO) was identified both in vitro and on processed 
meat products against L. monocytogenes and E. coli O157:H7 using the agar 
diffusion assay. The four EOs tested were seen to have the following activity 
from higher to lowest: oregano >> coriander > basil > anise. Consequentially, 
chitosan films containing oregano were added onto sausage bologna (an Italian 
delicacy) samples inoculated prior to application and stored for 5 days at 10oC. 
Films which were exclusively composed of chitosan were effective producing a 2 
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log reduction of L. monocytogenes and films with 1% and 2% oregano 
accounted for 3.6 and 4 log reductions, respectively and a 3 log reduction E. coli. 
Interestingly, the addition of oregano resulted in the decreases in tensile 
strength, permeability of water and rigidity of the films. These types of films 
may be applicable in food preservation as they showed promising antimicrobial 
activities against pathogens and have further benefits due to their 
biodegradability (Zivanovic et al., 2006).   
 
2.6.6.2 Chitosan Gels 
 
Hydrogels are also a promising application of chitosan partly due to the 
additional high water content and the similarity to human tissues allowing them 
to be potentially useful for a number of biomedical applications since they are 
able to control bleeding, aid the conservation of tissue orientation and prevent 
adhesions, they lend themselves to use in postoperative healing processes (Aziz 
et al., 2012; Lim and Hudson, 2004). 
 
Chitosan dextran-based (CD) hydrogels have been investigated for application 
such as endoscopic sinus surgery. The antimicrobial effect was tested against a 
range of microorganisms which can cause pathogenesis. CD hydrogels were 
found to be successful in terms of antimicrobial activity against S. aureus, E. 
coli, Streptococcus pyogenes and Clostridium perfringens when used at a 
surgical concentration of 50,000 mg/L. Scanning and transmission microscopy 
revealed cell wall damage, morphological disruption and loss of cytosolic 
contents which the hypothesis that chitosan binds to cells wall proteins and 
disrupt peptide bonds (Aziz et al., 2012). 
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Additionally, a study carried out by Ballal et al. (2009) analysed the 
antimicrobial capacity of 2% chlorhexidine (chemical antiseptic) and 2% chitosan 
(alone and together) gels against Candida albicans and Enterococcus faecalis. 
Initially, inoculae of the microorganisms was used in order to generate bacterial 
and fungal lawn on nutrient rich agar. Wells were made in each type of agar 
plate and the gels were incorporated and incubated for 37°C for 48 hours. 
Interestingly, chlorhexidine release was greater in absence of chitosan 
(determined by UV spectrophotometry). Also, the greatest antimicrobial effect 
was observed when the combination of chitosan and chlorhexidine was present 
in the gel (25.2mm zone of inhibition for C. albicans and 26mm for E. faecalis). 
Chlorhexidine alone was seen to have the next highest antimicrobial activity 
(20.6mm and 21.4mm, respectively), and chitosan the lowest (16.6mm and 
11.0mm, respectively). Thus, chitosan gels both alone and in conjunction 
possess antibacterial and fungal effects may be of use in order to curb microbial 
persistence. 
 
2.6.6.3 Bioremediation and Drug Delivery 
 
Chitosan can also be exploited as a means of removing various substances which 
are not desirable in specific systems, for instance water remediation has a great 
An example involved the enzymatic removal of phenol compounds from model 
wastewater and the synergistic effect of mushroom tyrosinase with chitosan 
beads. Variables including pH, temperature, dosage of tyrosine and also the 
hydrogen peroxide-to-substrate ratio were all considered. A chitosan film 
incorporated in a p-crersol and tyrosinase mixture was found to adsorb quinone 
derivatives, typical of greater adsorption with the onset of immersion. 
Additionally, chitosan beads were also seen to adsorb the quinone derivatives 
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which were enzymatically generated. The percentage removal of the various 
phenol compounds increased to 93% when chitosan beads were used as 
opposed to the films (Yamada et al., 2005).  
 
 
2.6.6.4 Nanotechnology  
 
Nanomedicine as a whole consists of components at a nanometre-scale size used 
for a defined goal relating to diagnosis, treatments or prevention of disease 
(EMRC, 2004). Generally the nano-scale encompasses a size range from 1 to 
100’s of nanometres. Nanotechnology in a medical sense usually concerns drug 
carriers in the form of particles, liposomes and so forth, that play an important 
role in the delivery of active compounds (I.e. drugs), intended to target various 
sites within the body (Nagpal et al., 2010). 
 
In order to treat a number of diseases, peptides and proteins have become the 
drugs of choice due to their advantages of high selectivity and subsequent 
effective action with fewer side effects (Frokjaer and Otzen, 2005). However, 
degradation of peptide and protein drugs occurs readily, as they are susceptible 
to enzymes found within the patient along with decreased permeability across 
the ileum (Zhang et al., 2010). In an attempt to combat this, the efficiency of 
oral uptake of drugs has been tested using various surfactants, protease 
inhibitors, enteric coatings, carrier systems and permeation enhancers 
(Nakashima et al., 2004; Carino et al., 2000).  
 
Chitosan has been reported to be an appropriate candidate for use in nano and 
microparticles with respect to controlled drug release their advantages include 
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good stability, low toxicity, simple and mild preparation methods as well as 
providing versatile routes of administration (Tiyaboonchai, 2003). 
 
Mucoadhesive nanoparticles have received much attention and have promising 
concepts (Takeuchi et al., 2001). In this case the degree of mucoadhesion relies 
on the particle size and also the superficial charge.  Chitosan occupies this 
mucoadhesive property due to the cationic polyelectrolyte of this particular 
polysaccharide and has the ability to attach to the mucosal surface and 
consequently open the junction between epithelial cells (Qian et al., 2006). 
   
With the somewhat limited application of chitosan due to restricted solubility in 
acidic conditions, the use of water-soluble chitosan has also been studied. This 
type of chitosan is easily soluble in neutral aqueous solution. With the advantage 
easily modified, it can be utilised in a variety of applications including as a gene 
or peptide drug carrier. Nanoparticles consisting of water-soluble chitosan with 
sodium tripolyphosphate were tested with respect to the efficiency of uptake of 
bovine serum albumin (BSA) as the model drug. In vitro results indicated that 
the nanoparticles enhanced and prolonged the intestinal absorption of BSA. 
These results also indicated that these nanoparticles could be used as a potential 
protein delivery system (Zhang et al., 2010). 
 
2.6.6.6 Available chitosan-related products 
 
A number of products are commercially available which use the characteristics of 
chitosan. Examples include Tegasorb™ (3M, USA) and Chitopack (Eisai, Japan) 
for wound-healing, Syvek NT Patch (Marine Polymer Technologies, USA) and 
Chito-Seal (Abott Vascular Devices, USA) for haemostatic dressing. Chitosan 
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hard capsules (Aicello Chemical, Japan) have also been produced for 
gastrointestinal drug delivery (Thanh et al., 2007). 
 
 
 
 
2.7 Aim and Objectives 
 
2.7.1 Aim 
 
To identify any potential mechanism(s) of survival of Campylobacter jejuni 
against sub-lethal exposure to low molecular weight chitosan.  
 
2.7.2 Objectives 
 
 Develop an isolate of C. jejuni with an enhanced tolerance towards 
chitosan, relative to the parental wild-type strain. 
 
 To establish the antimicrobial activity of chitosan against several C. jejuni 
strains/isolates under various environmental conditions. 
 
 To establish any phenotypic differences of C. jejuni strains/isolates in 
order to gain knowledge of how the organism grows/functions and may be 
inhibited upon exposure to chitosan.  
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 To analyse the potential transcriptional differences of C. jejuni after 
exposure to low molecular weight chitosan using molecular biological 
techniques. 
 
 To utilise bioinformatics tools to aid the analysis of the transcriptomics 
between the wild-type and ‘adapted’ isolates of C. jejuni NCTC11168. 
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Chapter 3 - Materials and Methods 
 
 
All chemicals were purchased from Sigma-Aldrich Company Ltd (Dorset, UK) or 
Fisher Scientific UK Ltd (Loughborough, UK).  Bacterial culture media was 
acquired from either Fisher Scientific UK Ltd (Loughborough, UK) or Oxoid Ltd 
(Basingstoke, UK). Identification kits were purchased from BioMérieux UK Ltd 
(Hampshire, UK) and Molecular biology kits from Qiagen, UK). 
 
3.1 Bacterial strains and growth conditions 
 
Campylobacter jejuni NCTC 11168 and NCTC 11828 (81116) were obtained from 
the National Collection of Type Cultures (NCTC), Health Protection Agency 
Culture Collection (Wiltshire, UK). Cells were incubated under microaerobic 
conditions at 42°C in both liquid and solid media for appropriate time periods 
unless stated otherwise.  
 
Campylobacter jejuni RM1221 and 11168CH were kindly provided by Prof. Julian 
Ketley (University of Leicester) and were cultivated in the same way as 
described above. 
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3.2 Liquid media 
 
3.2.1 Mueller-Hinton broth 
 
Mueller-Hinton broth (CM0405: Oxoid Ltd, UK) was added at a concentration  of 
1.05g in 50ml of distilled water, mixed to dissolve completely prior to sterilising 
by autoclaving at 121°C for 15 minutes. 
 
3.3 Solid media 
 
3.3.1 Mueller-Hinton agar 
 
Nineteen grams of Mueller-Hinton agar base (CM0337: Oxoid Ltd, UK) was 
added to 500ml of distilled water, dissolved entirely and sterilised by autoclaving 
at 121°C for 15 minutes. The agar was then allowed to cool to 50°C before the 
addition of 25ml of Defibrinated horse blood (SR0050: Oxoid Ltd, UK) giving a 
final concentration of 5% (v/v) of blood. After mixing, the agar was poured into 
sterile Petri dishes. 
 
3.3.2 Campylobacter Blood-free Selective Medium (Modified CCDA-
Preston) 
 
Campylobacter Blood-Free Selective Agar Base (CM0739: Oxoid Ltd, UK) was 
added in a concentration of 22.75g in 500ml of distilled water and brought to the 
boil in order to dissolve. The media was then sterilised by autoclaving at 121°C 
for 15 minutes, cooled to 50°C prior to 1 vial of CCDA Selective Supplement 
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(SR0155: Oxoid Ltd, UK) being aseptically added, mixed thoroughly and then 
poured into sterile Petri dishes. 
 
 
3.3.3 Agar Bacteriological 
 
Bacteriological agar was prepared at concentrations at 0.8% (w/v) and 0.4% 
(w/v) with 0.8g and 0.4g per 100ml of distilled water which was then sterilised 
by autoclaving at 121°C for 15 minutes, cooled to 50°C and used accordingly.  
 
3.4 CCDA Selective Supplement 
 
CCDA Selective Supplement (SR0155: Oxoid Ltd, UK) was suspended by addition 
of 2ml of sterile distilled water using aseptic techniques according to 
manufacturer’s instructions  
 
3.5 Phosphate Buffered Saline (PBS) 
 
Five PBS tablets (BR0014: Oxoid Ltd, UK) were dissolved in 500ml of distilled 
water, nine hundred microliter aliquots were transferred to micro-centrifuge 
tubes (Fisher Scientific, UK). These were then sterilised by autoclaving at 121°C 
for 15 minutes. PBS not distributed into mini-centrifuge tubes following 
sterilisation was stored at room temperature. 
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3.6 Chitosan 
 
A 1% (w/v) stock solution of low molecular weight chitosan (448869: Sigma-
Aldrich Company Ltd, UK) was prepared by dissolving 1g of 100ml diluent. Acetic 
acid (1% v/v) was used to dissolve the chitosan powder following titration to pH 
5.5, 6.0 and 6.5 with 2% (w/v) NaOH. The mixture was then filter sterilised and 
refrigerated at 4°C until required for experimental purposes. 
 
3.7 Culture techniques 
 
3.7.1 Sub-culturing 
 
Campylobacter jejuni NCTC 11168 was sent as a freeze-dried ampule and 
subsequently reconstituted as directed by the HPA (UK) guidelines.  C. jejuni 
strains were aseptically streaked onto both Mueller-Hinton agar with 5% (v/v) 
defibrinated horse blood and Campylobacter selective agar following incubation 
at 42°C for 48-72 hours under microaerobic conditions utilising CampyGen gas 
generation sachets and Oxoid gas jars.  Cultures were maintained by repeated 
re-streaking Mueller-Hinton agar for a maximum of three times, provided prior 
growth on the selective media was positive and incubated as above. 
 
3.7.2 Long-term storage of cultures 
 
Stock cultures of C. jejuni were stored at -80°C in vials containing Microbank 
beads (ProLab Diagnostics, Merseyside, UK) or in vials containing 20% glycerol 
and 80% PBS.  Several colonies from Mueller-Hinton agar plates were aseptically 
picked using a sterile inoculating loop and added to respective vials.  With 
regards to the Microbank beads vial, these were then closed and inverted a 
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number of times according to product guidelines after which the 
cryopreservation fluid was then aseptically removed by pipetting, closed and 
stored as above until needed. For glycerol stock vials, 800µl of suspension 
containing culture was aseptically added to 200µl of sterile glycerol, briefly 
vortexed and then stored as stated above. 
 
3.7.3 Recovery of Campylobacter jejuni from Microbank beads 
 
After three consecutive re-streaks on Mueller-Hinton agar plates enriched with 
5% (v/v) defibrinated horse blood, Campylobacter jejuni cultures were 
regenerated from Microbank beads limiting phenotypic variation through over-
passaging.  Here, aseptic removal of a Microbank bead or a 100µl of suspension 
in the case of the glycerol stocks were re-streaked and spread onto Mueller-
Hinton agar plate, respectively. These plates were then incubated under 
microaerobic conditions at 42°C for 48-72 hours after which plates were checked 
for correct morphology, Gram stained and re-streaked onto Campylobacter 
selective agar plates when necessary.  Colonies were then treated as described 
in section 3.7.1 above. 
 
3.7.4 Recovery of bacterial cultures from previous plates 
 
 
On a weekly basis a single colony from a previously refrigerated stock Mueller-
Hinton agar stock plate was aseptically streaked onto another agar plate (as 
before and all through) using a sterile inoculating loop and incubated in 
microaerobic conditions for 48-72 hours at 42°C. 
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3.7.5 Culture purity 
 
Purity of cultures was routinely checked and C. jejuni was identified through 
Gram staining using light microscopy, KOH string test, oxidase test, catalase test 
and the use of API Campylobacter test strips (BioMérieux UK Ltd, Hampshire, 
UK). Other features including size and morphology were observed using 
microscopy. All of the stated tests were carried out following standard protocols 
and guidelines which in the case of the API identification kit, were provided. 
Alternatively, cells were streaked onto mCCDA agar, following incubation for 72 
hours under microaerobic conditions (42°C). 
 
3.8 Standard experimental procedures 
 
3.8.1 Culture preparation 
 
 
Cultures were prepared by aseptically transferring several colonies from a sub-
cultured a Mueller-Hinton agar plate, to 50ml of Mueller-Hinton broth.  The broth 
was incubated with shaking at 150rpm at 42°C under microaerobic conditions for 
24 hours. 
 
3.8.2 Cell suspension preparation 
 
After 24 hours incubation cells were suspended in PBS to prevent organic matter 
interference.  The culture-containing PBS suspension was centrifuged at 10,000 
x g for 5 minutes at 25°C.  Following centrifugation the supernatant was 
decanted and cell pellet re-suspended in 50ml of PBS by the use of a vortex. 
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3.8.3 Enumeration 
 
Following serial dilutions in PBS cells were plated via the spread plating, Miles 
and Misra (Miles, Misra and Irwin 1938) or spiral plating method; after which 
plates were incubated at 42°C under microaerobic conditions for 72 hours and 
enumerated. 
 
3.8.4 Spread plating 
 
Unless stated elsewhere; 100µl of cell suspension was pipetted onto agar plates 
under aseptic conditions and evenly distributed across the plate surface and 
allowed to dry before being incubated at 42°C under microaerobic conditions and 
subsequently enumerated for 48-72 hours. 
 
3.8.5 Drop plating 
 
 
Twenty microliters of cell suspension from the relevant serial dilutions were 
aseptically pipetted onto pre-set agar plates in triplicate.  Similarly to the above, 
drops were allowed to dry before being incubated at 42°C under microaerobic 
conditions and enumerated for 48-56 hours (Miles, Misra and Irwin, 1938). 
 
3.9 Specific experimental procedures 
 
3.9.1 Growth curves 
 
 
Growth curves were carried out by inoculating 50ml Mueller-Hinton broth in 
centrifuge tubes with several colonies of C. jejuni. After inoculation, the capped 
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were loosened as to allow for gaseous exchange when placed in a gas jar. A 
CampyGen sachet was placed inside the gas jar and the lid closed immediately 
following incubation at 42°C for a total of 78 hours. One millilitre aliquots were 
then taken at various time intervals and diluted in PBS accordingly. These 
dilutions were then plated on Mueller-Hinton agar (Oxoid Ltd, UK) using the 
Miles, Misra and Irwin method (1938) and incubated at 42°C under microaerobic 
conditions for 72 hours. 
 
3.9.2 Determination of Minimum Inhibitory Concentration (MIC)  
 
3.9.2.1 Agar dilution method 
 
The MIC of chitosan at pH 6.0 and 6.5 was determined using the agar dilution 
method, adapted from Wiegand et al. (2008). This involved a series of sterile 
Petri dishes having a homogenous mixture of Mueller-Hinton agar, 5% (v/v) 
defibrinated horse blood and sterile 1% (w/v) chitosan stock solution according 
the desired final test concentration.  
 
One hundred microliter aliquots of an overnight culture of C. jejuni grown in 
Mueller-Hinton broth was added to each pre-set agar plates at a final 
concentration of 5 x 105 CFU/ml followed subsequent spreading, drying and 
incubation under microaerobic conditions at 42°C for 72 hours. The MIC value 
was determined as the concentration which no visible growth was observed. 
 
3.9.2.2 Broth micro-dilution method 
 
The broth micro-dilution method for determination of MIC was undertaken 
following an adapted method from Wiegand et al. (2008). Briefly, a doubling 
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concentration range of low molecular weight chitosan was incorporated in MH 
broth at a final pH of 5.5, 6.0 and 6.5. 
 
Briefly, a 2x109 overnight culture was diluted to a final starting count of 5x105 
CFU/ml and incubated at 42°C under microaerobic conditions for 48 hours and 
subsequently plated. The MIC value was determined as the lowest concentration 
required for no visible growth. 
 
3.9.2.3 Minimum bactericidal concentration  
 
In parallel to MIC values generated, the minimum bactericidal concentration 
(MBC) was carried out. Essentially, tubes which showed no visible growth were 
subject to MBC determination via three 100µl aliquots being spread onto 
separate MH broth plates supplemented with 5% (v/v) defibrinated horse blood, 
containing no chitosan. These plates were then incubated for 48-72 hours at 
42°C under microaerobic conditions. After incubation, the MBC was determined 
as the lowest concentration in which no growth was present on the agar plate. 
Sterility controls, growth control and tubes containing the cells which were 
subjected to the concentrations tested were included for verification purposes.  
 
3.10 Molecular techniques 
 
3.10.1 Primer specificity 
 
Forward and reverse primers were designed using the NCBI Primer-Blast 
software. Primer sequences were subsequently purchased from MWG Eurofins 
and were re-suspended in molecular grade Water to a stock concentration of 
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100pmol/µl. These stocks were further diluted to give a 10pmol/µl working stock 
concentration. 
 
3.10.2 Polymerase Chain Reaction (PCR) 
 
Endpoint PCR was performed using a Techne TC-512 thermal cycler (Bibby 
Scientific Ltd, Staffordshire, UK). 
 
3.10.3 Gel electrophoresis 
 
Samples were loaded in wells within a 1.2% (w/v) pre-set agarose gel. Samples 
were run for 30 minutes at 80v and carefully removed from the gel tank, 
following visualisation using a Gel Dock (SynGene). 
 
3.11 Statistical analysis  
 
 
All statistical analysis was undertaken using IBM SPSS Statistics version 20 
(SPSS Science Inc., Chicago, Ill, USA) for Windows with a significance set at p = 
0.05. Assumptions of normality were assessed using the Kolmorgorov-Smirnov 
test with variances of homogeneity checked by utilising Levine’s test. Providing 
all assumptions of a normal Gaussian distribution were met, individual t-tests or 
one-way analysis of variance (ANOVA) was carried out. In the case of data 
analysed by ANOVA, additional post-hoc testing (Tukey correction) was used to 
determine significant differences between groups mean data. 
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Chapter 4 – Generation of adapted isolate to 
low molecular weight chitosan 
 
 
 
4.1 Introduction 
 
 
Campylobacter jejuni is often isolated from foodstuffs, despite the ongoing 
efforts currently employed to control this microorganism in the food industry. 
Foodstuffs which have been derived from animal origin, particularly poultry are 
thought to serve as the main vehicle of infection in humans (Blaser et al., 1983). 
The percentage of contaminated/infected broiler chickens at time of slaughter is 
currently high, allowing for the opportunity for C. jejuni to spread from the initial 
intestinal region (initial point of colonisation), to the carcasses. Multiple studies 
have revealed contamination in both frozen and fresh poultry alike, highlighting a 
major concern for both the public health and the poultry industry (Giessen et al., 
1992). 
 
Antimicrobial resistance is considered a significant problem with respect to food-
borne pathogens such as C. jejuni which can amount to a serious problem (Mavri 
and Možina, 2012). Numerous biocides including triclosan, chlorhexidine and 
trisodium phosphate are commonly utilised in the prevention of bacterial 
contamination during food processing and also in a clinical setting (McDonnell 
and Russell, 1999; Møretrø et al., 2011).  
 
However, despite the usage of multiple biocides and disinfectants, elimination of 
food-borne pathogens is somewhat challenging due to under-dosing of the 
chosen disinfectants and also the lack of inadequate cleaning of surfaces prior to 
65 
 
disinfection, reducing the overall antimicrobial efficiency (Mavri and Možina, 
2012).  
 
Exposure to sub-lethal concentrations of a given antimicrobial agent may 
increase the likelihood of adaptation of a more susceptible bacterium (Davidson 
and Harrison, 2002; Mavri and Možina, 2012).  
 
The term resistance can be defined in several ways, Holah et al. (2002) describes 
this as the ability for microorganisms to become more suited to repetitive 
cleaning and disinfection programmes, leading to increased survival, which can 
be applied to antimicrobials/biocides use in general. 
 
According to Fernández and Hancock (2012), there are three key types of 
resistance which can arise, intrinsic, acquired and adaptive. Intrinsic relates to 
the innate properties which limit a microorganism’s susceptibility. Acquired 
resistance is achieved whereby incorporation of novel genetic material (e.g. 
plasmids and transposons) or mutational changes ensues. Lastly, adaptive 
resistance involves the temporary increase in survival due to changes in gene 
and/or protein expression through stressors namely, nutrient depletion and sub 
inhibitory levels of a given antimicrobial. 
 
Rajkovic et al. (2009) explains that when disabling a proportion of the total 
microbial load, it is feasible that either individual cells or sub-populations of 
various pathogens can develop resistance, influencing the degree of persistence 
and subsequent virulence characteristics of these cells.  
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Moreover, injury of microorganisms can also be induced by various treatments 
involving sub lethal heating, freezing, drying, irradiation, aerosolisation, high 
hydrostatic pressure, antibiotics, sanitising compounds and other chemical 
and/or natural compounds which possess antimicrobial properties. With injury 
comes the potential issue of the microorganisms repairing themselves under 
appropriate conditions (Wu, 2008). The population of microorganisms which are 
able to survive the sub lethal onslaught from these treatments can give rise to 
either dead cells which are lethally injured or are subject to irreversible injury, 
seemingly uninjured cells and injured cells which are subsequently stress 
‘hardened’, typical of reversible injury (Wu, 2008).  
 
Although food-related antimicrobials have been used for many years there is 
limited data with respect to the development of microbial resistance for these 
compounds (Davidson and Harrison, 2002). The lack of data may suggest that 
the issue of microbial resistance is a rare occurrence and/or that this does not 
pose much of an issue. However, concerns remain because resistance is 
increasingly found against these antimicrobial compounds and sanitizers used to 
control pathogen growth in foods. Tolerance to antimicrobials, sanitizers and 
currently used in preservation processing may also be heightened through 
exposure to other stresses (Davidson and Harrison, 2002). 
 
Therefore, it seems necessary to assess the ability for C. jejuni to develop an 
adaptive in response to chitosan, if this biopolymer is to be used as an effective 
control measure in such scenarios. By assessing a potential adaptive response 
which may result from chitosan challenge may provide additional information as 
to the role of stress induced adaptation on antimicrobial resistance (Kumar-
Phillips, 2013). 
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4.2 Aims and Objectives 
 
4.2.1 Aims 
 
The aims of the study outlined in this chapter were to investigate the potential 
ability of C. jejuni to survive low molecular weight chitosan exposure and to 
highlight any adaptation to sub lethal exposure to this natural antimicrobial. 
 
4.2.2 Objectives 
 
 
 
 To identify the differences in Minimum Inhibitory Concentrations (MICs) 
and Minimum Bactericidal Concentrations (MBCs) for several C. jejuni 
isolates/strains. 
 
 To assess the sub-lethal intensities needed for inhibition of C. jejuni cells. 
 
 To assess the ability of C. jejuni cells to adapt to low molecular weight 
chitosan following stepwise training of cells. 
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4.3 Methods 
 
4.3.1 MIC Agar dilution method 
 
Determination of the MIC of chitosan (pH 6.0) was determined as in section 
3.9.2.1. 
 
4.3.2 MIC Broth micro-dilution method 
 
The broth micro-dilution method for determination as described in section 
3.9.2.2. 
 
4.3.3 Minimum bactericidal concentration (MBC)  
 
 
In parallel to MIC values generated in MH broth, the MBC was carried according 
to section 3.9.2.3. 
 
4.3.4 Determination of Treatment intensities 
 
 
Firstly, the sub lethal treatment intensities were identified based on a 1-5 log 
cfu/ml reduction upon exposure to chitosan, centred on in-food reductions which 
were deemed realistic. These concentrations were then used in an attempt to 
generate resistant sub-populations of C. jejuni through exposure to low 
molecular weight chitosan. Methods adapted from Rajkovic et al. (2009) were 
carried undertaken. 
 
Overnight cultures of C. jejuni NCTC 11168 were prepared as described in 
section 3.8.1 and aliquots transferred to tubes containing 10ml of MHB with 
chitosan present (pH 6.0) giving a final starting concentration of 2x107cfu/ml. 
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These cultures were then incubated at 42°C for the time needed for a reduction 
in cell counts of 1-5 log cfu/ml.  
 
After chitosan exposure, 100µl aliquots were then removed and were subjected 
to serial dilution in PBS and subsequent enumeration using the drop plating 
method (Miles et al., 1938). A second 100µl aliquot was also removed and added 
to fresh MHB containing no chitosan and incubated for 24 hours under standard 
conditions as described previously. Upon re-growth, the exposure of bactericidal 
concentrations of chitosan was repeated for a total of 20 cycles with plating and 
enumeration being undertaken after each point to determine potential deviation 
in the log reduction when compared to the first inactivation data for day 1 to 
assess potential resistance. This experiment was repeated several times on 
separate occasions.  
 
4.3.5 Adaptation to sub lethal exposure via stepwise training 
 
In a further effort to generate low molecular weight chitosan adapted strains 
against, a method similar to that described in Mavri and Možina (2012) was 
employed. Briefly the C. jejuni NCTC11168 strain underwent challenge to 
increasing concentrations of chitosan (pH 6.0) over a course of 15 days. This 
particular strain was chosen, as it occupied the lowest pre-determined MIC of all 
strains/isolates tested. Overnight cultures of C. jejuni NCTC11168 were prepared 
from the addition of several colonies into fresh MH broth following 24 hours 
incubation at 42°C under microaerobic conditions with shaking at 75rpm. After 
24 hours, 100µl samples of the culture contents were added to tubes containing 
10ml of MHB with sub-lethal concentrations of low molecular weight chitosan (pH 
6.0), which were then incubated under the same conditions as previously 
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described. Cultures were then assessed for visual growth and 1ml samples were 
transferred to progressively higher sub-lethal concentrations, following the same 
incubation procedure. This was repeated for a total of 15 passages with 
subsequent increase as follows: 0.00004%, 0.00006%, 0.00008%, 0.00010%, 
0.00020%, 0.00040%, 0.00060%, 0.00080% and 0.0010% (w/v) chitosan. 
 
The potential adaptive resistance was determined after 5, 10 and 15 hours 
exposure to the gradually increasing concentrations of low molecular weight 
chitosan in MHB (pH 6.0). Here the MICs were carried out as previously 
described to highlight any changes present in relation to the control cells which 
had not been subjected to such stepwise exposure (control cell MICs determined 
in parallel). An alternative method of stepwise training was also used following 
the same basic principle as above, but using MH agar medium with 
supplementation of 5% (v/v) defibrinated horse blood. 
 
In these instances, C. jejuni NCTC 11168 cells were subjected to sub-lethal 
concentrations of chitosan following a step-wise training. Cells were grown under 
the conditions mentioned previously for 72 hours after which the contents of the 
plates were partitioned by carefully swabbing plates with the increased 
concentration of chitosan, plates with the same concentration and also on plates 
containing chitosan-free plates in the potential event of no visible growth in the 
others two cases. 
 
Cells generated through this method presenting an altered phenotype (visible 
growth above the wild-type MIC value) were stored temporarily on agar 
containing the maximum concentration of chitosan which permitted of growth. 
Multiple stocks were also prepared via transferring colonies from chitosan 
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containing plates and aseptically added to 20% (v/v) glycerol and 80% MH 
broth. Regular plating of wild-type C. jejuni NCTC 11168 on plates incorporating 
chitosan was performed in order to ensure the strain was not able to grow on the 
selective medium, which allowed for adapted cell growth. 
 
4.3.6 Determination of adaptive resistance via comparison of Minimum 
inhibitory concentration. 
 
 
Any adaptive resistance resulting from sub lethal exposure to low molecular 
weight chitosan was subject to MIC determination in parallel to the control strain, 
which was cultivated in chitosan-free medium. 
 
4.3.7 Determination of stability of adapted resistance 
 
 
 In order to test the stability of any adaptive responses, the adapted isolate was 
repeatedly sub-cultured on MH agar supplemented with 5% (v/v) horse blood 
containing no chitosan (pH 6.0). Cultured cells from this agar were then 
suspended in PBS and subsequently plated onto MH agar with and also the 
addition of chitosan (pH 6.0) following incubation under microaerobic conditions 
(42°C). This was repeated until no growth was present on the chitosan 
containing agar. The MIC was determined for the control isolate during this 
passage and also plated on non-selective and chitosan containing agar in parallel 
to the adapted isolate. Moreover, the culture purity was analysed at each stage 
with plating onto mCCDA selective agar with the appropriate antibiotics needed.  
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4.4 Results 
 
 
4.4.1 MIC/MBC data 
 
 
In order to obtain a general indication of the antimicrobial nature of low 
molecular weight chitosan, it is useful to perform MIC/MBC assays in both agar 
and broth medium.  
 
From the data presented in Table 4.1 the lowest MIC value was observed in the 
wild-type C. jejuni NCTC 11168 strain (0.0016% (w/v)) concerning pH 6.0 MH 
broth. This was followed by the RM1221 strain (0.0022% (w/v)), with the 
highest MIC found in both C. jejuni 81116 strain and the NCTC 11168CH isolate 
(both 0.0032% (w/v)). Interestingly, the MBCs for the wild-type NCTC11168, 
RM1221 and 81116 strains were consistent (0.0032% (w/v)) after 24 hours 
incubation at pH 6.0. The greatest MBC was seen for the isolate which had 
previously undergone passage through a chicken intestinal tract 
(NCTC11168CH). Due to the increase in low molecular weight chitosan 
concentration when comparing the MIC to the MBC for each isolate/strain 
(excluding the 81116 strain), it can be assumed that the antimicrobial action of 
chitosan is bacteriostatic. 
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Table 4.1: MIC and MBC values of C. jejuni strains/isolates when exposed low molecular weight 
chitosan (pH 6.0) in MH broth (n = 6, triplicate). 
 
Isolate/strain type MIC (% (w/v)) MBC (% (w/v)) 
C. jejuni wild-type NCTC11168  0.0016 0.0032 
C. jejuni NCTC11168CH 0.0032 0.0064 
C. jejuni RM1221 
C. jejuni NCTC81116 
0.0022 
0.0032 
0.0032 
0.0032 
 
 
 
 
Table 4.2: MIC values of C. jejuni strains/isolates when exposed low molecular weight chitosan 
(pH 6.0) on MH agar (n = 6, triplicate). 
 
Isolate/strain type MIC (% (w/v)) 
C. jejuni wild-type NCTC11168  0.012 
C. jejuni NCTC11168CH 0.028 
C. jejuni RM1221 
C. jejuni NCTC81116 
0.020 
0.020 
 
 
 
A similar trend was observed as in Table 4.1 with respect to the MICs generated 
using the agar dilution methods as described previously. The lowest MIC and 
therefore the most susceptible cells were that of the NCTC11168 strain of C. 
jejuni (MIC of 0.012% (w/v)). Equally values were observed in the RM1221 and 
NCTC81116 strains, with an MIC of 0.020% (w/v) low molecular weight chitosan. 
The greatest concentration of chitosan required to inhibit visible growth 
indicating the lowest susceptibility was that of the 11168CH isolate (Table 4.2). 
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4.4.2 Determination of sub-lethal intensities 
 
In order to determine the extent of low molecular weight chitosan, time kill 
assays were also undertaken in order to deduce sub-lethal intensities 
(concentrations) sufficient to reduce cell recovery over a 1 hour period. 
 
 
Figure 4.1: Mean recovery of C. jejuni NCTC 11168 upon 1 hour exposure to 0.005%, 0.01%, 
0.02% and 0.03% (w/v) low molecular weight chitosan (pH 6.0). Error bars represent SEOM of 4 
independent experiments, plated in triplicate. 
 
 
 
 
Figure 4.1 represents the effect of low molecular weight chitosan exposure at 
various concentrations after one hour of contact. Upon exposure to 0.005% 
(w/v) chitosan, there was a significant difference of typically a 0.5 log CFU/ml 
difference was observed when compared to the control cells (p = <0.05). As 
expected, with an increase in concentration of chitosan, less recovery of cells 
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were found upon challenging to these sub-lethal concentrations of chitosan. 
Significant differences in log CFU/ml were found for 0.01% (w/v), 0.02% (w/v) 
and 0.03% (w/v) low molecular weight chitosan, with differences of 0.97, 2.06 
and 2.87 differences compared to the control, respectively. It was decided that 
both 0.02% (w/v) and 0.03% (w/v) chitosan would be utilised for the stepwise 
exposure of sub-lethal concentrations to give a higher likelihood to generating 
resistant isolates of C. jejuni NCTC11168.  
 
4.4.3 Effect of repeat sub-lethal exposure on adaptive resistance 
 
 
The effect of repeated sub-lethal exposure to a given antimicrobial is also useful 
to investigate, as this may provide insight as to the microorganism’s ability to 
undergo adaptive resistance when challenged with stressors such as chitosan. 
 
76 
 
 
Figure 4.2: Mean log reductions of C. jejuni NCTC 11168 when subjected to 0.02% (w/v) low 
molecular weight chitosan. Errors bars relate to the SEOM of three independent experiments which 
were plated in triplicate. These log reductions were comparative to counts at time point ‘0’.  
 
 
 
 
The failure of C. jejuni NCTC 11168 to demonstrate resistance characteristics 
based on repeated exposure and subsequent growth in chitosan-free media can 
be seen. When cells were grown for 24 hours followed by challenge of 0.02% 
(w/v) low molecular weight chitosan, after which an aliquot was taken for 
enumeration purposes, no change of the resistant sub-population was obvious 
over the 20 days tested, R2 = 0.1758 (Figure 4.2). 
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Figure 4.3: Mean log reductions of C. jejuni NCTC 11168 when subjected to 0.03% (w/v) low 
molecular weight chitosan. Errors bars relate to the SEOM of three independent experiments which 
were plated in triplicate. These log reductions were comparative to counts at time point ‘0’.  
 
 
 
In addition, when applying the increased concentration of low molecular weight 
chitosan (0.03% (w/v)) in a separate set of experiments, upon repeated rounds 
of exposure over the course of 20 days, C. jejuni NCTC 11168 cells were unable 
to establish resistant sub-populations. With an R2 value of 0.0043, this implies no 
substantial decrease in log reduction throughout repeated exposure to 0.03% 
(w/v) chitosan over the 20 days tested. 
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4.4.4 Effect of gradual sub-lethal increases in chitosan concentration upon 
MIC value 
 
 
Table 4.3 Minimal Inhibitory Concentrations of C. jejuni NCTC 11168 when exposed to gradual 
increases in low molecular weight chitosan concentrations at 5, 10 and 15 days exposure. 
Experiments were performed on 4 separate occasions, MICs were conducted in triplicate.  
 
 MIC (% (w/v)) after: 
Experiment set no. 5 days exposure 10 days exposure 15 days exposure 
1 0.0016 0.0014 0.0016 
2 0.0016 0.0016 0.0016 
3 0.0016 0.0016 0.0016 
 
 
After 5, 10 and 15 days exposure, no increase in MIC was found after upon 
gradually increased concentrations of low molecular weight chitosan in MH broth 
(pH 6.0). Interestingly, in the first set of experiments, there appeared to be a 
decrease in MIC after 10 days exposure, which was not expected. With an 
absence of MIC increases present when tested at 5, 10 and 15 days exposure to 
this stepwise training, it can be said that this method was unable to cells with 
decreased susceptibility with regards to low molecular weight chitosan (Table 
4.3) 
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4.4.5 Effect of step-wise training in generating an adaptive response 
 
 
 
 
 
Table 4.4: Effect of step-wise training of C. jejuni NCTC 11168 using gradually increasing sub-
lethal concentrations of low molecular weight chitosan. Data represents 3 individual sets of 
experiments, plated in triplicate (n = 3).  
 
Chitosan concentration (% (w/v)) Control  Step-wise challenged 
0.001 + + 
0.002 + + 
0.004 + + 
0.008 + + 
0.012 - - 
0.016 - - 
0.018 - - 
(+ = visible growth present; - = no growth) 
 
 
 
Upon undertaking the first attempt of increasing the concentration of low 
molecular weight chitosan in step-wise increments, C. jejuni NCTC11168 was not 
seen to adapt compared to the non-challenged cells. The absences of visible 
growth on the agar plates in the case of the 0.016% (w/v) chitosan were 
consistent with the respective MIC agar values above. In the likelihood that the 
chitosan concentration increase was too severe for an adaptive response to be 
generated, a second set of attempts were made typical of smaller increments of 
0.002% (w/v) concentration (Table 4.4). 
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Table 4.5: Generation of step-wise trained C. jejuni NCTC 11168 isolate using gradually increasing 
sub-lethal concentrations of low molecular weight chitosan. Data represents 3 individual sets of 
experiments, plated in triplicate (n = 3). 
 
Chitosan Concentration (% (w/v)) Control Step-wise challenged 
0.002 +/+/+ +/+/+ 
0.004 +/+/+ +/+/+ 
0.006 +/+/+ +/+/+ 
0.008 +/+/+ +/+/+ 
0.010 +/+/+ +/+/+ 
0.012 -/-/- +/+/+ 
0.014 -/-/- +/+/- 
0.016 -/-/- +/+/- 
 -/-/- +/+/- 
0.040 -/-/- +/-/- 
0.042 -/-/- +/-/- 
0.044 -/-/- +/-/- 
0.046 -/-/- -/-/- 
0.048 -/-/- -/-/- 
(+ = visible growth present; - = no growth) 
 
The second attempt at generating an adaptive isolate of C. jejuni NCTC 11168 
was successful. A 3.83 fold increase in the MIC (0.012% (w/v) – 0.046% (w/v)) 
was observed when comparing this chitosan adapted isolate to those cells that 
did not undergo step-wise training.   
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4.4.6 Effect of repeated passage of ‘adapted’ isolate C. jejuni NCTC11168 
on growth 
 
 
In order to confirm whether the newly developed adapted isolate of C. jejuni 
NCTC11168 was stable and potentially indicating a mutational alteration, serial 
passaging was carried out as described previously (Table 4.6). 
 
 
Table 4.6: Confirmation of growth regarding repeated passage on the chitosan “adapted” isolates 
of C. jejuni NCTC 11168. Each passage was performed on 3 plates. 
 
Number of 
passages 
Growth on non-
selective agar  
“Adapted” isolate 
growth on selective 
agar 
Wild-type growth 
on selective agar  
1 +/+/+ +/+/+ -/-/- 
2 +/+/+ +/+/+ -/-/- 
3 +/+/+ +/+/+ -/-/- 
4 +/+/+ +/+/+ -/-/- 
5 +/+/+ +/+/+ -/-/- 
6 +/+/+ +/+/+ -/-/- 
7 +/+/+ +/+/+ -/-/- 
8 +/+/+ +/+/+ -/-/- 
9 +/+/+ +/+/+ -/-/- 
10 +/+/+ +/+/+ -/-/- 
11 +/+/+ +/+/+ -/-/- 
12 +/+/+ +/+/- -/-/- 
13 +/+/+ -/-/- -/-/- 
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After a 12 successive passages from non-selective MH agar to selective plates 
incorporating a final concentration of 0.044% (w/v) chitosan, one of the three 
replicates showed no visible growth when compared to the isolate which did not 
undergo step-wise exposure, typical of growth on the respective non-selective 
agar (Table 4.6). When the resistant isolate of C. jejuni NCTC 11168 was 
passaged 13 times, no growth was observed for all replicates on 0.044% (w/v) 
chitosan containing agar. The non-stable resistance observed in the chitosan 
‘adapted’ was referred to as an “adapted” isolate, as the cells did not succumb to 
permanent resistance, which may result from mutations. 
 
 
4.4.7 Updated MIC/MBC values including newly generated ‘adapted’ 
isolate of C. jejuni NCTC11168. 
 
 
To ensure that the MIC/MBC values remained consistent, these were tested a 
several occasions, alongside the newly developed ‘adapted’ isolate of C. jejuni 
NCTC11168, as presented is tables 4.7 and 4.8 (below).  
 
 
Table 4.7: Updated MIC values of C. jejuni strains/isolates when exposed low molecular weight 
chitosan (pH 6.0) on MH agar (n = 6, triplicate). 
 
Isolate/strain type MIC (% (w/v)) 
C. jejuni wild-type NCTC11168  0.012 
C. jejuni ‘adapted’ NCTC11168  0.046 
C. jejuni NCTC11168CH 0.028 
C. jejuni RM1221 
C. jejuni NCTC81116 
0.020 
0.020 
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Table 4.8: Updated MIC and MBC values of C. jejuni strains/isolates when exposed to low 
molecular weight chitosan (pH 6.0) in MH broth (n = 6, triplicate). 
 
Isolate/strain type MIC (% (w/v)) MBC (% (w/v)) 
C. jejuni wild-type NCTC11168  0.0016% 0.0032% 
C. jejuni ‘adapted’ NCTC11168  0.0032% 0.0064% 
C. jejuni NCTC11168CH 0.0032% 0.0064% 
C. jejuni RM1221 
C. jejuni NCTC81116 
0.0022% 
0.0032% 
0.0032% 
0.0032% 
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4.5 Discussion 
 
 
There has been evidence that foodborne pathogenic bacteria can adapt to sub-
lethal stresses leading to an increased resistance to lethal levels of both the 
homologous and heterologous stresses. Many of these adapted microorganisms 
can also show an enhanced virulence (Rowan, 1999). In the past it has been 
documented that whilst under the appropriate sub-lethal conditions, cells can 
undergo ‘stress-hardening’. Pathogens which can overcome various 
environmental stresses associated with foods and hosts based environments may 
lead to unforeseen shifts in physiological characteristics (Rowan, 1999).  
In order to survive a number of environmental challenges, C. jejuni must possess 
the capability to tolerate increasing concentrations of various 
biocides/antimicrobials. It has been previously documented that several 
organisms have illustrated the ability to adapt to a given stress, including E.coli, 
L. monocytogenes following repetitive sub-lethal inactivation with lactic acid, 
chlorine dioxide and intense light pulses (Rajkovic et al., 2009). In this study, C. 
jejuni strains were unable to mount a tolerance response to repeated sub-lethal 
challenge. 
Resistance in Campylobacter spp. remains relatively rare and despite the 
potential of chitosan for use in the food industry there is a surprising lack of 
reports on the effect of chitosan against this important foodborne pathogen 
(Ganan et al., 2009). It has been demonstrated that adaptive responses to 
biocides can account for an increased reduction in a microorganisms 
susceptibility both to the antimicrobial of choice and also dissimilar antimicrobials 
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and/or disinfectants, indicate of cross-protective resistance (Braoudaki and 
Hilton, 2005; Abdel Malek and Badran, 2010; Loughlin et al., 2002). 
 The results in this chapter successfully established the generation of an adaptive 
isolate of C. jejuni NCTC 11168 following step-wise increases in chitosan. No 
adaptive resistance to low molecular chitosan was observed when using repeated 
exposure following the methods adapted from Rajkovic et al. (2009) or to the 
step-wise training of cells following the methods described in Mavri and Možina 
(2012) in broth medium.  
Upon exposing C. jejuni NCTC 11168 to repeated sub-lethal concentrations of 
0.02% (w/v) and 0.03% (w/v) chitosan over the course of 20 days, indicative of 
2 and 3 log reduction in log CFU/ml recovery, R2 values of 0.1758 and 0.0043 
were calculated, respectively. The C. jejuni strains used in Rajkovic et al. (2009) 
were typically producing non-culturable cells after subsequent exposure to 
repeated cycles of lactic acid and 2 cycles of liquid chlorine dioxide. The findings 
described in this chapter did not find complete reduction in cells numbers after 
the 20 cycles tested, suggesting that C. jejuni NCTC 1168 was able to survive 
the sub-lethal concentrations of chitosan used.  
Moreover, the stepwise training of C. jejuni NCTC 11168 in MH broth with 
gradually increasing concentrations of low molecular weight chitosan, the lack of 
increased MIC values when testing after 5, 10 and 15 days exposure revealed 
that on these occasions C. jejuni NCTC 11168 was unable to develop increased 
resistance. Alternatively, it could be possible that the generation of an adapted 
isolate of C. jejuni NCTC 11168 may have been produced through prolonged 
exposure beyond the 15 day exposure used as well as increasing the number of 
cycles of inactivation when following a modified method from Rajkovic et al. 
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(2009). However, from the results observed, it was deemed unlikely that the 
successful generation of a resistant sub-population was to going to occur. 
The findings described here suggest that the development of resistance 
populations are subject to potentially numerous intricate factors and may also be 
dependent upon chance. It has been suggested that the degree of increased 
resistance to antimicrobials and the time for which this resistance persists after 
the stressor is absent is largely dependent on the dosage, the time of which the 
microorganism is challenged and the bacterial species (Fernández et al., 2011; 
Rusell, 2004). 
The generation of an adaptive isolate of C. jejuni NCTC 11168 was successful 
when applying a method to an agar based approach focused on gradual stepwise 
training typical of increasing the concentration of low molecular weight chitosan. 
 As was highlighted previously, this isolate was able to grow on 0.044% (w/v) 
chitosan containing MH plates (pH 6.0). In comparison to the wild-type C. jejuni 
NCTC 11168 strain, an increase of 3.83 fold (0.012% w/v – 0.046% w/v) was 
observed in the chitosan “adapted” isolate when comparing the MIC 
concentration of low molecular weight chitosan needed to inhibit visible growth 
when tested. This enhanced tolerance was seen to be stable for up to 12-13 
passages onto chitosan-free agar medium after which no visible growth was seen 
when plated onto the agar medium containing 0.044% (w/v) chitosan in parallel. 
The unstable characteristics of the adaptive isolate generated have previously 
been reported, with a loss in enhanced resistance (Thomas et al., 2000; Mavri 
and Možina, 2012). Thus, this is consistent with previous findings, alongside the 
failure of adaptive response which have also been reported with respect to E. coli 
and C. jejuni when challenged to biocides, as in Thomas et al. (2000) and Mavri 
and Možina (2012). There have also been cases whereby adaptive resistance has 
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been sustained in Peudomonas spp. and Salmonella enterica (Tattawasart et al., 
1999; Thomas et al., 2000 Braoudaki and Hilton, 2005). 
The findings in this chapter are probably the first documented case of adaptive 
responses to chitosan through step-wise exposure and the second instance of 
adaptive resistance of C. jejuni. A major challenge for the food manufacturing 
industry is therefore to ensure the necessary quantity and spectrum of 
antimicrobials are used in order to inhibit microbial growth of food borne 
pathogens which minimise the likelihood of developing adaptive resistance 
(Ruston et al., 2013).  
 
It is important to mention that the inability of C. jejuni to develop resistance in 
the majority of cases may be due to the possible existence of viable but non-
culturable (VBNC) populations of cells after treatment to stressors, in this 
instance, low molecular weight chitosan. If this phenomenon was to occur during 
stepwise training of cells under the various methods used there may be certain 
cells which may be ‘hidden’ to an extent, whereby any adaptive responses which 
may have arisen may not be quantified by a noticeable increase in MIC values 
for example. This arises from the inability of cells to form colonies on both agar 
and broth media (Rajkovic et al., 2009). In the particular case for C. jejuni, the 
rapid loss of culturability may not necessarily be directly correlated to death of 
exposed cells (Guillou et al., 2008).  
 
The newly developed chitosan ‘adapted’ isolate of C. jejuni NCTC11168 was seen 
to have the greatest MIC agar value when compared to the other strain/isolates 
tested (Table 4.6). When compared to the MIC values obtained using broth 
medium, the ‘adapted’ isolate was equally as high as the isolate which 
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underwent passage in a chicken (Table 4.7). This would suggest the previous 
exposure to low molecular weight chitosan can induce an increased survival 
potential, which may account for an increased degree of persistence. 
Nevertheless, the corresponding MBC for the ‘adapted’ isolate of C. jejuni NCTC 
11168 was also found to be equally the greatest in comparison to the other 
strains tested. 
 
The identification of Campylobacter spp. which have a degree of antimicrobial 
resistance, such as that seen in the generated ‘adapted’ isolate of C. jejuni 
NCTC11168, highlight concerns in terms of treatment of campylobacteriosis. Due 
to the decreased susceptibility, those strains which happen to develop resistance 
to a given antimicrobial, even temporarily, may give rise to prolonged illness 
associated with subsequent infection (Travers and Barza, 2002). 
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Chapter 5 – Comparative antimicrobial 
activity of low molecular weight chitosan 
against C. jejuni strains/isolates 
 
 
5.1 Introduction 
 
 
Despite the fastidious nature of Campylobacter jejuni, requiring microaerobic 
conditions and alongside specific nutrients allowing for ample growth in vitro, it 
poses an enormous burden to the public health, which raises the question as to 
how they are able to cause such an issue (Crushell et al., 2004). As with other 
pathogenic bacteria, there is the pressing issue of resistance which is perceived 
to only escalate in terms of severity with the chronic overuse of various 
antimicrobials/antibiotics. C. jejuni is no exception, with antimicrobial resistance 
having previously been observed (Wieczorek and Osek, 2013; Luangtongkum et 
al., 2009; Mavri and Možina, 2012).  
 
Low molecular weight chitosan has attracted an increasing amount of attention, 
owing to the potential for a variety of biological activities, including fat-binding, 
antithrombotic activity, antitumor and antimicrobial activity (Kim and Rajapakse, 
2005). Alongside other useful properties it the potential for use as a food 
preservative which has proven to be particularly appealing, mainly due to its 
natural origins and known antimicrobial activity against a variety of 
microorganisms (Devlieghere et al., 2004).  
 
The emergence and persistence of pathogenic microorganisms such as C. jejuni 
are often thought to found to have originated from a food origin (Altekruse et al., 
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1999). With the ever increasing need for more natural and sustainable 
antimicrobials in such environments as the food industry, chitosan may be an 
important biopolymer to consider with regards to reducing the bacterial load of 
C. jejuni, which could have a positive impact in reducing the incidence of human 
infections arising from this pathogen.  
 
The antimicrobial activity of chitosan is known to be dependent on numerous 
factors. This includes microbial factors, relating to the type of microorganism and 
respective cell age, intrinsic factors (I.e. positive charge density, Mw, 
concentration, chelating capacity and hydrophilic/hydrophobic nature), physical 
state and environmental factors, namely ionic strength, pH and temperature 
(Kong et al., 2010). 
 
Moreover, the antimicrobial activity of chitosan is fairly complex, with differences 
in reported efficacy with respect to Gram positive and Gram negative bacteria 
species. A number of studies have observed a greater antibacterial activity 
towards Gram negative bacteria, as oppose to Gram positive species (Chung et 
al., 2004; No et al., 2002). Whilst in other studies, the opposite was found, with 
Gram positive bacteria being more susceptible (Zhong et al., 2008). Despite this, 
a study conducted by Wang et al. (2004) found no significant differences in 
antimicrobial activity, suggesting a generic degree of variance between bacteria 
species. 
 
In more recent times, there has been an increasing interest in the development 
of film forming materials which harbour antimicrobial activity (Tripathi et al., 
2009). Chitosan films have a promising potential application with respect to 
antimicrobial packaging, one of the most encouraging active packaging systems 
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(Dutta et al., 2012). These packaging systems have illustrated a high degree of 
inhibition or direct killing of pathogenic microorganisms associated with 
contaminating foodstuffs (Salleh et al., 2007). 
 
The overall goals of any antimicrobial are to limit or prevent microbial growth 
either by extending the lag phase with a reduction in growth rate or a decrease 
in viable counts (Han, 2000). It therefore seemed appropriate to assess the 
antimicrobial activity of chitosan at concentrations which would be likely both 
permit and the inhibition of growth in C. jejuni strain/isolates and also at 
concentrations which are lethal, resulting in loss a total loss of cell viability over 
a shorter time period.  
 
5.2 Aims and Objectives 
 
5.2.1 Aim 
 
The aim of this study was to investigate the general antimicrobial efficacy of low 
molecular weight chitosan against different strains and isolates of C. jejuni, 
highlighting any trends/discrepancies in susceptibility.  
 
 
5.2.2 Objectives 
 
 
 To determine the MICs and MBCs of chitosan against C. jejuni 
strains/isolates in broth and agar medium under different pHs. 
 
 To assess the effect of chitosan films regarding several C. jejuni 
strains/isolates. 
 
92 
 
 To establish the effect of lethal chitosan exposure upon cell 
viability/recovery in nutrient rich (MH broth) and limited (PBS) 
environments. 
 
 To compare the growth of C. jejuni strains/isolates when exposed to sub-
lethal concentrations of chitosan.   
 
 
5.3 Methods 
 
5.3.1 Microorganisms 
 
 
C. jejuni strains and isolates are summarised in section 3.1. The culture 
conditions and media utilised are described as in section 3.8 
 
5.3.2 Chitosan  
 
Low molecular weight chitosan was prepared as described in the materials and 
methods chapter and pH adjusted to pH 5.5, 6.0 or 6.5 consistent with the pH of 
MH broth/PBS diluent utilised, dependent upon the experiment required. 
 
5.3.3 Determination of Minimum Inhibitory Concentration (MIC) 
  
5.3.3.1 Agar dilution method 
 
The agar dilution methods were carried out as described in section 3.9.2. 
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5.3.3.2 Broth micro-dilution method 
 
 
Broth micro-dilution methods were carried as in section 3.9.2. 
 
5.3.4 Time Kill assay 
 
 
Time kill experiments were conducted utilising pre-grown early stationary phase 
C. jejuni cultures grown in MH broth (incubated at 42°C under microaerobic 
conditions). In the case of the PBS assay, the contents of the broth were then 
placed into a sterile 50ml centrifuge tube and centrifuged for 8 minutes at 
10,000 x g. The supernatant was discarded and the same volume of PBS was 
added into the tube as compared to the initial volume of the culture media. The 
pellet was then vortexed and re-suspended in diluent. Several 10ml aliquots 
were transferred from the initial culture into sterile 15ml tubes along with a 
specific volume of chitosan from a 1% (w/v), giving a final starting cell 
concentration of approximately 2x107 CFU/ml at a final concentration of 0.01% 
(w/v) and 0.02% (w/v) chitosan (final of pH 6.0 or 6.5), depending on the 
experiment. PBS with no chitosan added was used for control samples. Aliquots 
were taken from these respective tubes at various time intervals during 
incubation (150rpm shaking) under conditions mentioned previously, serial 
diluted and plated utilising the Miles and Misra technique (Miles, Misra and Irwin, 
1938). The same procedure was undertaken with in the case of studies 
concerning the incorporation of chitosan in MH broth (nutrient rich conditions). 
 
 
 
 
 
94 
 
5.3.5 Preparation of chitosan films 
 
Chitosan was dissolved in 1% (w/v) acetic acid in order to prepare a 1% (w/v) 
low molecular weight chitosan solution. Ten millilitres of the solution was poured 
into a Petri dish at and dried in a lamina flow hood at room temperature for 48 
hours. The resulting film was then washed with 2% (w/v) NaOH for neutralisation 
purposes and then with distilled water and added into a 2% (w/v)  H2SO4  cross-
linking solution for 1 hour. After fully cross-linking, the film was then washed 
with distilled water and left to dry for a further 24 hours (adapted from Tripathi 
et al., 2009). 
 
5.3.6 Chitosan Film Assay 
 
 
One centimetre chitosan films were aseptically cut using a sterile borer. The 
plugs were subsequently transferred to centrifuge tubes containing MH broth (pH 
6.0) with a final concentration of approximately 2 x 105 CFU/ml from an 
overnight culture and shaken at 150rpm. Aliquots were taken at 0, 4, 8, 24, 48 
and 52 hours, plated and enumerated described previously. 
 
5.3.7 Growth Inhibition Study 
 
 
 
Several colonies of respective C. jejuni cultures were inoculated into 50 ml of 
Mueller Hinton broth and were incubated for 24 hours (early stationary phase) 
under microaerobic conditions at 42°C. 
 
After these overnight cultures of C. jejuni had been grown, aliquots were taken 
and diluted to a final concentration of approximately 2x106 CFU/ml (final volume 
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of 10ml consisting of MH broth (adjusted to pH 6.0) and a volume low molecular 
weight chitosan added (also pH 6.0). 
 
At various time intervals, aliquots were taken from samples, serially diluted and 
subsequently plated at 42°C for a maximum of 56 hours under microaerobic 
conditions. Counts were then enumerated as described previously. 
 
 
5.4 Results 
 
 
 
To reinforce the notion that chitosan antimicrobial activity is dependent aspects 
including pH, a comparison of susceptibility of C. jejuni strains/isolates with in 
relation to this was investigated (below).  
 
5.4.1 MIC broth micro-dilution 
 
 
 
Table 5.1: MIC and MBC values of C. jejuni when exposed low molecular weight chitosan (pH 5.5) 
in MH broth (n = 6, triplicate).  
Isolate/strain type MIC (w/v) MBC (w/v) 
C. jejuni wild-type NCTC11168 * 0.0001% 
C. jejuni ‘adapted’ NCTC11168 * 0.0001% 
C. jejuni NCTC11168CH * 0.0001% 
C. jejuni RM1221 
C. jejuni NCTC81116 
* 
* 
0.0001% 
0.0001% 
* = not quantifiable (lowest concentration tested = 0.0001% (w/v)) 
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The MIC values for all of the strains/isolates of C. jejuni upon exposure to 
chitosan at pH 5.5 were unable to be deduced, as no visual turbid growth was 
observed in the treated samples (as represented by the asterisk in Table 5.1). 
After the aliquots from the plates were spotted onto MH agar with 5% (v/v) 
defibrinated horse blood, the same MBC values regarding chitosan were 
concluded for all C. jejuni isolates/strains tested (0.0001% w/v). Only the control 
samples showed recovery upon spot plating onto the non-chitosan containing 
media.  
 
 
 
Table 5.2: MIC and MBC values of C. jejuni when exposed low molecular weight chitosan (pH 6.0) 
MH broth (n = 6, triplicate). 
Isolate/strain type MIC (w/v) MBC (w/v) 
C. jejuni wild-type NCTC11168  0.0016% 0.0032% 
C. jejuni ‘adapted’ NCTC11168 0.0042% 0.0064% 
C. jejuni NCTC11168CH 0.0032% 0.0064% 
C. jejuni RM1221 
C. jejuni NCTC81116 
0.0022% 
0.0032% 
0.0032% 
0.0032% 
 
 
From the MIC data presented in Table 5.2 (above), the lowest MIC value was 
observed in the wild-type C. jejuni NCTC11168 strain (0.0016% (w/v)) 
concerning pH 6.0 MH broth. This was followed by the RM1221 strain (0.0022% 
(w/v)). Equally greater MIC values were typical of both the C. jejuni NCTC81116 
strain and the NCTC11168CH isolate (both 0.0032% (w/v)). The highest MIC 
concerned the ‘adapted’ NCTC11168 isolate of C. jejuni (0.0042% (w/v)).  
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Interestingly, the MBCs for the wild-type NCTC 11168, RM1221 and 81116 
strains were consistent (0.0032% (w/v)) after 24 hours incubation at pH 6.0. 
The greatest MBC was found in both the ‘adapted’ isolate NCTC11168 isolate and 
NCTC11168CH, which had previously undergone passage through a chicken. With 
an increase in low molecular weight chitosan concentration when comparing the 
MIC to the MBC for each isolate/strain (excluding the 81116 strain), it can be 
assumed that the antimicrobial activity of chitosan is bacteriostatic. 
 
 
Table 5.3: MIC and MBC values of C. jejuni when exposed to low molecular weight chitosan (pH 
6.5) in MH broth (n = 6, triplicate). 
Isolate/strain type MIC (w/v) MBC (w/v) 
C. jejuni wild-type NCTC11168  0.0260% 0.0700% 
C. jejuni ‘adapted’ NCTC11168 0.0480% 0.0960% 
C. jejuni NCTC11168CH 0.0400% 0.0940% 
C. jejuni RM1221 0.0300% 0.0920% 
C. jejuni NCTC81116 0.0300% 0.0840% 
 
 
When subjected to concentrations of chitosan with an increase in overall pH 
(6.5), increases in MICs were identified in all strain/isolates of C. jejuni tested. 
After being incubated at the pH 6.5 with exposure to a range of concentrations of 
low molecular weight chitosan, the greatest MIC and subsequent MBC value was 
observed in the ‘adapted’ isolate of C. jejuni NCTC11168 (0.0480% (w/v)), which 
was followed by the NCTC11168CH isolate with a concentration of 0.0400% 
(w/v) needed. The RM1221 and 81116 C. jejuni strains were seen to possess 
equal MICs (0.0300% (w/v)) and the wild-type NCTC 11168 occupying to lowest 
MIC of all the above tested. Similar to the MIC generated under pH 6.5, the MBC 
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value was also seen to be the lowest with regard to the wild-type NCTC 11168 
strain, which was then followed by the NCTC81116 strain, RM1221 strain, 
NCTC11168CH and the ‘adapted’ NCTC11168 cells occupying the highest MBC of 
all the tested strains/isolates (0.0940% (w/v)) (Table 5.3).  
 
5.4.2 MIC agar dilution results 
 
 
The antimicrobial effects of low molecular chitosan were also undertaken at pH 
6.0 and 6.5 in agar medium to establish if alterations in final pH affected 
chitosan activity. 
 
Table 5.4: MIC values of C. jejuni when exposed low molecular weight chitosan (pH 6.0) on MH 
agar   (n = 3, triplicate). 
Isolate/strain type Concentration (w/v) 
C. jejuni wild-type NCTC11168 0.012% 
C. jejuni ‘adapted’ NCTC11168 0.046% 
C. jejuni NCTC11168CH 0.028% 
C. jejuni RM1221 
C. jejuni NCTC81116 
0.020% 
0.020% 
 
As expected, the lowest MIC value in using the MIC agar dilution method at pH 
6.0 was also found in the wild-type NCTC11168 strain (0.012% (w/v)), whilst the 
greatest MIC was typical of the ‘adapted’ NCTC11168 isolate (0.046% (w/v)). 
Identical values were found with respect to the RM1221 and NCTC81116 strains 
(0.020% (w/v)). Likewise, the second highest MIC value was observed in the 
NCTC11168CH isolate of C. jejuni upon exposure to chitosan concerning pH 6.5 
(Table 5.4). 
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Table 5.5: MIC values of C. jejuni when exposed low molecular weight chitosan (pH 6.5) on MH 
agar (n = 3, triplicate). 
Isolate/strain type Concentration (w/v) 
C. jejuni wild-type NCTC 11168 0.090% 
C. jejuni ‘adapted’ NCTC 11168 0.160% 
C. jejuni 11168CH 0.120% 
C. jejuni RM1221 
C. jejuni NCTC 11828 (81116) 
0.120% 
0.120% 
 
 
An increase in pH from 6.0 to 6.5 also accounted for greater MIC values in all 
strains/isolates of C. jejuni when employing the MIC agar dilution method, as 
expected (Table 5.5). Once again, the lowest MIC of chitosan was found in the 
wild-type NCTC11168 strain (0.090% (w/v)). This was followed by equal values 
of 0.120% (w/v) characteristic of the NCTC81116, RM1221 and NCTC11168CH 
isolate. Moreover, the highest MIC was typical of the ‘adapted’ isolate of 
NCTC11168 (0.160% (w/v)). 
 
5.4.3 Chitosan film activity  
 
Addition of 1cm chitosan films into MH broth medium (pH 6.0) accounted for an 
inhibition of growth relative to the respective control cells which were not subject 
to film exposure. The degree of growth inhibition in the presence of the chitosan 
film was found to be similar in all C. jejuni strains/isolates tested. Individual t-
tests comparing growth regarding the various strains/isolates revealed no 
significant differences from 0-52 hours as tested (p>0.05). Significant reductions 
were apparent during 4-48 hours for all strain/isolates of C. jejuni, relative to the 
respective control cells (p<0.05). Interestingly, after 52 hours incubation, all 
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strains/isolates exposed to chitosan films illustrated a substantial recovery, 
indicated by no significant differences in relation to their respective controls 
(Figure 5.1). 
 
 
 
Figure 5.1: Effect of chitosan film exposure with regards to C. jejuni strains/isolates relative to the 
untreated controls over the course of 52 hours at 42°C under microaerobic conditions (pH 6.0). 
Experiments were conducted n = 3 and plated in triplicate. Data represents mean values; error 
bars indicate SEOM. 
 
 
 
 
 
 
 
 
4.00
5.00
6.00
7.00
8.00
9.00
10.00
0 4 8 24 28 32 48 52
Lo
g (
10
) 
C
FU
/m
l r
e
co
ve
ry
 
Time (Hours) 
wt control Ad control 11168CH Control RM1221 Control
81116 Control 11168CH w/ film RM1221 w/film 81116 w/ film
Wt w/ film Ad w/ film
101 
 
 
5.4.4 Time kill inactivation results (MH broth) 
 
Time kill experiments were undertaken in both nutrient rich (MH broth) and 
nutrient limited (PBS) conditions to establish the extent to which nutrient 
availability may have on antimicrobial efficacy of chitosan.  
 
The figure overleaf (Figure 5.2) illustrates the difference in cell recovery following 
exposure to 0.01% (w/v) and 0.02% (w/v) chitosan with respect to C. jejuni 
strains/isolates under nutrient rich conditions, as provided by MH broth. 
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Figure 5.2: Effects of 0.01% (w/v) and 0.02% (w/v) chitosan exposure against wild-type NCTC11168 (A), “adapted” NCTC11168 (B), RM1221 (C), 81116 
(D) and 11168CH (E) C. jejuni strains/isolates over a time period of 6 hours, relative to untreated control samples (pH 6.0). Experiments were conducted n 
= 4, plated in triplicate. Data represents mean values; error bars indicate SEOM. 
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Upon exposure to 0.01% (w/v) and 0.02% (w/v) chitosan in MH broth (pH 6.0) 
with respect to the wild-type NCTC11168 strain of C. jejuni, no detectable cells 
were found to be viable after 6 hours and 4 hours, respectively (detection limit of 
1.50E+02 CFU/ml).  Significant differences were observed when comparing the 
untreated control cells relative to those which were subject to 0.01% (w/v) 
chitosan (F (13, 154) = 5370, p<0.0001) and 0.02% (w/v) chitosan treatment 
(F (13, 154) = 8251, p<0.0001), revealed by ANOVA analysis. Post hoc analysis 
revealed significant reductions in both 0.01% and 0.02% (w/v) chitosan treated 
cells, as oppose to the respective controls from 1-6 hour time intervals (p<0.05). 
However, no significant differences were found in relation to the control and 
respective treated cells at time point 0, as expected (p>0.05).  
 
Upon exposure of the chitosan ‘adapted’ isolate of C. jejuni NCTC11168 to 0.01% 
and 0.02% (w/v) chitosan incorporated in MH broth resulted in noticeable 
reductions from 2 – 6 hours, relative to the respective untreated cells (Figure 
5.2). When compared to the control cells, the respective chitosan treated cells 
illustrated a significant reductions in cell viability with respect to 0.01% (w/v) 
chitosan (F (13, 154) = 3824, p<0.0001) and 0.02% (w/v) chitosan (F (13, 154) 
= 10596, p<0.0001). Additional post hoc analysis revealed statistically 
significant decreases in cells recovery in all chitosan treated cells in relation to 
the respective untreated cells from 2-6 hours (p<0.05). A greater degree of 
antimicrobial activity was also found with an increase in chitosan concentration 
utilised (0.02% (w/v)), as expected.  
 
Interestingly, the ‘adapted’ treated cells were seen to be viable after 6 hours 
exposure to chitosan, whereas no wild-type NCTC11168 cells treated with 
chitosan were recovered after 6 hours when treated with 0.01% (w/v) chitosan 
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as shown in Figure 5.2. Moreover, substantial decreases were apparent with 
respect to 0.02% (w/v) chitosan exposure, with no viable cells recovered after 4 
hours exposure in the wild-type NCTC11168 cells, whilst for the ‘adapted’ 
NCTC11168 cells, viability cells were absent after an increased exposure time of 
6 hours.  
 
Similar to the wild-type NCTC11168 cells exposed to 0.01% (w/v) chitosan 
(Figure 5.2), cells regarding the RM1221 strain of C. jejuni were not found to be 
viable after 6 hours of exposure, suggesting that the RM1221 was also more 
susceptible to chitosan when compared to the ‘adapted’ NCTC11168 cells (Figure 
5.2). Significance decreases in cell viability were observed when comparing the 
treated control cells of RM1221 C. jejuni, relative to those exposed to 0.01% (F 
(13, 154) = 6616, p<0.0001) and 0.02% (w/v) chitosan (F (13, 154) = 19018, 
p<0.0001). Significant decreases in recovery were found as a result of post hoc 
analysis from 1-6 hours in respective chitosan treated cells of RM1221 (p<0.05). 
As expected, greater reductions were found in a time dependant manner with 
regards to those cells exposed to 0.02% (w/v) chitosan. Significant differences 
were found when comparing 0.02% (w/v) exposed cells to those treated with 
0.01% (w/v), from 3-6 hours (p<0.05). 
 
Additionally, significant differences in cell recovery was identified concerning the 
81116 C. jejuni strain when exposed to 0.01% (w/v) (F (13, 154) = 2918, 
p<0.0001) and 0.02% (w/v) chitosan (F (13, 154) = 9239, p<0.0001), relative 
to the untreated control cells. These decreases in recovery were seen to increase 
in a time dependant manner, with post hoc testing highlighting significantly lower 
recovery in respective chitosan treated cells versus the control from 1-6 hours 
(p<0.05). Interestingly, an absolute loss in cell recovery was not observed in the 
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RM1221 strain during the 6 hour time period (Figure 5.2), unlike the wild-type 
NCTC11168 and RM1221 strains which underwent treatment with chitosan at 
0.01% (w/v). However, when exposed to 0.02% (w/v) chitosan, no recoverable 
cells were detected after 6 hours. This absence in viable cells was similar with 
respect to the ‘adapted’ NCTC11168 cells upon treatment with 0.02% (w/v), 
accounting for no cell recovery after the same contact time. 
 
A similar inability of total cell viability loss after 6 hours exposure was typical of 
those treated with 0.01% (w/v) chitosan with regards to the 11168CH isolate 
(Figure 5.2), as in the ‘adapted’ NCTC11168 and 81116 cells. Once again, 
significant decreases in cell viability were indicated by ANOVA testing when 
comparing 0.01% (w/v) and 0.02% (w/v) chitosan treated cells relative to the 
control cells (F (13, 154) = 3974, p<0.0001; F (13, 154) = 4110, p<0.0001). 
Upon exposure to 0.02% (w/v) chitosan, no cells were recovered above the 
detection limit after 5 hours exposure, which was also the case for 0.02% (w/v) 
chitosan treated RM1221 cells.  
 
 
5.4.5 Time kill inactivation results (PBS) 
 
 
Results in Figure 5.3 represent the effect of low molecular weight chitosan upon 
the same C. jejuni strains/isolates tested previously, but in nutrient limited 
conditions: 
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Figure 5.3: Effects of 0.01% (w/v) and 0.02% (w/v) chitosan exposure against wild-type NCTC11168 (A), “adapted” NCTC11168 (B), RM1221 (C), 81116 
(D) and 11168CH (E) C. jejuni strains/isolates under nutrient limiting conditions (from 1-6 hours), relative to untreated control samples (pH 6.0). 
Experiments were conducted n = 4, plated in triplicate. Data represents mean values; error bars indicate SEOM.
A B C 
D E 
107 
 
No detectable cells were found after 4 and 3 hours when exposed to 0.01% 
(w/v) and 0.02% (w/v) chitosan in nutrient limited conditions (PBS), 
respectively (Figure 5.2). Significant differences were observed when comparing 
the untreated control cells in relation to those exposed to 0.01% (w/v) chitosan 
(F (13, 154) = 5264, p<0.0001) and also 0.02% (w/v) chitosan (F (13, 154) = 
9264, p<0.0001). As with illustrated in Figure 5.2 previously, the antimicrobial 
efficacy was also found to be dose and time dependant, with post hoc testing 
highlighting significant decreases in cells treated with both 0.01% and 0.02% 
(w/v) chitosan after 1 hour exposure onwards (p<0.05). 
 
When compared to the wild-type NCTC11168 treated cells under nutrient 
depleted conditions (Figure 5.3), a decreased susceptibility was generally 
observed in the ‘adapted’ NCTC11168 cells (Figure 5.3). Significant decreases 
were found in relation to the chitosan treated cells of the ‘adapted’ NCTC11168 
cells when treated to 0.01% (w/v) and 0.02% (w/v) chitosan in relation to the 
untreated control cells from 2-6 hour exposure (F (13, 154) = 24826, p<0.0001) 
and from 1-6 hours (F (13, 154) = 15224, p<0.0001), respectively. No viable 
cells were viable, above the detection limit after 5 hours and 4 hours exposure to 
0.01% (w/v) and 0.02% (w/v) chitosan, when compared to the wild-type 
NCTC11168 treated cells in which no viable cells were found after 4 hours and 3 
hours under the same concentrations, respectively.  
 
Exposed C. jejuni RM1221 cells to concentrations of 0.01% (w/v) and 0.02% 
(w/v) chitosan caused significant decreases in cell recovery with respect to 
untreated cells from 1-6 hours in both cases (F (13, 154) = 26151, p<0.0001) 
and (F (13, 154) = 19492, p<0.0001), respectively (p<0.05). This was similar to 
treated wild-type NCTC11168 cells (Figure 5.3), indicative by a lack of viability 
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after 4 hours and 3 hours exposure to 0.01% (w/v) and 0.02% (w/v) chitosan, 
respectively.  
 
An increased chitosan tolerance, comparable to the ‘adapted’ NCTC11168 cells 
appeared was apparent with regards to the 81116 C. jejuni cells upon exposure 
to 0.01% (w/v) and 0.02% (w/v) chitosan (Figure 5.3). Significant differences 
were found from 1-6 hours exposure to chitosan at both 0.01% (w/v) (F (13, 
154) = 24819, p<0.0001) and 0.02% (w/v) of chitosan concentrations used (F 
(13, 154) =2611, p<0.0001). Similarly, a total loss of cell recovery was also 
observed after 4 and 5 hours chitosan exposure to 0.02% (w/v) and 0.01% 
(w/v) chitosan in nutrient limiting conditions for NCTC11168CH cells, respectively 
(Figure 5.3). Nevertheless, significant decreases were also observed from 1-6 
hours upon exposure to 0.01% (w/v) (F (13, 154) = 14330, p<0.0001) and 
0.02% (w/v) chitosan (F (13, 154) = 17212, p<0.0001), relative to untreated 
control, confirmed by post hoc testing (p<0.05). 
 
 
5.4.6 Effects of chitosan on growth inhibition  
 
The effects of sub-lethal concentrations of low molecular weight chitosan equal to 
0.5X and 1X wild-type NCTC11168 MIC (0.0008% and 0.0016% (w/v), 
respectively) were also investigated over a period of 26 hours (Figure 5.4).
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Figure 5.4: Inhibition of growth following exposure to 0.0008% (w/v) and 0.0016% (w/v) chitosan with regards to wild-type NCTC11168 (A), ‘adapted’ 
NCTC11168 (B), RM1221 (C), 81116 (D) and 11168CH (E) C. jejuni cells grown under control conditions (pH 6.0). Experiments were performed n = 4 and 
plated in triplicate. Data represents mean values; error bars indicate SEOM. 
A B C 
D E 
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Growth in MH broth (pH 6.0) with final concentrations of 0.0008% (w/v) and 
0.0016% (w/v) chitosan were found to significantly inhibit wild-type C. jejuni 
NCTC11168 recovery in comparison to the untreated control cells as expected. 
Log reductions of 1.6, 1.55, 1.7 and 1.28 were typical upon exposure to 
0.0008% (w/v) chitosan after 14, 18, 22 and 26 hours exposure, respectively. 
As expected, when a greater inhibition was observed in relation to cells 
subjected to 0.0016% (w/v) chitosan, with log reductions typical of 3.15, 3.70, 
4.04 and 3.88 after 14, 18, 22 and 26 hours exposure, respectively (Figure 5.4). 
Significant reductions in viable cells were also found from 14-26 hours sampled 
for both chitosan concentrations used relative to the respective controls at the 
given time point F (8, 80) = 7043, p<0.0001), confirmed by post hoc analysis. 
Lesser significant decreases in cell recovery were also found in relation to the 
‘adapted’ NCTC11168 cells when grown in the presence of chitosan at 0.0008% 
(w/v) and 0.0016% (w/v) chitosan (F (8, 80) = 936.5, p<0.0001). This was 
seen to be dose dependant, with log reductions typical of 0.8, 0.78, 0.65 and 
0.30 when exposed to 0.0008% (w/v) chitosan and 1.47, 1.92, 1.8 and 1.59 
with regards to 0.0016% (w/v) chitosan exposure at 14, 18, 22, and 26 hours, 
respectively (Figure 5.4). 
Growth was also seen to be significantly inhibited with respect to RM1221 cells 
exposed to 0.0008% (w/v) and 0.0016% (w/v) chitosan over the course of 26 
hours tested (F (8, 80) = 1431, p<0.0001). Upon exposure to 0.0008% (w/v) 
chitosan, log reductions typical of 0.8, 1.16, 1.01 and 0.95 were seen after 14, 
18, 22 and 26 hours exposure relative to the respective control counts (p<0.05). 
Greater reductions were found observed with respect to the cells grown in the 
presence of 0.0016% (w/v) chitosan, typical of log CFU/ml decreases totalling 
1.97, 2.37, 2.28 and 2.22 after 14, 18, 22 and 26 hours growth (Figure 5.4). 
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Growth was also found to be inhibited when the 81116 cells were exposed to 
chitosan, with a greater inhibition when grown in 0.0016% (w/v) chitosan 
(Figure 5.4). Significant differences were observed from 14-26 hours incubation, 
with log reductions of 0.88, 1.11, 0.9 and 0.59 at 14, 18, 22 and 26 hours 
growth relative to the untreated control samples (p<0.05). Log reduction in 
relation to the control cells of the 81116 strain were found to be 1.54, 1.92, 1.87 
and 1.48 when grown in the presence of 0.0016% (w/v) chitosan (F (8, 80) = 
1246, p<0.0001). 
 
Upon exposure of the NCTC11168CH isolate to 0.0008% (w/v) and 0.0016% 
(w/v) chitosan, significant decreases in growth were observed as indicated by a 
reduction in viable cells during 14, 18, 22 and 26 hours (p<0.05). After 14, 18, 
22 and 26 hours of growth, log reductions of 0.7, 0.77, 0.93 and 0.67 were 
found when cells were grown in the presence of 0.0008% (w/v) chitosan 
(p<0.05). Whereas, when exposed to 0.0016% (w/v) chitosan, greater 
significant log decreases in growth were observed after 1.83, 1.74, 1.84 and 
1.63 during 14, 18, 22 and 26 hours growth (F (8, 80) = 5030, p<0.0001). 
 
When comparing the viable cells after 26 hours of incubation when grown in 
0.0008% (w/v) chitosan, the greatest growth inhibition was established in the 
wild-type NCTC11168 cells (8.32 log CFU/ml), followed by the RM1221 cells 
(8.53 log CFU/ml), 81116 cells (8.77 log CFU/ml), NCTC11168CH cells (9.00 log 
CFU/ml) and lastly the ‘adapted’ NCTC11168 cells (9.30 log CFU/ml), found to 
represent the lowest amount of total growth inhibition. These differences were 
identified to be significantly different (F (4, 40) = 259.2, p<0.0001), as 
confirmed by post hoc testing (p<0.05). 
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A similar trend in the overall growth inhibition typical of cells grown for 26 hours 
under an increased concentration of 0.0016% (w/v) chitosan was evident. Once 
again, the wild-type NCTC11168 was seen to illustrate the greatest susceptibility 
in viable cells recovered (5.72 log CFU/ml), followed by RM1221 cells (7.26 log 
CFU/ml), 81116 (7.88 log CFU/ml), ‘adapted’ NCTC11168 (8.01 log CFU/ml) and 
the lowest in the NCTC11168CH cells (8.04 log CFU/ml). One way ANOVA 
revealed that a significant differences between mean log CFU/ml values between 
strains/isolates tested (F (4, 40) = 6415, p<0.0001). Post hoc analysis indicated 
that cell recovery in relation to the ‘adapted’ and NCTC11168CH isolates was not 
significantly different (p>0.05). 
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5.5 Discussion 
 
The antimicrobial activities of chitosan are widespread, having been identified in 
a range of microorganisms including fungi, yeasts and bacteria species alike 
(Raafat and Sahl, 2009). This chapter demonstrated there are indeed differences 
in the antimicrobial susceptibility of low molecular weight chitosan against the C. 
jejuni strains/isolates tested. 
 
When comparing MIC values of the C. jejuni strains/isolates tested, the 
antimicrobial activity of chitosan was found to be dependent upon the pH. MIC 
Fold increases of 16.25, 10.43, 13.6, 12.5 and 9.4 were found with regards to 
the wild-type NCTC11168, ‘adapted’ NCTC11168, RM1221, 11168CH and 81116 
upon increasing to pH 6.5, as oppose to the MIC values obtained at pH 6.0. 
 
This coincides with previous studies have previously indicated that antimicrobial 
activity for chitosan is pH dependent (Kong, 2008). This is thought to be the 
case, as chitosan is only soluble in an acidic environment and becomes 
polycationic at pH values below the pKa (6.3-6.5) (Lim and Hudson, 2004). It 
has also been reported that chitosan only exerts antimicrobial activity under 
acidic conditions exclusively (Helander et al., 2001). 
 
The rationale for performing the time kill and growth inhibition studies 
exclusively at pH 6.0 was based on recurrent issues with solubility when 
adjusting low molecular weight chitosan to a final pH of 6.5. As a result of this, 
experiments utilising pH6.5 media/chitosan were avoided. At pH greater than 
6.5, chitosan solutions is said to exhibit phase separation, whereas when at a pH 
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below 6.5, chitosan is readily soluble, carrying an positive charge via protonation 
of amino groups (Kumirska et al., 2011; Elsabee et al., 2009). Chitosan is 
considered as a strong base due to the possession of amino groups which have a 
pKa value of around 6.3 (Saied and Aider, 2014). The presence of these amino 
groups suggest that pH may change the state of both charge and properties of 
the chitosan, when the pH is below the pKA of chitosan, it is polycationic whilst 
at pH of 4 and below, chitosan is completely protonated (Jayakumar et al., 
2010).  
 
To summarise, the time kill assays concerning chitosan exposure over a period of 
6 hours revealed clear differences in susceptibility between the C. jejuni 
strains/isolates tested. Exposure to both 0.01% (w/v) and 0.02% (w/v) chitosan 
revealed varying degrees of total cell viability/recovery over this period of 6 
hours exposure. In general, the most susceptible C. jejuni strains were found to 
be the wild-type NCTC11168 and RM1221 strains, both indicating an absence 
viable cells detected after 6 hours exposure to 0.01% (w/v) chitosan when 
incorporated in MH broth. Similar observations were found upon challenging to 
the same concentrations of chitosan in the time kill experiments involving 
nutrient limited conditions, as simulated by a PBS environment. Both the wild-
type NCTC11168 and RM1221 cells were not recovered after 4 hour and 3 hours 
when challenged to 0.01% (w/v) and 0.02% (w/v) chitosan, respectively.  
 
The greatest tolerance to chitosan indicated by the time kill experiments was 
observed in the ‘adapted’ NCTC11168 cells of C. jejuni. Viable cells were found 
even after 6 hours exposure to 0.01% (w/v) chitosan (3.59 log CFU/ml), which 
was found to be significantly higher than the recovery found after 6 hours 
exposure with respect to the 81116 cells (2.50 log CFU/ml detected) and 
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NCTC11168CH cells (2.60 log CFU/ml detected). Exposure to 0.02% (w/v) 
chitosan indicated a similar susceptibility pattern between the ‘adapted’ 
NCTC11168 and the 81116 cells challenged, indicative of a total loss of viable 
cells after 6 hours exposure in all cases.  
 
Moreover, comparable losses in cell viability were observed when concerning the 
‘adapted’ NCTC11168, 81116 and NCTC11168CH cells to 0.01% (w/v) and 
0.02% (w/v) chitosan when suspended in PBS (nutrient limitation conditions), 
with no detectable cells following 5 and 4 hours, respectively for all 
strains/isolates. In contrast, an increased susceptibility was apparent with 
regards to the wild-type NCTC11168 and RM1221 exposed cells, with a complete 
loss in cell recovery after 4 and 3 hours exposure to 0.01% (w/v) and 0.02% 
(w/v) chitosan, respectively for both strains. These findings suggest that under 
nutrient depleted conditions (PBS), all strains/isolates of C. jejuni were found to 
have a greater degree of susceptibly when challenged to chitosan in MH broth, 
indicated by prolonged cell viability with respect to the latter condition.  
 
Time kill experiments were also seen to be consistent with findings with respect 
to chitosan susceptibility in growth inhibition studies, at sub-lethal concentrations 
of both 0.0008% (w/v) and 0.0016% (w/v) chitosan. For example, after 26 
hours of incubation when growth in 0.0008% (w/v) chitosan, the greatest growth 
inhibition was identified for the wild-type NCTC11168 cells with the ‘adapted’ 
NCTC11168 cells occupying the lowest degree of inhibition under the same 
conditions. The resulting inhibition following growth in 0.0016% (w/v) chitosan 
accounted for a substantial decrease in cell recovery with respect to the wild-
type cells, whereas both the ‘adapted’ and NCTC11168CH isolates were seen to 
have an enhancement in growth following 26 hours exposure. 
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Generally, these above findings support the MIC values obtained at pH 6.0, with 
the lowest MIC values, with the particular respect to the wild-type NCTC11168 
strain when compared to the other strains/isolates tested. Results also coincide 
with greater tolerance seen in the ‘adapted’ NCTC11168 isolate in particular 
comparison to the wild-type NCTC11168 cells upon challenge to chitosan. 
 
Previous studies on the antimicrobial activity of chitosan with respect to 
Campylobacter are limited. One study conducted by Ganan et al. (2009), 
illustrated differences in the antimicrobial activity of chitosan against strains of 
Campylobacter even when utilising chitosan previously adjusted to pH 7.0. In 
this study, all strains of C. jejuni were found to be inhibited at a chitosan 
concentration of 0.05% (w/v), although at a lower concentration of 0.01% (w/v), 
C. jejuni LP1 strain did not show any significant decrease in cell number when 
challenged at pH 7.0 relative to the untreated control. In contrast, the C. jejuni 
NCTC11168 and NCTC11351 strains illustrated varying degrees of inhibition upon 
exposure to the same concentration of chitosan. Results in this study concluded 
the Campylobacter species in a general sense illustrated greater sensitivity to 
chitosan, reinforced by a lower susceptibility found in P. aeruginosa, S. aureus 
and Lactobacillus spp. under the same conditions (Ganan et al., 2009).  
 
Discrepancies between findings in this chapter with respect to results found in 
the above study are more than likely due to the differences in the pH of chitosan 
and diluent used. Chitosan has been shown to illustrate a stronger inhibition 
towards bacterial species at lower pHs, with a weakening at pH values above the 
pKa (Kong et al., 2008). Although it seems chitosan is not completely inactive in 
terms of antimicrobial activity at pH 7, as indicated by Ganan et al. (2009), an 
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increased susceptibility in C. jejuni strains/isolates established in this chapter 
may reflect the reduced ability of chitosan to remain bactericidal at pH 7. This 
may be due to the presence of a larger quantity of uncharged amino groups and 
well as poor solubility at this pH (Sudarshan et al., 1992). Thus, it seems 
relatively small shifts in pH can account for a drastic alteration in the 
antimicrobial activity of chitosan (Jumaa et al., 2002; Devlieghere et al., 2004). 
The differences in sensitivity of C. jejuni strains/isolates tested may explain how 
such fragile microorganisms can potentially become much more of an issue 
through decreases in susceptibility to antimicrobials such as chitosan. With 
particular attention to the generated ‘adapted’ isolate of C. jejuni NCTC11168, it 
is clear that an adaptive tolerance response towards low molecular weight 
chitosan can allow for significant increases in the ability to withstand such sub-
inhibitory and lethal concentrations of chitosan.  
 
With respect to the antimicrobial activity of chitosan films when added to MH 
broth (pH 6.0), although effective in significantly reducing growth of all C. jejuni 
strains/isolates tested, no significant differences between the strains/isolates 
tested were established. It can therefore be concluded that chitosan film activity 
is broadly effective towards C. jejuni in a global sense. Additionally, chitosan 
films could be of use in decreasing the bacterial load of Campylobacter species 
with respect to foodstuffs, for instance during poultry processing. This suggests 
the need for further study using food models to determine if these films exert 
similar effects in a real world scenario. Surprisingly, there appears to be no 
literature with regards to the antimicrobial efficacy of chitosan film activity 
against Campylobacter species. 
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C. jejuni strains have previously been found to have differing degrees of 
sensitivity to a range of antibiotics, which has been shown to be isolate 
dependant (Kumar-Phillips et al., 2013). Exposure to sub-lethal stresses may 
give rise to increasing amounts of resistance of C. jejuni, assisting in an 
increased survival potential. This can potentially prove to play a major role 
differences in aspects such as cross protection towards different stressors 
(Kumar-Phillips et al., 2013). Bacteria exposed to non-lethal (sub-inhibitory) 
concentrations of antibiotics have been suggested to play an important role upon 
generation of resistance; such changes may induce variability in genotype and 
phenotype (Andersson and Hughes, 2014).  
 
With the above in mind, the exploration of the phenotypic and genotypic aspects 
resulting from C. jejuni challenge to chitosan was subsequently tested in the 
following chapters (chapter 6 and 7, respectively).  
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Chapter 6 – Phenotypic differences of C. 
jejuni in relation to biofilm, production, 
motility and chemotaxis 
 
 
6.1 Introduction 
 
 
In order for C. jejuni to become established in a given host and food-related 
environment, it must also be able to undergo phenotypic alterations which can 
ultimately lead to an increased survival potential. Several factors are believed to 
have a bearing upon survival, virulence and subsequent pathogenesis of C. 
jejuni. These include, but are not limited to biofilm formation, motility and 
chemotaxis. 
 
Many microorganisms are thought to be able to form biofilms. The primary 
feature of this phenotype involves the production of extracellular materials which 
function as a protective mechanism of cell embedment (Flemming and Wingener, 
2010). Food contact surfaces are ideal environments which can allow for the 
formation of biofilms. Despite strict cleaning and disinfection regimes, planktonic 
cells can often settle in hard to access regions due to surface irregularities for 
instance (Orgaz et al., 2011). In the event of improper cleaning, microbial cell 
transfer can occur from the biofilm onto foodstuffs, which is hazardous from a 
food safety and quality perspective (Shi and Zhu, 2009). 
 
Usually, in natural, industrial or clinical environments, bacteria species are more 
likely to be found as a biofilm, as oppose to a planktonic state (O’Toole et al., 
2000; Reeser et al., 2007). Increased protection from various stresses such as 
sanitizers and antibiotics/antimicrobials can occur as a result of biofilm 
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formation. This is thought to be due partly to an increased nutrient access as 
well as genetic exchange between the cellular community within the biofilm 
(Hanning and Slavik, 2009). Formation of biofilms has been found to increase 
following stresses related to nutrient depletion (Ryu et al., 2004). Also it has 
been previously documented that Campylobacter species can form biofilm in a 
range of environments including aquatic environments, on stainless steel and 
also on glass (Somers et al., 1994: Buswell et al., 1998; Joshua et al., 2006). 
 
Motility observed in C. jejuni is often associated with the process of chemotaxis, 
another factor thought to contribute to the overall virulence potential. 
Essentially, chemotaxis has been shown to facilitate the migration of C. jejuni 
towards favourable conditions and also away from unfavourable environmental 
conditions (Hermans et al., 2011). A number of genes are believed to be 
associated with the chemotactic response in C. jejuni, these include energy taxis 
response genes, cetA and cetB (Golden and Archeson, 2002). In terms of overall 
regulation of the chemotactic response to stimuli, the cheY gene, coding for a 
response regulator, has been found also to govern flagellar rotation (Stephens et 
al., 2006). In one study, mutants deficient in cheY have been reported to affect 
the degree of colonisation of the intestinal tract of chicks (Hendrixson and 
DiRita, 2004).  
 
Additionally, flagella are often associated with bacterial biofilm formation, in 
many microorganisms including Pseudomonas (Barken et al., 2008), Yersinia 
(Kim et al., 2008) and Vibrio species (Watnick et al., 2001). There has also been 
evidence to suggest that biofilm formation is dependent upon flagella in C. jejuni 
(Reuter et al., 2010). C. jejuni mutant deficient in FlaAB have been shown to 
occupy a reduced ability to form biofilms when compared to motile wild-type C. 
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jejuni NCTC11168. Additionally, when comparing a non-motile variant of C. 
jejuni against a motile NCTC11168 variant, after 48 hours of biofilm growth, a 
reduction of over 50% was observed with respect to the non-motile variant 
(Reuter et al., 2010). Interestingly, a study has also suggested the potential role 
of flagella as an adhesion factor during biofilm formation (Kirov et al., 2004).  
Nevertheless, flagellar components have also been recognised as important 
initiators of biofilm formation both in terms of solid surfaces (attached) and also 
pellicle formation within liquid cultures. This was indicated by an enhanced 
expression of proteins thought to be involved in the flagellar motility complex 
(Kalmokoff et al., 2006). 
  
Therefore, it can be assumed that these phenotypes present in C. jejuni are 
linked. This chapter attempted to assess the phenotypes regarding motility, 
biofilm and chemotaxis phenotypes was undertaken to illustrate any 
trends/discrepancies which may occur amongst C. jejuni strains/isolates 
previously tested. 
 
6.2 Aims and objectives 
 
6.2.1 Aim 
 
This chapter aimed to assess any differences in phenotypes related to motility, 
chemotaxis and biofilm formation. 
 
6.2.2 Objectives 
 
 To determine any differences in motility between C. jejuni strains/isolates. 
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 To establish the chemotactic response of C. jejuni to the presence of low 
molecular weight chitosan in relation to control chemicals. 
 
 To assess potential differences in biofilm formation/eradication in relation 
to several C. jejuni strains/isolates in the presence and the absence of 
chitosan. 
 
 
6. 3 Materials and Methods 
 
6.3.1 Motility assay 
 
 
In order to establish the degree of motility between strains/isolates of C. jejuni, 
methods adapted from Tareen et al., (2010) were employed. Briefly, 2µl of an 
overnight culture of approximately 1x108 was stabbed into the centre of an agar 
plate containing 0.4% MH agar (pH 7.0) with a sterile pipette tip. Plates were 
then incubated at 42°C under microaerobic conditions for 24, 48 and 72 hours. 
The low concentration of Mueller-Hinton agar allowed the bacteria to swarm 
within the agar. Each experiment was performed 3 times in triplicate. 
 
6.3.2 Chemotaxis assay 
 
 
A chemotaxis assay was undertaken as described by Hugdahl et al. (1988) and 
Vegge et al. (2009). Overnight cultures of C. jejuni Mueller-Hinton broth were 
washed in phosphate-buffered saline (PBS) and the bacterial concentration 
adjusted to approximately 2x109 cfu/ml with temperate soft Bacteriological agar 
(0.4% v/v). Ten millilitres of bacterial suspension was poured into a sterile petri 
dish and 2cm filter discs (Whatman, UK) saturated with test chemicals (0.1 M 
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and pH 6) were placed on the solidified soft agar comprising of the bacterial 
suspension. Following 4 hours of incubation at 42°C under microaerobic 
conditions, the chemotactic activity was examined over a light source provided 
by the GeneSys Gel Dock (SynGene). Bacterial accumulations or clearing zones 
were interpreted as zones of chemo-attraction and migration away from a test 
chemical was considered as chemo-repulsion. 
 
6.3.3 Biofilm formation assay 
 
Biofilm formation experiments were performed adapted from Reeser et al. 
(2007). The wells of 96-well polystyrene plates contained either 200µl Mueller-
Hinton broth (pH 6.0) of a mixture of MH broth and low molecular chitosan (pH 
6.0) to a final concentration ranging from 0.002% (w/v) – 0.032% (w/v) 
following inoculation from prepared overnight cultures of C. jejuni to a final 
concentration of 1x107 cfu/ml. Plates were then incubated under microaerobic 
conditions at 42°C for 48 and 72 hours.  
 
The well contents were then removed via pipetting and residues were dried for 
30 minutes at 55°C, after which 250µl 0.1% (w/v) crystal violet (CV) was added 
for 5 min at room temperature. Unbound CV was then removed, and the wells 
were washed twice with sterile distilled water. The wells were dried once again 
at 55°C for 15 minutes prior to bound CV undergoing de-colourisation with 250µl 
of an 80% ethanol-20% acetone mix. One hundred microliters of the solution 
from each well was removed and placed in a 96-well plate, and the absorbance 
at 595nm was determined using a Bio-Rad 680XR Microplate reader. 
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6.3.4 Biofilm eradication assay  
 
Biofilm eradication was investigated using a similar methodology as above, with 
the exception 48 hours prior incubation in the absence of chitosan. This was 
then followed by media replacement with a subsequent 24 hour incubation to 
follow. With respect to control pre-formed biofilms, chitosan-free MH media 
replenishment was administered. The remaining biofilms were exposure to the 
same range of chitosan concentrations as above and exposed for 24 hours. This 
was then followed by crystal violet staining and absorbance quantification, as 
before.  
 
 
6.4 Results 
 
6.4.1 Motility comparison in C. jejuni strains/isolates 
 
Data in Figure 6.1 demonstrates an increase in motility over the course of 
incubation time period, ranging from 24 hours to 72 hours. This was indicated by 
highly significant differences which was apparent upon conducting one way 
ANOVA regarding all strains/isolates tested (F (14, 255) = 159.6, p<0.0001). 
Post hoc testing confirmed this, with all respective C. jejuni strains/isolates 
illustrating significant increases in motility with an increase in incubation time, as 
expected (p<0.05). 
 
The greatest overall motility was generally observed in the RM1221 strain, the 
“adapted” C. jejuni NCTC11168 isolate was the next most motile, followed by 
the NCTC11168 isolate which had previously undergone passage through a 
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chicken (11168CH). The 81116 and the wild-type NCTC11168 cells were found 
to be least motile. This trend was representative at all time points. 
 
 
 
Figure 6.1: Motility comparison between several strains/isolates of C. jejuni. Experiments were 
performed n = 6, triplicate. Data represents mean values; error bars indicate SEOM. 
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Figure 6.2: Representative motility comparison between (A) wild-type NCTC11168, (B) ‘adapted’ 
NCTC11168, (C) RM1221, (D) 81116 and (E) 11168CH strains/isolates of C. jejuni representative 
of 72 hours incubation under microaerobic conditions at 42°C.  
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D E 
127 
 
One way ANOVA testing identified significant differences between motility in the 
C. jejuni strains/isolates tested were typical after 24 hours (F (4, 85) = 30.07, 
p<0.0001), 48 (F (4,85) = 260.2, p<0.0001) and 72 hours incubation (F (4,85) 
= 14.78, p<0.0001). 
 
Further post hoc analysis revealed that the amount of motility observed after 24 
hours of incubation was seen to be significantly different when comparing all C. 
jejuni strains/isolates, with the exception of the “adapted” NCTC11168  isolate 
versus  the RM1221 strain (p<0.05). Overall, the greatest difference in motility 
was seen in the RM1221 strain, with an increase of 1.08cm relative to the wild-
type isolate of C. jejuni NCTC11168.  
 
With respect to motility post 48 hours incubation, post hoc analysis indicated 
significance when comparing C. jejuni strains/isolates tested, excluding the 
negligible difference between the chitosan “adapted” and 11168CH isolates, with 
a slight variance 0.16cm in diameter (p<0.05). Similar to the degree of motility 
after 24 hours incubation, the greatest decrease in motility was found in the 
wild-type C. jejuni NCTC 11168 isolate relative to the RM1221 strain (-2.09cm). 
Additionally,  after 72 hours of incubation, post hoc analysis suggested 
significant differences in C. jejuni strains/isolates compared bar the wild-type 
NCTC11168 versus the 81116 strain, “adapted” NCTC11168 isolate in relation to 
the RM1221 strain and also the 81116 strain when compared to the 11168CH 
isolate (p<0.05). Similar to the above, the greatest significant decrease in 
motility between strains/isolates was typical of the wild-type NCTC11168 cells in 
relation to the RM1221 strain (-1.54cm).  
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6.4.2 Chemotaxis of C. jejuni strains/isolates 
 
 
The following figure represents chemotactic activity of C. jejuni strains/isolates 
after 4 hours incubation at 42°C under microaerobic conditions (Figure 6.3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3: Representative Chemotaxis activity of C. jejuni strains/isolates in response to 0.1M L-
cysteine, 0.1M deoxycholic acid, 0.25% (w/v) chitosan and PBS (pH 6.0) for 4 hours. Experiments 
were performed at 42°C under microaerobic conditions and repeated on three independent times 
in triplicate. 
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The chemotactic response was found to be similar in all C. jejuni strains/isolates 
tested (Figure 6.3). Chemo-attraction was observed when C. jejuni were 
exposed to positive control, 0.1M L-cysteine, as indicated by the accumulation of 
cells around the saturated disk. Chemo-repulsion was typical in response to 
0.1M deoxycholic acid (negative control), typical of a clearing of cells from this 
stimulus. 0.25% (w/v) of chitosan produced a chemo-repulsive phenotype for all 
strains of C. jejuni, whilst no response was found with regards to PBS. 
 
 
6.4.3 Biofilm formation after 48 hours incubation 
 
 
Figure 6.4: Comparison of wild-type C. jejuni NCTC 11168 biofilm formation after 48 hours 
incubation in the absence or presence of various concentrations of chitosan, whilst under 
microaerobic conditions at 42°C (pH 6.0). Data shown concerns mean absorbance values. 
Experiments were performed three times in triplicate, error bars indicate the SEOM. (Note: 
negative control wells containing non-inoculated MH broth accounted for an average mean 
absorbance of 0.043nm at 595nm). 
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The degree of biofilm formation with respect to wild-type C. jejuni NCTC 11168 
after 48 hour incubation at pH 6.0, as represented by the amount of absorbance 
was found to be significantly different when comparing those grown in the 
absence of chitosan (control) against those which were formed in the presence 
of low molecular weight chitosan (F (5, 48) = 65.05, p<0.0001). Post hoc 
analysis revealed significant differences in biofilm formation with respect to all 
those formed in all concentrations of chitosan when compared to the control 
(p<0.05). Interestingly, an increase in biofilm formation (0.08nm) was found 
with regards to the 0.002% (w/v) chitosan, relative to the cells which were not 
exposed to chitosan. A decrease in biofilm formation was typical from 0.004% 
(w/v) to 0.032% (w/v) relative to those formed under control conditions. These 
decreases were found to be 0.09nm, 0.15nm, 0.15 and 0.18, respectively 
(Figure 6.4). 
 
Figure 6.5: Comparison of ‘adapted’ C. jejuni NCTC 11168 biofilm formation after 48 hours 
incubation in the presence or absence of chitosan, whilst under microaerobic conditions at 42°C 
(pH 6.0). Data shown concerns mean absorbance values. Experiments were performed three times 
in triplicate, error bars indicate the SEOM. (Note: negative control wells containing non-inoculated 
MH broth accounted for an average mean absorbance of 0.043nm at 595nm). 
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Similar to the biofilm formation seen in the wild-type C. jejuni NCTC 11168, the 
chitosan ‘adapted’ isolate of C. jejuni NCTC 11168 was seen to differ in terms 
formation when exposed to different concentrations of chitosan over the course 
of 48 hours. Biofilm formation was found to be substantially increased in the 
presence of 0.002% (w/v) chitosan in comparison to the control cells grown in 
the absence of chitosan. An apparent decrease in formation was typical for those 
biofilms which were grown in final concentrations of 0.004% (w/v) – 0.032% 
(w/v) chitosan, as oppose to those in the control conditions. These differences 
were found to be statistically significant (F (5, 48) = 107.6, p<0.0001) and 
typical of 0.05, 0.21, 0.21 and 0.24nm, respectively. Post hoc analysis 
reinforced these observations with the exception of those biofilms formed in 
0.004% (w/v) chitosan, which was not deemed significantly different from the 
control samples (p>0.05) (Figure 6.5). 
 
Figure 6.6: Comparison of C. jejuni RM1221 biofilm formation after 48 hours incubation in the 
presence or absence of chitosan, whilst under microaerobic conditions at 42°C (pH 6.0). Data 
shown concerns mean absorbance values. Experiments were performed three times in triplicate, 
error bars indicate the SEOM. (Note: negative control wells containing non-inoculated MH broth 
accounted for an average mean absorbance of 0.043nm at 595nm). 
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After 48 hours of biofilm formation with respect to the RM1221 strain of C. 
jejuni, statistically significant differences in the absorbance from biofilm 
formation was observed when comparing those cells grown in the presence of 
chitosan against the cells characteristic of the control (F (5, 48) = 11.63, 
p<0.0001). However, post hoc analysis identified no significant difference 
between the biofilm formed under control conditions in relation to 0.002% (w/v), 
0.004% (w/v), 0.008% (w/v) or 0.016% (w/v) chitosan (p>0.05). The only 
significant difference was found in relation to the biofilms formed under control 
conditions versus those exposed to 0.032% (w/v) chitosan (p<0.05). 
Interestingly, the amount biofilm formation was found to be fairly consistent 
when comparing the control against those formed in concentrations of chitosan 
ranging from 0.002% (w/v) – 0.016% (w/v) (Figure 6.6). 
 
 
Figure 6.7: Comparison of C. jejuni 81116 biofilm formation after 48 hours incubation in the 
presence or absence of chitosan, whilst under microaerobic conditions at 42°C (pH 6.0). Data 
shown concerns mean absorbance values. Experiments were performed three times in triplicate, 
error bars indicate the SEOM. (Note: negative control wells containing non-inoculated MH broth 
accounted for an average mean absorbance of 0.043nm at 595nm). 
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A similar trend was observed in Figure 6.7, concerning the 81116 strain of C. 
jejuni with regards to consistent biofilm formation under control conditions and 
chitosan concentrations of 0.002% (w/v) – 0.016% (w/v). Although one-way 
ANOVA analysis found a significant difference between the control biofilm 
formation against those formed under chitosan conditions (F (5, 48) = 33.32, 
p<0.0001), post hoc testing suggested no significant difference in relation to the 
biofilm formation under control conditions against those concerned with 0.002% 
(w/v), 0.004% (w/v) and 0.016% (w/v) chitosan exposure (p>0.05). However, 
a significant difference in absorbance was reported between the control and both 
the 0.008% (w/v) and 0.032% (w/v) conditions (p<0.05) and were typical of 
0.05nm and 0.17nm, respectively.  
 
 
Figure 6.8: Comparison of C. jejuni 11168CH biofilm formation after 48 hours incubation in the 
presence or absence of chitosan, whilst under microaerobic conditions at 42°C (pH 6.0). Data 
shown concerns mean absorbance values. Experiments were performed three times in triplicate, 
error bars indicate the SEOM. (Note: negative control wells containing non-inoculated MH broth 
accounted for an average mean absorbance of 0.043nm at 595nm). 
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The degree of biofilm formation regarding the 11168CH isolate was found to 
follow a similar trend as in the ‘adapted’ isolate of C. jejuni NCTC 11168. This 
was typical of an increase significant increase in formation of biofilms between 
control and 0.002% - 0.004% (w/v) chitosan samples, followed by a decrease 
from 0.008% (w/v) – 0.032% (w/v) chitosan conditions (F (5, 48) = 40.65, 
p<0.0001). However, post hoc analysis found that no significant difference was 
typical when comparing the control biofilm formation against both that of 
0.004% (w/v) and 0.016% (w/v) chitosan exposure (p>0.05) (Figure 6.8). 
 
 
6.4.4 Biofilm formation after 72 hours incubation 
 
 
 
Figure 6.9: Comparison of C. jejuni wild-type NCTC11168 biofilm formation after 72 hours 
incubation in the presence or absence of chitosan, whilst under microaerobic conditions at 42°C 
(pH 6.0). Data shown concerns mean absorbance values. Experiments were performed three times 
in triplicate, error bars indicate the SEOM. (Note: negative control wells containing non-inoculated 
MH broth accounted for an average mean absorbance of 0.043nm at 595nm). 
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After 72 hours of incubation, the degree of biofilm formation was seen to be 
somewhat similar to wild-type C. jejuni NCTC 11168 cells after 48 hours (Figure 
6.9). A small initial increase in the degree of biofilm formation as indicated by 
the relative increase in absorbance was observed with respect to growth under 
0.002% (w/v) chitosan. Biofilms grown in 0.004% (w/v) – 0.032% (w/v) 
chitosan were seen to be diminished, when compared to that of the control. 
One-way ANOVA accounted for a significant difference between control and 
chitosan exposed biofilms (F (5, 48) = 42.15, p<0.0001). Although post hoc 
analysis highlighted significant differences when comparing the biofilm formation 
under control conditions versus those grown under 0.004%, 0.008%, 0.016%, 
and 0.032% (w/v) chitosan (p<0.05), the increase in biofilm formation seen in 
the 0.002% (w/v) chitosan relative to the control was not deemed significant 
(p>0.05). Although one-way ANOVA indicated significant differences between 
the biofilm formation between 48 and 72 hours (F (11, 96) = 55.27, p<0.0001), 
significant differences were typical when comparing biofilms formed in the 
presence of 0.008% (w/v) and 0.016% (w/v) chitosan (p<0.05). 
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Figure 6.10: Comparison of C. jejuni ‘adapted’ NCTC11168 biofilm formation after 72 hours 
incubation in the presence or absence of chitosan, whilst under microaerobic conditions at 42°C 
(pH 6.0). Data shown concerns mean absorbance values. Experiments were performed three times 
in triplicate, error bars indicate the SEOM. (Note: negative control wells containing non-inoculated 
MH broth accounted for an average mean absorbance of 0.043nm at 595nm). 
 
 
 
When comparing the biofilm formation after 72 hours incubation compared to 48 
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ANOVA analysis revealed significant increases in formation (F (11, 96) = 45.75, 
p<0.0001). Post hoc analysis confirmed this significance when comparing the 
respective control, 0.004%, 0.008%, 0.016% and 0.032% (w/v) chitosan grown 
biofilms (p<0.05). However, no significant difference was found when comparing 
the 0.002% (w/v) chitosan grown biofilms (p>0.05). 
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in biofilm formation were apparent when applying post hoc analysis with regards 
to the control biofilms formed versus those grown in 0.008% (w/v), 0.016% and 
0.032% (w/v) chitosan (p<0.05). However, no significant differences in biofilm 
formation were typical of those grown in the presence of chitosan at a final 
concentration of 0.002% (w/v) and 0.004% (w/v) (p>0.05) (Figure 6.10). 
 
 
 
Figure 6.11: Comparison of C. jejuni RM1221 biofilm formation after 72 hours incubation in the 
presence or absence of chitosan, whilst under microaerobic conditions at 42°C (pH 6.0). Data 
shown concerns mean absorbance values. Experiments were performed three times in triplicate, 
error bars indicate the SEOM. (Note: negative control wells containing non-inoculated MH broth 
accounted for an average mean absorbance of 0.043nm at 595nm). 
 
The degree of biofilm formation was also found to be significantly different when 
comparing all conditions in the RM1221 strain of C. jejuni when concerning 48 
and 72 hours incubation (F (11, 96) = 18.64, p<0.0001). Post hoc analysis 
revealed that significant increases in biofilm formation were typical of under 
control, 0.008% (w/v) and 0.032% (w/v) chitosan conditions (p<0.05). 
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No significant difference in the amount of biofilm formed was characteristic of 
those concerning control when compared to 0.002% (w/v), 0.004% (w/v) and 
0.008% (w/v) chitosan conditions after 72 hours incubation (p>0.05). A 
significant decrease in biofilm formation was only apparent when formed in wells 
containing 0.016% (w/v) and 0.032% (w/v) chitosan, relative to these control 
conditions (p<0.05) (Figure 6.11). 
 
 
 
Figure 6.12: Comparison of C. jejuni 81116 biofilm formation after 72 hours incubation in the 
presence or absence of chitosan, whilst under microaerobic conditions at 42°C (pH 6.0). Data 
shown concerns mean absorbance values. Experiments were performed three times in triplicate, 
error bars indicate the SEOM. (Note: negative control wells containing non-inoculated MH broth 
accounted for an average mean absorbance of 0.043nm at 595nm). 
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formed in the presence of chitosan at concentrations from 0.002% (w/v) – 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
0.5
0.55
0.6
0.65
Control 0.002 0.004 0.008 0.016 0.032
B
io
fi
lm
 f
o
rm
at
io
n
 O
.D
 (
5
9
5
n
m
) 
Chitosan concentration (% (w/v)) 
139 
 
0.032% (w/v) (F (5, 48) = 28.29, p<0.0001). Further analysis implied that the 
formation of biofilms significantly decreased with respect those grown in 0.016% 
(w/v) and 0.032% (w/v) chitosan when compared to under control conditions 
(p<0.05) (Figure 6.12). 
 
Additionally, when comparing formation after 72 hours incubation to that 
concerning 48 hours, a significant difference was apparent (F (11, 96) = 33.51, 
p<0.0001). Although the post hoc testing identified a significant increase in 
biofilm formation when comparing those grown under 0.008% (w/v) chitosan 
after 72 hours, as oppose to 48 hours incubation (p<0.05). 
 
 
 
Figure 6.13: Comparison of C. jejuni 11168CH biofilm formation after 72 hours incubation in the 
presence or absence of chitosan, whilst under microaerobic conditions at 42°C (pH 6.0). Data 
shown concerns mean absorbance values. Experiments were performed three times in triplicate, 
error bars indicate the SEOM. (Note: negative control wells containing non-inoculated MH broth 
accounted for an average mean absorbance of 0.043nm at 595nm). 
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When concerning biofilm formation after 72 hours incubation in the 11168CH 
isolate of C. jejuni (Figure 6.13), one-way ANOVA revealed that significant 
differences were  observed under control and 0.002% (w/v) – 0.032% (w/v) 
growth conditions (F (5, 48) = 48.01, p<0.0001). However, when compared to 
the biofilms formed in under control conditions, only those grown in 0.016% 
(w/v) and 0.032% (w/v) chitosan occupied a significant decrease biofilm 
production, as highlighted by post hoc analysis (p<0.05). Additionally, when 
comparing formation of biofilms in after 72 hours versus to those formed post 48 
hours incubation, significant differences were indicated (F (11, 96) = 64.17, 
p<0.0001). Further analysis via post hoc testing indicated significant increases 
in biofilm formation when comparing all conditions, excluding the comparison 
between 0.032% (w/v) exposed cells (p>0.05). A summary of biofilm formation 
regarding all C. jejuni strains/isolates after 48 and 72 hours incubation can be 
seen overleaf (Figure 6.14 and 6.15, respectively). 
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Figure 6.14: Summary of biofilm formation after 48 hours incubation in the presence or absence of 
chitosan, whilst under microaerobic conditions at 42°C (pH 6.0). Data shown concerns mean 
absorbance values. Experiments were performed three times in triplicate, error bars indicate the 
SEOM. (Note: negative control wells containing non-inoculated MH broth accounted for an average 
mean absorbance of 0.043nm at 595nm). 
 
 
Figure 6.15: Summary of biofilm formation after 72 hours incubation in the presence or absence of 
chitosan, whilst under microaerobic conditions at 42°C (pH 6.0). Data shown concerns mean 
absorbance values.  Experiments were performed three times in triplicate, error bars indicate the 
SEOM. (Note: negative control wells containing non-inoculated MH broth accounted for an average 
mean absorbance of 0.043nm at 595nm). 
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With respect to Figure 6.15, a significant increase in biofilm formation was 
consistently observed with respect to the ‘adapted’ isolate of C. jejuni 
NCTC11168 in relation to all strains/isolates under control conditions and when 
formed under 0.02% (w/v) chitosan (p<0.05). Conversely, the wild-type 
NCTC11168 cells were generally found to form the least amount of biofilm with 
respect to control (no chitosan added) and 0.002% (w/v) – 0.008% (w/v) 
whereby significant decreases were apparent with in contrast to all 
strains/isolates tested (p>0.05). 
 
6.4.5 Eradication of pre-formed biofilms following 24 hours exposure to 
chitosan  
 
 
In order to assess the effect of low molecular weight chitosan upon pre-formed 
biofilms of C. jejuni, exposure to 0.002% - 0.032% (w/v) chitosan for a period 
of 24 hours was tested. 
Figure 6.14: Eradication of C. jejuni wild-type NCTC11168 pre-formed biofilms after 24 hours 
exposure to concentrations of chitosan, whilst under microaerobic conditions at 42°C (pH 6.0). 
Data shown concerns mean absorbance values. Experiments were performed three times in 
triplicate, error bars indicate the SEOM. (Note: negative control wells containing non-inoculated 
MH broth accounted for an average mean absorbance of 0.043nm at 595nm). 
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Following 24 hours exposure of varying concentrations of chitosan ranging from 
0.002% (w/v) – 0.032% (w/v) of pre-formed biofilms previously grown in the 
absence of chitosan, statistically significant differences in biofilm production was 
apparent (F (5, 48) = 17.60, p<0.0001). Post hoc testing indicated that 
although no significant difference was found when comparing the control versus 
the 0.002% (w/v), 0.004% (w/v) and 0.008% (w/v) chitosan exposed biofilm, 
significant differences resulted from the addition of 0.016% (w/v) and 0.032% 
(w/v) addition for 24 hours after an initial 48 hours of growth in the absence of 
chitosan (p<0.05). Thus biofilm eradication was found in biofilms exposure to 
0.016% (w/v) and 0.032% (w/v) chitosan (Figure 6.14). 
 
 
 
Figure 6.15: Eradication of C. jejuni ‘adapted’ NCTC11168 pre-formed biofilms after 24 hours 
exposure to concentrations of chitosan whilst under microaerobic conditions at 42°C (pH 6.0). 
Data shown concerns mean absorbance values. Experiments were performed three times in 
triplicate, error bars indicate the SEOM. (Note: negative control wells containing non-inoculated 
MH broth accounted for an average mean absorbance of 0.043nm at 595nm).  
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Significant differences were observed in relation to the ‘adapted’ C. jejuni NCTC 
11168 biofilms when comparing those challenged for 24 hours exposure to 
varying concentrations of chitosan to the control biofilms, which had non 
chitosan-containing media replenishment (F (5, 48) = 30.44, p<0.0001). 
Supplementary testing revealed a significant increase in the amount of biofilm 
remaining with respect to those treated with 0.002% (w/v) and 0.004% (w/v) 
chitosan for 24 hours (p<0.05). Whereas, biofilm eradication was found occur 
when comparing the 0.032% (w/v) challenged biofilms relative to control 
samples (p<0.05). Despite an apparent increase in biofilm growth following 
exposure to 0.008% (w/v) and reduction in remaining biofilm when exposed to 
0.016% (w/v) challenged biofilms, their differences in relation to the control 
were not deemed significant (p>0.05) (Figure 6.15). 
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Figure 6.16: Eradication of C. jejuni RM1221 pre-formed biofilms after 24 hours exposure to 
concentrations of chitosan, whilst under microaerobic conditions at 42°C (pH 6.0). Data shown 
concerns mean absorbance values. Experiments were performed three times in triplicate, error 
bars indicate the SEOM. (Note: negative control wells containing non-inoculated MH broth 
accounted for an average mean absorbance of 0.043nm at 595nm). 
 
 
After previously formed biofilms were subject to 24 hours exposure to chitosan 
concentrations typical of 0.002% (w/v) – 0.032% (w/v), differences in the 
amount of biofilm production were found (F (5, 48) = 21.12, p<0.0001). Post 
hoc analysis revealed significant decrease in the amount of biofilm present 
following 24 hour exposure to 0.016% (w/v) and 0.032% (w/v) chitosan, 
relative to the control samples (p<0.05). No significant differences were 
accountable between 0.002% (w/v) – 0.008% (w/v) exposure for chitosan for 
the same period of time (p>0.05) (Figure 6.16) 
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Figure 6.17: Eradication of C. jejuni 81116 pre-formed biofilms after 24 hours exposure to 
concentrations of chitosan, whilst under microaerobic conditions at 42°C (pH 6.0). Data shown 
concerns mean absorbance values. Experiments were performed three times in triplicate, error 
bars indicate the SEOM. (Note: negative control wells containing non-inoculated MH broth 
accounted for an average mean absorbance of 0.043nm at 595nm). 
 
 
 
 
Pre-formed biofilms which were subject to chitosan exposure for 24 hours were 
deemed significantly different following ANOVA analysis (F (5, 48) = 10.80, 
p<0.0001), as seen in Figure 6.17. However, subsequent post hoc analysis 
indicated that the only significant decrease in the amount of biofilm in relation to 
the control was found when biofilm were subject to 0.032% (w/v) chitosan for 
24 hours (p<0.05). Interestingly, the opposite was found in the case of 0.002% 
(w/v) exposure, characteristic of an increase in the quantity of biofilm relative to 
the control (p<0.05). No significant difference was found when comparing 
biofilms treated with concentrations ranging from 0.004% (w/v) – 0.016% (w/v) 
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chitosan when compared with biofilm which received chitosan-free media 
replenishment (p>0.05). 
 
 
Figure 6.18: Eradication of C. jejuni 11168CH pre-formed biofilms after 24 hours exposure to 
concentrations of chitosan, whilst under microaerobic conditions at 42°C (pH 6.0). Data shown 
concerns mean absorbance values. Experiments were performed three times in triplicate, error 
bars indicate the SEOM. (Note: negative control wells containing non-inoculated MH broth 
accounted for an average mean absorbance of 0.043nm at 595nm). 
 
 
Twenty four hours exposure of pre-formed biofilms to chitosan at concentrations 
ranging from 0.002% (w/v) – 0.032% (w/v) with respect to the 11168CH isolate 
of C. jejuni NCTC 11168 were found to be significantly different (F (5, 48) = 
67.73, p<0.0001). Further post hoc analysis indicated that biofilms exposed to 
0.002% (w/v) and 0.004% (w/v)  allowed for a significant increase in the 
amount of biofilm present in comparison to the control biofilm typical of chitosan 
absent media replenishment (p<0.05). Significant decreases in biofilm 
production were typical of 0.016% (w/v) and 0.032% (w/v) chitosan exposed 
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pre-formed biofilms in relation to those concerning the control (p<0.05). In 
contrast, no significant difference was observed when comparing the control 
versus the biofilms challenged with 0.008% (w/v) chitosan (p<0.05) (Figure 
6.18). 
 
 A summary of findings with regards to biofilm eradication can be seen in Figure 
6.19: 
 
 
Figure 6.19: Summary of pre-formed biofilm eradication in several C. jejuni strains/isolates after 
24 hours exposure to concentrations of chitosan, whilst under microaerobic conditions at 42°C (pH 
6.0). Data shown concerns mean absorbance values. Experiments were performed three times in 
triplicate, error bars indicate the SEOM. (Note: negative control wells containing non-inoculated 
MH broth accounted for an average mean absorbance of 0.043nm at 595nm). 
 
 
 
The general trend with regards to the remaining pre-formed biofilm after 24 
hours exposure to chitosan revealed that the both the ‘adapted’ isolate and 
11168CH isolate were seen to occupy the greatest amount of remaining biofilm 
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the other strains/isolates. Significant increases in remaining biofilm were 
observed in both isolates 0.002% (w/v) – 0.008% (w/v) chitosan, including 
controls which were subject to media replacement with no chitosan present 
(p<0.05). No significant difference was observed between these two isolates 
with respect to the subject to control conditions (no chitosan addition) and 
exposure to 0.002% (w/v) – 0.016% (w/v) chitosan for a period of 24 hours 
(p<0.05) (Figure 6.19). 
 
6.5 Discussion 
 
In summary, the chemotactic responses were found to be consistent amongst all 
strain/isolates of C. jejuni tested, with chemo-attraction in response to L-
cysteine, chemo-repulsion following deoxycholic acid and chitosan exposure and 
no attraction/repulsion observed in relation to PBS. Chemotactic responses in 
the positive, negative and neutral controls were found to be consistent with taxis 
in NCTC11168 as in Vegge et al. (2012). It was established that no isolate/strain 
tested illustrated a deficiency in chemotaxis. 
 
As mentioned previously, motility is said to play an important part in 
Campylobacter colonisation, as this organism must penetrate through mucus 
before subsequently adhering and invading host epithelial cells. Reduction in 
motility has previously been seen to account for a diminished ability of C. jejuni 
81-176 to infect human epithelial cells, which in turn has a negative impact on 
pathogenesis (Stef et al., 2013). 
 
With respect the overall findings in this chapter, the greatest degree of motility 
after 72 hours incubation was observed in the RM1221 strain of C. jejuni (figure 
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6.1, 6.2). This was followed by the previously generated chitosan ‘adapted’ 
isolate of C. jejuni NCTC 11168, despite this no significant difference was found 
between the two groups (p>0.05). In contrast, the lowest motility as indicated 
by the zone diameter was found in the wild-type C. jejuni NCTC 11168 cells after 
24, 48 and 72 hours incubation at 42oC under microaerobic conditions. 
 
It is possible that lower degree of motility in particular relation to 24 hours and 
48 incubation may link to the lower MIC values as seen in the wild-type C. jejuni 
NCTC 11168 strain, as oppose to the other strains/isolates tested, especially 
with regards to the ‘adapted’ isolate of C. jejuni NCTC 11168. 
 
The increase motility in the chitosan ‘adapted’ C. jejuni isolate particularly when 
compared to the wild-type equivalent cells could also potentially be associated 
with an increase the significant increase in biofilm formation after 72 hours 
incubation with respect to control conditions and those formed under 0.002% -
0.008% (w/v) chitosan. This general trend was also accounted for with respect 
to 48 hours incubation excluding significant increases in biofilm formed under 
0.008% (w/v) chitosan (p<0.05). Such findings may be resultant from alteration 
in specific genes for example.  
 
Although many genes relating to the pathogenicity of C. jejuni have been 
previously reported, the relationships between these genes are not obvious 
(González-Hein et al., 2013). C. jejuni is known to possess regulatory systems 
which function in the adaptation to external stress (Gundogdu et al., 2011). It 
has been suggested that regulatory proteins such as CsrA (carbon starvation 
regulator), may be particularly vital in both the regulation of virulence and also 
stress responses. For instance, this regulator has been show enhance biofilm 
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formation, intestinal cell adherence and survival to oxidative stress (Fields and 
Thompson, 2008). Therefore, in order to allow for an increased understanding of 
various alterations in aspects such as biofilm formation, analysis of 
transcriptome may prove to be advantageous.  
 
As expected, biofilm formation was seen to generally increase after 72 hour 
incubation, as oppose to 48 hours. In addition, biofilm formation appeared to be 
absent with respect to that of the wild-type C. jejuni NCTC11168 strain from as 
low as 0.008% (w/v) after 48 hours incubation, whereas the other 
strains/isolates show varying amount of biofilm. This implied that the wild-type 
C. jejuni NCTC11168 strain occupied the greatest sensitivity when grown in 
chitosan, which is in accordance with previous MIC data, found to be most 
susceptible in broth and agar-based susceptibility testing (chapter 4). 
 
In the case of the chitosan ‘adapted’ isolate, the enhanced phenotypes in both 
biofilm formation and motility may be a potentially resultant of step-wise 
exposure to low molecular weight chitosan. Additionally, the ‘adapted’ isolate 
may through an enhanced phenotype, be more able to not only from chitosan 
induced stress but perhaps cross tolerance to other antimicrobials. However, in 
order to confirm this, additional susceptibility testing would need to be carried 
out to establish potential differences. 
 
The greatest amount of remaining pre-formed biofilms exposed a range of 
concentrations of chitosan for a 24 hour time period was generally observed with 
regards to the ‘adapted’ isolate and also the 11168CH isolate of C. jejuni NCTC 
11168. Surprisingly, the resultant amount of remaining biofilm was found to be 
increased after exposure to 0.002% (w/v) – 0.008% (w/v) chitosan for 24 hours 
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in relation to control samples which were subject to media replacement in both 
the ‘adapted’ and 11168CH isolates of C. jejuni NCTC 11168. This implies that 
chitosan exposure to pre-grown biofilms can allow for subsequent formation. 
Absolute biofilm eradication was not observed in any of the strain/isolates tested 
after 24 hours chitosan exposure of pre-formed biofilms.  
 
Two properties are thought to be attributable to surface-attached bacteria, 
namely an increased synthesis of EPSs (extracellular polymeric substances) and 
the development of antibiotic resistance. These are believed to assist in the 
production of a protective environment, which accounts for issues in terms of 
biofilm eradication (O’Toole et al., 2000). It has been shown previously that 
microorganisms can become resistant to even the highest deliverable 
concentrations of antibiotics whilst growing under biofilm conditions (Vergeres 
and Blaser, 1992).  
 
Whilst few regulatory networks governing biofilm formation are exclusively 
devoted to this process (Ghigo, 2003), several global regulators, two-
components regulatory systems and quorum sensing regulators may be 
responsible for biofilm formation and increases in general stress defence in both 
Gram negative and Gram positive bacteria (Davies et al., 1998; Davies et al., 
1995; Jackson et al., 2002; Otto, 2004). The ability of Campylobacter jejuni to 
survive in unfavourable conditions, for instance outside the host, is vital for its 
survival; however the mechanisms which account for this are poorly defined 
(Theoret et al., 2012). Strategies which may allow for this enhanced survival 
conditions outside of the host are likely to exist through changes in aspects such 
as biofilm formation (Theoret et al., 2012).  
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A study conducted by Hanning and Slavik (2009) found that there was no 
significant correlation between the degree of biofilm formation in C. jejuni and 
passage through the chick gastrointestinal tract. However, because biofilm 
formation is recognised by some as a virulence factor in some bacteria Parsek 
and Singh (2003) and that passage through the gastrointestinal tract has 
illustrated an increase in subsequent virulence Sang et al. (1988), it would make 
theoretical sense that this would enhance biofilm formation. 
 
With particular respect to biofilm formation, the second greatest biofilm former 
was seen to be the 11168CH isolate under control conditions and was seen to be 
comparable to the enhanced degree of biofilm formation under 0.004% (w/v) 
and 0.008% chitosan, in relation to the ‘adapted’ isolate of NCTC11168 (Figure 
6.15). This suggests that previous passage through host environments for 
example chickens may allow for enhanced biofilm formation both in the absence 
and presence of stresses such as chitosan. This may also suggest a degree of 
cross protection which is particularly important for an increased survival 
potential.  
 
With the increases in biofilm formation and motility observed with particular 
respect to the ‘adapted’ isolate when compared to that of the wild-type C. jejuni 
NCTC11168, it may therefore be more be feasible that these phenotypic 
alterations similar to that in the NCTC11168CH isolate may account for increases 
in survival, virulence and/or pathogenesis in a general sense. It is likely that 
with alterations in phenotype, lies an underlying difference in terms of 
transcriptional alterations, which could contribute to increased survival under 
stress inducing conditions.  
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To conclude, the results of this study show that C. jejuni is able to persist in an 
environment which is undesirable. Bacteria have the ability to undergo 
alterations in phenotype with regards to biofilm formation, often making them 
several times more resistance to a given antimicrobial (Costerton et al., 1995). 
The unexpected enhancement of biofilm formation at concentrations of chitosan 
which exceed planktonic MIC values illustrates that biofilm formation is an 
effective means of survival. Such aspects are likely to be fundamental with 
regards to overcoming numerous stresses encountered in a variety of 
environments. Further exploration into the possible transcriptional differences 
resultant from exposure to stresses such as chitosan, may provide additional 
information as to the precise mechanisms required for this enhanced survival of 
C. jejuni. 
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Chapter 7 – Transcriptional differences 
between wild-type and chitosan ‘adapted’ C. 
jejuni NCTC11168 isolates 
 
 
 
7.1 Introduction 
 
 
 
In order for bacteria to become more established under stressful conditions 
which do not allow for optimal growth, an increase in genetic variation can result 
in a selective advantage of a bacterial population. Bacteria species often possess 
several responses which provide mutational advantages in the way of an 
increase in mutation rates (Foster, 2005). 
 
Stress hardening can also be developed by phenotypic alterations through 
changes in the expression of various genes thus contributing to an increased 
probability of survival. Bacteria are known to respond to stressful conditions by 
alterations in their patterns of gene expression. Responses can either be 
organised in coherent pathways in some cases, although functions in some 
cases, seen to overlap (Foster et al., 2005). 
 
Environmental stress can be defined  as the factors of an external nature which 
pose adverse effects on the physiological well-being of bacterial cells, resulting 
in either a reduction in the growth rate of the given microorganism or the 
complete inhibition, both in terms to individual and populations of cells 
(McMahon et al., 2007). There are numerous food preservation processes which 
have a purpose of extending the lag phase of bacterial growth in foodstuffs via 
the use of hurdle technology approaches whereby either one or using a hurdle 
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technology approach, involving multiple environmental stressors accounting for a 
desired slowing or prevention of bacterial growth (McMahon et al., 2007).  
 
The absence of growth during stress does not always invoke an absence of 
metabolic or genetic activity, as bacterial cells can reduce the influence of 
environmental stresses via changes in genotypic adaptations which can 
ultimately lead to variation of phenotype (Storz and Hengge-Aronis, 2000). 
 
Modifications in key components, for example protective shock proteins can 
provide a resistance to not only subsequent exposure to the initial stressor but 
other potentially unforeseen environmental stresses through cross-protection 
(Katzif et al., 2003; Rowan, 1999; McMahon et al., 2007). The ability of C. jejuni 
to respond to a wide variety of environmental stimuli via alterations in gene 
expression is paramount for the degree of pathogenesis, commensalism and 
thus survival outside the host organism (Grabowska et al., 2011). 
 
Previous experiments have revealed numerous transcriptional changes as a 
result of changes in environmental stimuli. Alterations resultant from differences 
in temperature (Reid et al., 2008), iron concentration (Holmes et al., 2005), pH 
of culture medium (Stintzi et al., 2005), oxygen limitation and also sodium 
deoxycholate concentration (Woodall et al., 2005; Malik-Kale et al., 2008), have 
been previously documented. 
In order to survive a given stress, C. jejuni must be adaptable and respond 
appropriately (Fields and Thompson, 2008). However, unanswered questions still 
remain with regards to increased survival through molecular mechanisms, 
accounting for enhanced pathogenesis virulence properties of Campylobacter 
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(Gundogdu et al., 2011; Fields and Thompson, 2008). A increased 
understanding in the response mechanisms which help combat the stresses 
encountered are needed to assist with applicable interventions  to reduce the 
problems arising from C. jejuni-associated disease (Pittman et al., 2007). 
Survival mechanisms in the genome sequenced C. jejuni NCTC11168 strain 
provide limited clues, as compared to other enteric bacteria including Salmonella 
spp. and Escherichia coli, the capacity for regulation of gene expression appear 
to be rather limited (Park, 2002). Many key regulators involved in stress defence 
which are not present in C. jejuni, include examples such as SoxRS and OxyR, 
involved in oxidative stress, GbsAB and BetAB involved in osmoprotection, a 
major cold-shock protein (CsPA) and RpoH which regulates heat-shock response, 
all of which are present in E. coli. However, they do possess two-component 
regulatory systems that are not usually found in other bacteria species, thought 
to be involved in stress defence (Murphy et al., 2006). Two-component 
regulators are thought to respond to alterations in environmental conditions via 
the regulation of set of genes, increasing the survival potential (Park, 2002). 
Two-components signal transduction systems (TCS) encompass a sensory 
histidine kinase, located within the cytoplasm and a response regulator 
positioned in the cytoplasmic membrane (Stock et al., 2000). According to 
Parkhill et al. (2000), there are said to be five putative TCSs with accompanying 
histidine kinase and response regulator within the C. jejuni NCTC11168 genome. 
Such survival mechanisms may be paramount for the enhanced phenotype in 
the previously generated ‘adapted’ isolate of C. jejuni NCTC11168. Thus, it was 
deemed appropriate to investigate potential transcriptional which may be 
responsible for the alterations in phenotype in relation to the ‘adapted’ isolate 
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and wild-type C. jejuni NCTC11168 both in the presence and absence of low 
molecular weight chitosan. 
 
7.2 Aims and Objectives 
 
7.2.1 Aim 
 
This chapter aims to elucidate the transcriptional alterations caused by low 
molecular weight chitosan exposure in relation to both wild-type and the 
chitosan “adapted” isolate of C. jejuni NCTC11168. 
 
7.2.3 Objectives 
 
 To identify transcriptional changes which allow for differences in growth 
characteristics when exposed to a sub lethal concentration of low 
molecular weight chitosan between the two different isolates of C. jejuni 
NCTC11168. 
 
 To propose transcriptional mechanisms accounting for the differences 
accounted for in the phenotype and gene expression with regards to the 
C. jejuni NCTC isolates.    
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7.3 Materials and methods 
 
7.3.1 Growth Inhibition Study 
 
Several colonies of respective C. jejuni cultures were inoculated into 75 ml of 
Mueller Hinton broth and were incubated for 24 hours (early stationary phase) 
under microaerobic conditions at 42°C. 
 
After these overnight cultures of C. jejuni had reached this stage, aliquots were 
then  taken and diluted to a final concentration of approximately 3x106 CFU/ml in 
a final volume of 40ml consisting of MH broth (adjusted to pH 6.0) and a volume 
low molecular weight chitosan added (pH 6.0) resulting in 0.0008% (w/v) or 
0.0016% (w/v). 
 
At various time intervals, aliquots were taken from samples, serially diluted and 
subsequently plated at 42°C for a maximum of 24 hours under microaerobic 
conditions. Counts were then enumerated as described previously. 
 
7.3.2 RNA extraction and microarray analysis 
 
In order to compare the potential transcriptional differences which are 
accountable for the alteration in the phenotype when comparing the wild-type 
and adapted isolates of C. jejuni NCTC 11168, microarray analysis was 
performed. The RNA of cells following sub-lethal exposure to a pre-defined 
concentration of low molecular weight chitosan for 16 hours at 42°C under 
microaerobic conditions was utilised. 
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After late exponential phase was reached in the respective tubes containing the 
wild-type and adapted isolates of C. jejuni NCTC 11168 with no chitosan 
present, an aliquot was taken from these broths and transferred into fresh MH 
broth (pH 6.0) containing either MH broth without low molecular weight chitosan 
(pH 6.0) or a final concentration of 0.0008% (w/v) low molecular weight 
chitosan and were subsequently incubated as described previously for 16 hours. 
 
Immediately upon reaching the 16 hour time interval aliquots (mid exponential 
phase) were taken from both the control and treated samples of both the wild-
type and adapted C. jejuni cells. These aliquots were then transferred into 
centrifuge respective centrifuge tubes containing a 1/10 volume of ice-cold 
(10%/90%) phenol/ethanol stop solution (Konkel et al., 2007). Contents were 
then centrifuged at 4°C at 8000 x g for 10 minutes and the supernatant 
discarded carefully into an appropriate waste container. The remaining 
procedure was then carried by the using the RNeasy Mini Kit (Qiagen, UK) 
according to manufacturer’s instructions. Optional steps included the use of 
DNase to reduce the likelihood of DNA contamination. Modifications included 
extra washes with RPE buffer, increases in centrifugation times for various steps 
and drying of opened columns prior to eluting RNA with RNase free water (30µl 
volume). Quantification of RNA was achieved with a Nanodrop 2000c instrument. 
 
When necessary, ethanol precipitation was performed in order to improve 
260/280 and in particular 260/230 ratios. Here, 1/10th the volume of total 
sample volume of 3M sodium chloride was added along with 1µl RNase / DNase 
free glycogen and 2 volumes of 100% molecular grade ethanol followed by 
mixing via pipette. The contents were then stored at -80°C for a minimum of 2 
hours after which the contents were centrifuged for 20 minutes at 13,400 x g. 
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the supernatant was removed and 100µl of 70% ethanol was added and 
centrifuged once more for 5 minutes at 13,400 x g. The supernatant was then 
removed and the tubes were left to air-dry for 5 minutes after which 30µl of 
RNase free water was added to re-suspend the tube contents. RNA samples were 
stored at -80°C until required. 
 
The transcriptional changes when comparing the different isolates of C. jejuni 
NCTC11168 were assessed using a custom Campylobacter specific microarray 
design, kindly provided by the Bacterial Microarray Group at St George’s 
University (London) - BμG@S. The microarrays with this design were purchased 
from Agilent (Agilent Technologies UK Ltd, Berkshire, UK) and were sent to the 
Functional Genomics, Proteomics and Metabolomics Facility (The University of 
Birmingham) with extracted samples for subsequent processing. 
 
Before labelling and hybridisation, the RNA integrity of samples was assessed 
using an Agilent Bioanalyser RNA 6000 Nano Kit (Agilent Technologies UK Ltd, 
Berkshire, UK). Samples which had an RNA Integrity Number (RIN) value of 7 or 
greater were deemed appropriate for microarray analysis due to sample quality 
purity. 
 
Five nanograms of good quality RNA (260/230 and 260/280 ratio ≥1.8) of each 
sample was subsequently labelled with an Agilent Low Input Quick Amp WT kit, 
One Colour, according to manufacturer’s instructions. The efficiency and yield 
following labelling were assessed using a nanodrop device and samples yielding 
600ng cRNA with a labelling efficiency of 6pmol/µgRNA were used for 
hybridisation. 
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Labelled RNA was hybridised to the microarray slides using the Agilent 
hybridisation Kit in accordance with manufacturer’s guidelines.   Hybridisations 
were achieved using an Agilent oven following baking for 17 hours at 65°C. 
Microarray slides were then washed with an Agilent Gene Expression Wash 
Buffer kit. These slides were then scanned with an Agilent scanner utilising the 
one-colour HD setting for each of the 8x15k arrays characteristic of a scan 
resolution of 5µm, PMT 100%, 10%, 16 bit. The resulting image for each array 
was then imported into Agilent feature extraction software. Raw data were 
normalised and p values were adjusted by a False Discovery Rate of 5% and 
differential expression was confirmed when p<0.05.  
 
Upon receiving data output from the Functional Genomics, Proteomics and 
Metabolomics Facility, inverse log calculations were undertaken using the 
normalised log2 data, which was then utilised to establish the fold changes. The 
following comparisons were deduced from these data: wild-type control vs. wild-
type treated, wild-type control vs. adapted control, wild-type treated vs. adapted 
treated and adapted control vs. adapted treated cells. Significant differences 
were assessed by means of relative fold changes in the gene targets, which 
illustrated a 2 fold or greater change in gene expression. In order to deduce the 
names of the genes which were seen to occupy significant transcriptional 
changes in the comparisons mentioned above, the respective probe IDs were 
inputted into the Bugsbase database 
(http://bugs.sgul.ac.uk/bugsbase/tabs/search.php). 
 
The frequently used two-fold change threshold in order to determine significant 
changes is based upon an arbitrary figure (Bilban et al., 2002). Fold changes 
measured by microarray and/or qPCR which were greater or equal to a two-fold 
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change have previously been deemed a valid result (Rajeevan et al., 2001; 
Morey et al., 2006). Thus, in order to ensure that differentially expressed genes 
were biologically relevant, a two-fold or greater change in gene expression was 
utilised in the microarray analysis in this chapter. Another requirement was also 
adopted, namely t test results having a probability P value of ≤0.05 (Woodall et 
al., 2005). Additionally, the rationale for using the arbitrary two-fold change 
threshold is reinforced from its common use regarding microarray analysis, with 
examples concerning the transcriptional differences regarding C. jejuni in 
numerous other studies (Reid et al., 2008, Woodall et al., 2005, Palyada et al., 
2009, Xia et al., 2013, Guo et al., 2008).  
 
 
7.3.3 cDNA synthesis 
 
Aliquots of extracted RNA (500ng) were reverse transcribed to cDNA utilising a 
High Capacity RNA -cDNA kit (Applied Biosystems). Individual test samples (9µl) 
were added to 10µl of 2 x RT buffer and either a final 1µl of either molecular 
grade water (negative control) or 20 x RT enzyme mix . 
 
Reaction tubes were added to a thermal cycler (Techne) and underwent reverse 
transcription involving 60 minutes incubation at 37°C and inactivation at 95°C. 
Resulting cDNA was then stored at -20°C for long term storage. 
 
 
7.3.4 Validation of Microarray analysis using real-time PCR 
 
The microarray findings were validated by running quantitative real-time PCR on 
the cDNA originating from the same RNA samples used in the microarray 
experiment. Several target genes were selected based upon fold changes, 
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representative of the general findings. Briefly, two upregulated genes, two down 
regulated  genes and a neutral gene target were chosen concerning comparison 
between the control and treated cells for each isolate type (wild-type and 
adapted). Additionally, the GapA (GAPDH) gene target was used as a 
housekeeping gene, theoretically possessing constant expression regardless of 
chitosan exposure or not.  
 
These various targets were analysed using the method described previously and 
the resulting expression was compared to that of the fold changes observed in 
the microarray analysis. A correlation was then made with regards to the related 
target genes generated form the microarray data and the quantitative real-time 
PCR data. The differences in gene transcript levels of the sub-lethally treated 
cells were compared against the respective calibrators (control samples). 
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Table 7.1: Primer sequences used for microarray validation via qRT-PCR. 
 
Target 
Gene 
Forward sequence (Tm - °C) Reverse sequence (Tm  - °C) Product 
length 
(bp) 
GapA TTCTACAGGCGCAGCAAAAG  
(59) 
TGGCACACGCATACTTTGTC  
(59) 
82 
DapB  AGGTACAACAGGGCTTGATGAG  
(60) 
CGGCATCACTTCACTAGCAC  
(59) 
64 
KpsM AGTTGGGGAGCCTATGAGTATTG  
(59) 
TTGCCTGAGTTCCATTCATAAGC  
(59) 
179 
Cj0025c GGGGTACCTGGAAGTGCAAC  
(59) 
AGTGCCGAAGTCATAGCTCC  
(60) 
158 
Cj1586 ATGGCGATTTTAATGGCGGC  
(59) 
AGGCAAGCTCCAACTATAGGAT  
(58) 
131 
Cj1358c ATACATGGCAGGACCACACTC  
(59) 
TTGCTCTTGGTTCGCCTTTG  
(59) 
50 
Cj0731 GGGGTGTAAGTGTTTTGCCTG  
(59) 
TACTGCCCACACAAACAAGC  
(58) 
114 
Cj1487c AGTGTTCGGCTTGTCATGGA  
(59) 
GCAGCACCAAGCATTTCTCC  
(60) 
151 
Cj1489c AGGACCTGATCTTGCTCGTG  
(59) 
TTCATGCCAATCAGCCGTTC  
(59) 
52 
Cj1560 CAAAGCGCTCACAATCCTAGC  
(59) 
GCACCGATAAAAACTGCCAC  
(58) 
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7.3.5 Quantitative Real-time PCR 
 
In order to determine the required input needed for real-time PCR analysis, the 
Stock I method was utilised (Gallup and Ackermann, 2008). Essentially, two 
stock mixes of cDNA were prepared; here equal volumes of wild-type control and 
wild-type treated cDNA were pooled to give a representative wild-type stock. 
The same was carried out with respect to the adapted samples (adapted control 
and treated cDNA was pooled in a separate tube).  
 
Serial dilutions (1:10) were then performed for each stock mix with molecular 
biology grade water as the diluent. The concentrations tested ranged from 20ng 
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– 0.002ng total cDNA for each of the mixes for each of gene targets. The 
efficiency of the real-time PCR using the different concentrations was generated 
using a standard curve for each of the target genes. Only concentrations which 
fell within the standard curve range were deemed suitable for subsequent 
qualitative analysis.  
 
Quantitative RT-PCR was undertaken in 20µl reactions for each well used within 
the 96-well plates used. The Fast SYBR green mastermix (Life Technologies UK 
Ltd) was used for respective reactions according to manufacturer’s guidelines, 
using 5ng of respective cDNA for each reaction alongside forward and reverse 
primer depending on the sample type at a final concentration of 200nM. 
   
Relative expression was evaluated by comparing the wild-type control versus the 
wild-type treated samples and also the adapted control versus the adapted 
treated samples using the comparative CT method which subsequent analysis 
following the method described in Pfaffl (2001). The gene encoding GAPDH was 
used as the reference target genes for all comparisons. Furthermore no template 
controls, where molecular biology grade water was added as oppose to cDNA 
template and reverse transcription negative controls (no reverse transcriptase 
added) were added to rule out potential background contaminants such as gDNA 
within the samples used. Melt curve analysis was also carried for each primer set 
to detect the absence of primer dimer formation and primer specificity. 
 
In order to establish the statistical significance of changes in transcript levels 
between the respective control versus treated cells, t-tests were performed by 
comparing ΔCt values (reference Ct – target Ct), as described in Yuan et al. 
(2006). 
167 
 
7.4 Results 
 
 
 
7.4.1 Determination of growth inhibition parameters for microarray 
analysis  
 
In order to determine the concentration of chitosan and the exposure time 
parameters, prior to RNA extraction and subsequent microarray analytical 
purposes, both the wild-type and previously generated ‘adapted’ cells of C. jejuni 
NCTC 11168 were challenged to 0.0008% (w/v) or 0.0016% (w/v) chitosan. 
The concentration of chitosan required for use in the transcriptional 
experimentation was based on a noticeable statistically significant difference 
between the wild-type and ‘adapted’ treated cells (0.0008% (w/v)). In addition, 
the time point used for RNA extraction purposes would require the control cells 
for each isolate of C. jejuni NCTC 11168 to not enter stationary phase, as any 
differences in gene expression may be based partially upon the comparison of 
the difference in growth phases. Also, the cell concentration was deemed 
important, as previous RNA extractions utilising less than 1 x 107 CFU/ml was 
seen to result in a low yield of RNA. Thus, the RNA extracted form samples 
would ideally need to be 1 x 107 CFU/ml or above.  
Furthermore, the decision to utilise the one concentration of chitosan for both 
the wild-type and ‘adapted’ cell exposure was undertaken, as a direct 
comparison could then be made between the two isolates of C. jejuni 
NCTC11168.  
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Figure 7.1: Growth inhibition of wild-type and ‘adapted’ C. jejuni NCTC 11168 during exposure to 
0.0008% (w/v) low molecular weight chitosan (pH 6.0). Data represents mean values from 
experiments which were conducted n = 4, plated in triplicate. Error bars indicate SEOM.  
 
 
Upon exposure to 0.0008% (w/v) low molecular weight chitosan, statistically 
significant differences were observed with regards to the wild-type and ‘adapted’ 
cells of C. jejuni NCTC 11168, as indicated via one way ANOVA analysis (p 
<0.05). Post hoc analysis revealed significant differences which were apparent 
when comparing the difference between the treated wild-type and ‘adapted’ cells 
at 16, 18, 20 and 24 hours exposure time (F(7, 88) = 962.9, p <0.0001). These 
differences were found to be 1.11, 0.86, 1, 1.12 and 1.32 log CFU/ml difference 
with respect to 16, 18, 20 and 24 hours, respectively (Figure 7.1). 
5.00
6.00
7.00
8.00
9.00
10.00
0 16 18 20 24
Lo
g 
(1
0)
 C
FU
/m
l r
e
co
ve
ry
 
Time (Hours) 
Wt Control Ad Control Wt 0.0008% (w/v) Ad 0.0008% (w/v)
169 
 
 
 
 
 
 
Figure 7.2: Growth inhibition of wild-type and ‘adapted’ C. jejuni NCTC 11168 during exposure to 
0.0016% (w/v) low molecular weight chitosan (pH 6.0). Data represents mean values from 
experiments which were conducted n = 4, plated in triplicate. Error bars indicate SEOM. 
 
As expected, with an increase in chitosan concentration (0.0016% w/v), 
statistically significant differences were found when comparing the wild-type and 
‘adapted’ cells, following one way ANOVA analysis (p <0.05). Post hoc analysis 
indicated significant differences when comparing the difference between the two 
isolate types after 16, 18, 20 and 24 hours exposure (F(7, 88) = 3749, p 
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<0.0001). Differences of 1.54, 1.82, 2.24, 2.40 and 2.59 log CFU/ml reduction 
were seen between the wild-type and the ‘adapted’ cells (Figure 7.2). 
It was decided that a chitosan concentration of 0.0008% (w/v) and 16 hours 
exposure would be the most suitable conditions to extract RNA from, as the 
largest log CFU/ml difference was observed. Although greatest differences in 
terms of log CFU/ml were observed upon 20 and 24 hours exposure, they were 
deemed inappropriate time intervals to extract RNA from, owning to the control 
samples appearing to enter stationary phase, whilst the respective chitosan 
treated cells were still at exponential phase of growth.  
Another set of parameters which may have been used to extract RNA from 
included the 16 hours exposure at 0.0016% (w/v) chitosan, as a difference 
between the treated cells of the wild-type and ‘adapted’ cells of just over 1.5 log 
CFU/ml. However, this time interval at this concentration of chitosan was not 
used, due to the low cell count expressed in the wild-type cells (5.78 log 
CFU/ml). Additionally, the wild-type cells exposed to 0.0016% (w/v) chitosan did 
not seem to show accumulative growth over the course of exposure. Therefore, 
due to the interest in the inhibition of growth, as oppose to lethal killing of cells, 
this concentration was not chosen for use. 
 
7.4.2 Determination of target input range and qRT-PCR efficiency 
 
 
 
When undertaking qRT-PCR analysis, it is essential to consider the efficiency of 
PCR reactions (Pfaffl, 2001). A standard curve was produced from each set of 
primers. In an attempt to establish the PCR efficiency of each primer set used to 
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amplify products, the stock I method was adopted (typical of pooled cDNA), 
which can be used to determine the input range of cDNA needed for comparable 
testing (Gallup and Ackermann, 2008). 
 
Figure 7.3 illustrates the standard curve prepared from a ten-fold dilution series 
of pooled cDNA of both wild-type and pooled cDNA of the ‘adapted’ samples. 
These pooled cDNA samples originate from reverse transcribed RNA from 
respective control and treated samples. These Ct values at the given 
concentrations of pooled cDNA represent the housekeeper gene, GapA (encoding 
a GAPDH protein). All gene targets were assessed in terms of the generated R2 
values and percentage efficiency. cDNA input quantity was chosen based on an 
input range found to be within the linear standard curve. 
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Figure 7.3: Representative standard curve of the housekeeper target gene, GapA and represent 
pooled cDNA versus Ct value.  
 
 
 
Melt curve analysis was also performed following qRT-PCR reactions, assessing 
the PCR product specificity. Specific binding and an absence of abnormalities 
such as primer-dimer formation was indicative of multiple uniform peaks for 
each primer set. Figures 7.4 and 7.5 illustrate examples of specific primer 
binding following qRT-PCR reactions with respect to microarray validation 
analysis. 
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Figure 7.4: Melt curve of various primer pairs used for qRT-PCR microarray validation. Peaks are 
indicative of target genes required for wild-type treated vs. wild-type control comparison. 
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Figure 7.5: Melt curve concerning primer pairs used for qRT-PCR microarray validation. Peaks are 
indicative of target genes required for ‘adapted’ treated vs. ‘adapted’ control comparison. 
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7.4.3 RNA extractions  
 
 
In order to investigate any transcriptional differences between control 
(untreated) and chitosan exposure cells of C. jejuni, RNA extraction was 
required. The findings upon undertaking mock RNA extractions reiterate the 
initial concern with using a cell concentration less than 1 x 107 CFU/ml with 
especially in the case of RNA extracted from chitosan exposed cells of C. jejuni 
NCTC11168. 
 
The yield and subsequent A260/280 and A260/230 ratios with respect to control 
cells were not found to be an issue. In the example below, when utilising 10ml of 
culture, adequate yield and quality was achieved. 
 
However, when attempting to extract RNA from wild-type cells which had 
undergone chitosan exposure for 16 hours under microaerobic conditions at 
42°C, a very low yield along with inadequate A260/280 and A260/230 ratio, was 
observed (Table 7.2).  
 
 
 
Table 7.2: RNA Profiles following exposure to low molecular weight chitosan (0.0008% w/v) at pH 
6 after 16 hours under standard conditions (n = 1). 
Sample ID Nucleic Acid Conc. A260/280 A260/230 
Wt 1 Control 16hrs 772.2 2.2 2.51 
Wt 1 Treated 16hrs 29 1.87 1.31 
 
 
 
 
 
Table 7.3: Representative CFU/ml concerning treated and non-treated to low molecular weight 
chitosan for 16 hours (n = 1). 
Sample type Av. CFU/ml (0hrs) Av.  CFU/ml (16hrs) 
Wt 1 Control 16hrs 4.60E+06 7.17E+08 
Wt 1 Treated 16hrs 4.56E+06 2.25E+07 
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Notably, chitosan exposure was seen to hinder both RNA yield and quality (data 
not shown). Thus, in order to combat this problem, an increase the yield as well 
an increase in the A260/280 and A260/230 ratios, the amount of culture was 
increased accordingly under the same 16 hours exposure. 
 
When using 80ml of culture per samples of the wild-type treated cells of C. 
jejuni, a small increase in RNA yield was apparent. However, the A260/230 
ratios indicated the RNA quality was not suitable. A decrease in the A260/230 
ratio, indicative of salt contamination, was seen to be a regular occurrence, 
especially upon an increase in culture volume (Table 7.4). 
 
 
Table 7.4: RNA profiles following exposure to low molecular weight chitosan (0.0008% w/v) at pH 
6 after 16 hours under standard conditions (n = 1). 
Sample ID Nucleic Acid Conc. A260/280 A260/230 
Wt 1 Control 16hrs 753.1 2.2 2.43 
Wt 1 Treated 16hrs 37.8 2.05 1.32 
 
 
 
 
 
Table 7.5: Representative CFU/ml data samples both treated and non-treated to low molecular 
weight chitosan for 16 hours (n = 1). 
Sample type Av. CFU/ml (0hrs) Av.  CFU/ml (16hrs) 
Wt 1 Control 16hrs 4.20E+06 6.00E+08 
Wt 1 Treated 16hrs 4.08E+06 2.33E+07 
 
 
 
An increase in culture volume filtered through the spin columns accounted for a 
build-up of residue on the silica membrane, assumed to be resultant from 
increases in chitosan and media. This phenomenon was absent in RNA extracted 
using a lesser volume of culture volume (I.e.10ml for the control samples). This 
may have affected both the amount of RNA which could bind to the silica 
membrane and also the decrease in A260/230 ratio. Guanidine salt found in the 
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RLT and RW1 buffers may be less efficiently removed from the column via the 
RPE washing step in the event of membrane residue. In order to rectify the on-
column residue, an RNase free pipette tip was carefully used to retrieve any 
residue which had collected on parts of the silica membrane. Additional washes 
with RPE were also undertaken, including inversion of the columns after closing 
the caps. 
 
In the event of increasing the culture volume to 160ml, including the additional 
step mentioned above, the following RNA extractions were carried out (Table 
7.6). 
 
 
 
Table 7.6: RNA profiles regarding exposure to low molecular weight chitosan (0.0008% w/v) at pH 
6 after 16 hours under standard conditions (n = 1). 
Sample ID Nucleic Acid Conc. A260/280 A260/230 
Wt 1 Control 16hrs 390 2.18 2.34 
Wt 1 Treated 16hrs (240ml) 129.3 2.08 2.08 
 
 
 
 
 
Table 7.7: Representative CFU/ml data concerning samples both treated and non-treated to low 
molecular weight chitosan for 16 hours (n = 1). 
Sample type Av. CFU/ml (0hrs) Av.  CFU/ml (16hrs) 
Wt 1 Control 16hrs 4.22E+06 5.00E+08 
Wt 1 Treated 16hrs 4.20E+06 3.25E+07 
 
 
 
The additional steps and increase in the amount of culture utilised appeared to 
rectify the issues faced with extraction of wild-type RNA from chitosan treated 
cells. Moreover, the yield and corresponding A260/280 and A260/230 ratios 
were found to be appropriate for downstream application. 
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RNA was then extracted for subsequent use in microarray analysis, employing 
the additional steps with particular attention to the wild-type treated cells. Ten 
millilitres of culture was used to obtain RNA via extraction for both the wild-type 
and ‘adapted’ cells after 16 hours exposure, as above. Culture volumes of 40ml 
were used to extract RNA per sample. 
The first set of RNA extraction along with respective cell counts can be seen 
below: 
 
 
Table 7.8: RNA profiles regarding exposure to low molecular weight chitosan (0.0008% w/v) at pH 
6 after 16 hours under standard conditions (n = 2). 
 
 
 
 
Table 7.9: Representative CFU/ml data concerning samples both treated and non-treated to low 
molecular weight chitosan for 16 hours (n = 2).  
Sample type Av. CFU/ml (0hrs) Av.  CFU/ml (16hrs) 
Wt Control 1 4.00E+06 7.33E+08 
Wt Control 2 4.33E+06 6.83E+08 
Ad Control 1 3.32E+06 7.50E+08 
Ad Control 2 3.50E+06 6.50E+08 
Wt Treated 1 4.12E+06 1.33E+07 
Wt Treated 2 4.20E+06 2.88E+07 
Ad Treated 1 2.56E+06 2.25E+08 
Ad Treated 2 3.15E+06 2.92E+08 
 
 
 
 
 
 
 
 
 
 
 
Sample ID  RNA yield (ng/µl) A260/280 A260/230 
Wt 1 Control 16hrs 281.3 2.18 2.14 
Wt 2 Control 16hrs 274.7 2.15 1.96 
Wt 1 Treated 16hrs 179.3 2.08 2.08 
Wt 2 Treated 16hrs 181.9 2.11 2.01 
Ad 1 Control 16hrs 1079.5 2.21 2.46 
Ad 2 Control 16hrs 1110.2 2.21 2.43 
Ad 1 Treated 16hrs 214.7 2.17 2.06 
Ad 2 Treated 16hrs 232.7 2.17 2.21 
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A second set of samples were then subject to RNA extraction: 
 
 
Table 7.10: RNA profiles regarding exposure to low molecular weight chitosan (0.0008% w/v) at 
pH 6 after 16 hours under standard conditions (n = 2). 
Sample ID  RNA yield (ng/µl) A260/280 A260/230 
Wt 1 Control 16hrs 575   2.22 2.57 
Wt 2 Control 16hrs 582   2.11 2.36 
Ad 1 Control 16hrs 545 2.21 2.49 
Ad 2 Control 16hrs 547.8 2.22 2.55 
Wt 1 Treated 16hrs 132   2.03 2.00 
Wt 2 Treated 16hrs 146.3   2.04 2.01 
Ad 1 Treated 16hrs 154.6 2.14 1.86 
Ad 2 Treated 16hrs 191.1 2.17 1.87 
 
 
As highlighted in the above, the yield appeared to be very low with respect to 
the wild-type treated samples and consequently the 260/230 ratios suffered. 
 
The actual counts for the above data can be seen in Table 7.11, below. 
 
 
Table 7.11: Representative CFU/ml data concerning samples both treated and non-treated to low 
molecular weight chitosan for 16 hours (n = 2).  
 
 
 
 
 
 
 
 
 
 
 
Sample type Av. CFU/ml (0hrs) Av.  CFU/ml (16hrs) 
wt 1 C 16hrs 4.21E+06 6.15E+08 
wt 2 C 16hrs 4.42E+06 5.70E+08 
ad 1 C 16hrs 3.48E+06 6.12E+08 
ad 2 C 16hrs 3.50E+06 6.53E+08 
Wt 1 Treated 16hrs 4.11E+06 2.17E+07 
Wt 1 Treated 16hrs 4.30E+06 3.44E+07 
Ad 1 Treated 16hrs 3.00E+06 2.25E+08 
Ad 2 Treated 16hrs 3.00E+06 1.50E+08 
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A summary of RNA profiles is shown below which were sent to the Functional 
Genomics, Proteomics and Metabolomics Facility (University of Birmingham). 
 
Table 7.12: Summary of RNA samples used for microarray analysis, with respective 
ratios. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tube ID 
Description of 
contents 
RNA yield 
(ng/µl) 
A260/280 
ratio 
A260/230 
ratio 
JW 1 Wild-type control  1 281.3 2.18 2.14 
JW 2 Wild-type control  2 274.7 2.15 1.96 
JW 3 Wild-type control  3 575 2.22 2.57 
JW 4 Wild-type control  4 582 2.11 2.36 
JW 5 Adapted control  1 1079.5 2.21 2.46 
JW 6 Adapted control  2 1110.2 2.21 2.43 
JW 7 Adapted control  3 545 2.21 2.49 
JW 8 Adapted control  4 547.8 2.22 2.55 
JW 9 Wild-type treated 1 179.3 2.08 2.08 
JW 10 Wild-type treated 2 181.9 2.11 2.01 
JW 11 Wild-type treated 3 132 2.03 2 
JW 12 Wild-type treated 4 146.3 2.04 2.01 
JW 13 Adapted treated 1 214.7 2.17 2.06 
JW 14 Adapted treated 2 232.7 2.17 2.21 
JW 15 Adapted treated 3 154.6 2.14 1.86 
JW 16 Adapted treated 4 191.1 2.17 1.87 
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7.4 Microarray results 
 
 
 
7.4.1 Transcriptional comparison of ‘adapted’ control versus wild-type 
control C. jejuni NCTC 11168 cells 
 
 
 
Several genes were seen to have differences in expression when comparing the 
wild-type and chitosan ‘adapted’ isolates of C. jejuni NCTC 11168 in the absence 
of low molecular weight chitosan (p <0.05). Five genes were seen to show at 
least 2 fold increases in expression in the ‘adapted’ isolate, as opposed to the 
wild-type C. jejuni NCTC 11168 cells when incubated for 16 hours at pH 6.0, 
under microaerobic conditions (42°C). These genes included Cj1500, encoding 
an inner membrane protein, Cj0289c (PEB3) encoding an antigenic peptide, 
Cj0017c a gene involved in disulphide bond formation, kpsM believed to encode 
a protein functioning as an inner membrane protein involving exporting capsule 
polysaccharides and Cj0294 thought to encode a probable MoeB/ThiF family 
protein (Table 7.13). 
 
Additionally, four genes were down regulated in the ‘adapted’ isolate under the 
same conditions as mentioned above. These included Cj0025c, thought to 
encode a sodium-dicarboxylate family transmembrane symporter, a two-
component regulator (Cj1608), CjaA a gene believed to encode an amino acid 
transporter substrate-binding protein and Cj1666c, encoding a putative 
periplasmic protein. Of these down regulated genes, the greatest decreases were 
observed in Cj0025c and Cj1608, with 9.2 fold and 6.6 fold decreases, 
respectively.  
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Table 7.13: Genes significantly up/down regulated  (2 fold threshold) when comparing ‘adapted’ 
control relative to wild-type control samples of C. jejuni NCTC11168, following 16hrs growth at 
42°C under microaerobic conditions (pH 6.0).  
 
Gene 
name 
Product function Fold 
change 
kpsM capsule polysaccharide export system inner membrane protein 
 
+ 2.2 
Cj0289c 
(PEB3) 
major antigenic peptide 
 
 
+ 2.4 
Cj1500 inner membrane protein 
 
+ 2.2 
Cj0294 Putative MoeB/ThiF family protein + 2.4 
   
Cj0017c Disulphide bond formation protein (dsbI) 
 
+ 2.0 
Cj1666c putative periplasmic protein 
 
- 2.0 
Cj0982c 
(cjaA) 
Probable amino acid transporter substrate-binding protein 
 
- 3.6 
 
Cj1608 two-component regulator 
 
- 6.6 
Cj0025c putative sodium-dicarboxylate family transmembrane 
symporter 
- 9.2 
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7.4.2 Transcriptional comparison of ‘adapted’ treated versus wild-type 
treated versus C. jejuni NCTC11168 cells 
 
 
Following exposure to low molecular weight chitosan at a concentration of 
0.0008% (w/v) for 16 hours under the same microaerobic conditions, differences 
in expression level of various genes were also apparent between wild-type and 
chitosan ‘adapted’ isolates of C. jejuni NCTC 11168.  
 
Up regulation of 8 different genes was observed regarding the ‘adapted’ isolate 
compared to the wild-type cells upon chitosan challenge. The genes included 
PEB3, encoding for a major antigenic peptide, CmeR, a gene involving a protein 
responsible for regulation of transcription, Cj0294, thought to encode a protein 
with a similar function to members of the HesA/MoeB/ThiF family, CjE1107 
thought to encode a protein with functionality of a TraG-like protein, a probable 
periplasmic protein encoding gene (Cj0420), Cj0088 (dcuA) encoding an 
anaerobic C4-dicarboxylate transporter, Cj0017c (dsbI) involved in disulphite 
bond formation or ATP/GTP binding protein and a C8J_0913 which is unknown in 
terms of function (Table 7.14).  
 
The greatest degree of up regulation of gene expression was noted for the 
Cj0289c and Cj0294 when comparing the ‘adapted’ treated cells to the wild-type 
C. jejuni NCTC 11168 cells, representative of 2.8 fold and 2.5 fold increases, 
respectively (Table 7.14). 
 
Conversely, 18 genes were typical of a twofold or greater down-regulation with 
respect to the chitosan ‘adapted’ isolate when compared to the wild-type C. 
jejuni NCTC 11168. These genes included Cj1167 (ldh), Cj0873c, Cj0876c, 
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Cj17683-01, Cj0263 (ZupT), Cj0171 Cj0753c (TonB3), Cj0874c, Cj8486_1775c, 
Cj1584c, transcriptionally coupled; Cj1628 (exbB2) and Cj1629 (exbD2), 
CJJ81176_0884, Cj1659, Cj1358c (nrfH), Cj0982c (cjaA), Cj1608 and Cj0025c 
(Table 7.14). Similarly to the substantial down regulation of Cj1608 and Cj0025c 
in Table 13, these genes were also found to show the greatest decrease in terms 
of gene expression, totalling a 3.6 and 6.2 fold decreases, respectively.  
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Table 7.14: Genes significantly up/down regulated (2 fold threshold) when comparing ‘adapted’ 
relative to wild-type treated (0.0008% w/v) samples of C. jejuni NCTC11168, following 16hrs 
growth at 42°C, under microaerobic conditions (pH 6.0). 
 
Gene name Product function Fold 
change 
Other notes 
Cj0289c (PEB3) major antigenic peptide 
 
+ 2.8  
CmeR transcriptional regulator 
 
+ 2.1  
Cj0294 Unknown (similar to members of the 
hesA/moeB/thiF family) 
 
+ 2.5  
CJE1107 TraG-like protein 
 
+ 2.2  
Cj0420 putative periplasmic protein 
 
+ 2.0  
Cj0088 (dcuA) anaerobic C4-dicarboxylate transporter 
 
+ 2.1  
Cj0017c (dsbI) disulphide bond formation protein 
(probable ATP/GTP binding protein)  
 
+ 2.0  
C8J_0913 hypothetical protein 
 
+ 1.9  
Cj1167 (ldh) L-lactate dehydrogenase 
 
- 2.0  
Cj0873c unknown 
 
- 2.0  
Cj0876c putative periplasmic protein 
 
- 2.0  
Cj17683-01 
 
Unknown  - 2.0  
Cj0263 (ZupT) zinc transporter  
 
- 2.0  
Cj0171 Unknown 
 
- 2.2  
Cj0753c (TonB3) TonB transport protein 
 
- 2.2  
Cj0874c putative cytochrome C 
 
- 2.2  
Cj8486_1775c similar to Campylobacter coli RM2228 
YeeE/YedE family protein family 
(CCO0026) 
 
- 2.2  
Cj1584c peptide ABC transporter substrate-
binding protein 
 
- 2.2  
Cj1628 (exbB2) ExbB/TolQ family transport protein 
 
- 2.9  
CJJ81176_0884 cytochrome c family protein, degenerate 
 
- 2.2  
Cj1659 Putative a high-affinity iron transporter - 2.2 Proposed by 
Chan et al. 
(2010) 
Cj1358c (nrfH) Cytochrome C nitrite reductase 
 
- 2.6  
Cj1629 (exbD2) ExbD/TolR family transport protein - 3.1  
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Cj0982c (cjaA) Probable amino acid transporter 
substrate-binding protein 
 
- 3.0  
Cj1608 two-component regulator 
 
- 3.6  
Cj0025c sodium:dicarboxylate family 
transmembrane symporter 
- 6.2  
 
 
 
 
 
 
7.4.3 Transcriptional comparison of wild-type exposed versus wild-type 
control C. jejuni NCTC11168 cells 
 
 
 
Nevertheless, numerous genes were found to be up regulated in the wild-type 
cells exposed to 0.0008% (w/v) chitosan in contrast to the wild-type control 
samples (no exposure to chitosan) after 16 hours incubation under the 
conditions mentioned previously (p <0.05). Twenty four genes were observed as 
having a twofold or higher gene expression, these were Cj0046, Cj1211, Cj0731, 
Cj1560, Cj0730, Cj0967, Cj0444, Cj0179 (exbB1), Cj1158c, Cj0301c (modB), 
Cj0035c , Cj0676, Cj0563, Cj1539c, Cj0742, Cj1395, CJE1049, Cj0291c, Cj0967, 
Cj0874c, Cj1038, Cj0379c (YedY), Cj1530 (coaE) and Cj0201c. 
 Two genes were found to be equally down regulated in the wild-type C. jejuni 
NCTC 11168 cells exposed to low molecular weight chitosan compared to the 
non-chitosan exposed control samples, these were Cj1497c (ccoP) and Cj1489c 
(ccoO), encoding cytochrome C oxidase subunits (Table 7.15).  
 
 
 
187 
 
Table 7.15: Genes significantly up/down regulated (2 fold threshold) when comparing wild-type 
treated (0.0008% w/v) and wild-type control (no chitosan exposure) samples of C. jejuni 
NCTC11168, following 16hrs growth at 42°C under microaerobic conditions (pH 6.0). 
 
Gene name Product function Fold 
change 
Other notes 
Cj0046 Pseudogene (probable 
transport protein) 
+ 2.4 putative sodium:sulphate 
transmembrane transport 
protein 
 
Cj1211 putative competence family 
protein 
 
+ 2.5  
Cj0731 ABC transporter permease 
 
+ 2.3  
Cj1560 Putative permease 
 
+ 2.6  
Cj0730 putative ABC transport system 
permease 
+ 2.3 Part of a binding-protein-
dependent transport 
system. Probably 
responsible for the 
translocation of the 
substrate across the 
membrane 
 
Cj0967 putative periplasmic protein 
 
+ 2.4  
Cj0444 pseudogene + 2.8 putative TonB-dependent 
outer membrane receptor 
 
Cj0179 (exbB1) biopolymer transport protein  
 
+ 2.2  
Cj1158c small hydrophobic protein 
 
+ 2.5  
Cj0301c (modB) molybdenum transport system 
permease  
 
+ 2.2  
Cj0035c  putative efflux protein 
 
+ 2.2 Antibiotic resistance (Ge et 
al., 2005) 
 
Cj0676 pseudogene (KdpA) + 2.6 potassium transporting 
ATPase A chain 
 
Cj0563 hypothetical protein 
 
+ 2.2  
Cj1539c putative anion-uptake ABC-
transport system permease 
protein 
 
 
 
+ 2.2 Part of a binding-protein-
dependent transport 
system. Probably 
responsible for the 
translocation of the 
substrate across the 
membrane 
Cj0742 pseudogene 
 
+ 2.1  
Cj1395 pseudogene 
 
+ 2.0 putative MmgE/PrpD 
family protein 
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CJE1049 hypothetical protein + 2.1 
 
 
Cj0291c glycerol-3-phosphate 
transporter  
 
+ 2.0 probable pseudogene 
Cj0874c putative cytochrome C 
 
+ 2.0  
Cj1038 putative cell 
division/peptidoglycan 
biosynthesis protein 
 
+ 2.0  
Cj0379c (YedY) putative sulphite oxidase 
subunit  
 
+ 2.4  
Cj1530 (coaE) dephospho-CoA kinase 
 
+ 2.0  
Cj0201c putative integral  
membrane protein 
 
+ 2.0  
Cj1487c (ccoP) cb-type cytochrome C oxidase 
subunit III 
 
- 2.0  
Cj1489c (ccoO) cbb3-type cytochrome c 
oxidase subunit II 
- 2.0  
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7.4.4 Transcriptional comparison of ‘adapted’ chitosan treated versus 
‘adapted’ control exposed C. jejuni NCTC11168 cells 
 
 
 
When comparing the gene expression between the chitosan ‘adapted’ isolate 
exposed C. jejuni cells against those which were grown in chitosan free 
conditions, 17 genes were seen to be upregulated, all of which were typical of a 
twofold or higher increase (p <0.05). These genes associated with an up 
regulation were found to be Cj0025c, C8J_0988, Cj8486_1111, C8J_1082, 
Cj0240c (iscS), Cj0939c, Cj0239c (NifU), Cj0379c (YedY), Cj1665, Cj0539, 
Cj1448c (kpsM), Cj1663, Cj1637c, Cj1375, Cj0779 (tpx), Cj1280c and Cj1104. 
Of these genes, the highest fold increase was apparent with respect to the 
Cj0025c (5.2 fold), which was the opposite in comparison the wild-type control 
cells versus those wild-type cells which were exposed to chitosan (Table 7.16). 
 
Sixteen genes were also seen to be down regulated in the chitosan treated 
‘adapted’ isolate in comparison to that of the control samples which indicative of 
a twofold or greater decrease in expression (p <0.05). The greatest down 
regulation was typical of the Cj1358c (5.5 fold), Cj0465c (8.4 fold), Cj1586 
(20.3 fold) genes. Other genes showing statistically significant twofold or higher 
decreases in gene expression included Cj0783, Cj0782 (napH), Cj8486_0800, 
Cj0438 (sdhB), Cj0453 (ThiC), Cj1357c, Cj0439, Cj0437, CJJ81176_0069, 
Cj1500, CJE0515, Cj0358 and Cj0761. 
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Table 7.16: Genes significantly up/down regulated (2 fold threshold) when comparing and 
‘adapted’ treated (0.0008% w/v chitosan)  relative to ‘adapted’ control (no chitosan exposure) 
samples of C. jejuni NCTC 11168, following 16hrs growth at 42°C under microaerobic conditions 
(pH 6.0). 
 
Gene name Product function Fold Change 
Cj0025c Putative sodium:dicarboxylate family 
transmembrane symporter 
 
+ 5.2 
C8J_0988 Hypothetical protein + 3.1 
 
Cj8486_1111 similar to Campylobacter jejuni  
RM1221 hypothetical protein CJE1052 
 
+ 3.0 
C8J_1082 hypothetical protein + 2.1 
 
Cj0240c (iscS) cysteine desulfurase 
 
+ 3.2 
Cj0939c hypothetical protein 
 
+ 2.3 
Cj0239c (NifU) Nitrogen fixation protein 
  
+ 2.3 
Cj0379c (YedY) putative sulfite oxidase subunit  
 
+ 2.3 
Cj1665 putative lipoprotein thioredoxin 
 
+ 2.3 
Cj0539 hypothetical protein + 2.2 
Cj1448c (kpsM) capsule polysaccharide export system inner 
membrane protein 
 
+ 2.4 
Cj1663 putative ABC transport system ATP-binding 
protein 
 
+ 2.2 
Cj1637c putative periplasmic protein 
 
+ 2.1 
Cj1375  probable multidrug efflux transporter 
 
+ 2.3 
Cj0779 (tpx) thiol peroxidase 
 
+ 2.1 
Cj1280c putative ribosomal  
pseudouridine synthase 
 
+ 2.0 
Cj1104 4-diphosphocytidyl-2-C-methyl-D-erythritol 
kinase 
 
+ 2.1 
Cj0783 periplasmic nitrate reductase small subunit 
(cytochrome C-type protein) 
 
- 2.1 
Cj0782 (napH) quinol dehydrogenase membrane subunit  
 
- 2.1 
Cj8486_0800 similar to Campylobacter jejuni NCTC 11168 
putative ferredoxin - Cj0782 
 
- 2.0 
Cj0438 (sdhB) putative succinate dehydrogenase iron-sulfur 
protein 
 
- 2.2 
Cj0453 (ThiC) thiamine biosynthesis protein  - 2.4 
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Cj1357c putative periplasmic cytochrome C 
 
- 3.2 
Cj0439 putative succinate dehydrogenase subunit C 
 
- 2.2 
Cj0437 succinate dehydrogenase flavoprotein subunit 
 
- 2.3 
CJJ81176_0069 hypothetical protein 
 
- 2.0 
Cj1500 putative inner membrane protein 
 
- 2.4 
CJE0515 hypothetical protein - 2.3 
Cj0358 putative cytochrome C551 peroxidase 
 
- 2.7 
Cj1358c (nrfH) cytochrome c nitrite reductase 
 
- 5.5 
Cj0761 unknown protein 
 
- 4.0 
Cj0465c (ctb) group III truncated haemoglobin 
 
- 8.4 
Cj1586 single domain haemoglobin -20.3 
 
 
 
Several genes were also found to overlap between the initial comparisons tested 
(Table 7.17). For instance, the PEB3 gene was found to be significantly over 
expressed in the ‘adapted’ isolate of C. jejuni with respective control and 
chitosan exposure cells of the wild-type C. jejuni NCTC11168. An increase in 
expression was also found in the Cj0017c and Cj0294 in the ‘adapted’ C. jejuni 
cells control and chitosan treated cells in relation to the respective cells wild-
type C. jejuni. 
 
In contrast, similarities were found in Cj0025c, Cj1608 and Cj0982c genes which 
were consistently down regulated in the comparison between ‘adapted’ control 
and chitosan treated cells, relative to the wild-type C. jejuni cells which exposed 
under the respective conditions. In the case of the Cj0025c gene, an over 
expression in relation to the ‘adapted’ treated versus control cells was found. 
With respect to the Cj0379c gene, a consistent over expression in both the wild-
type and ‘adapted’ isolates which were treated with chitosan was identified, 
relative to their respective controls.  
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Table 7.17: Summary of overlapping genes found to be significantly up/down regulated in more 
than one initial comparison.  
 
Gene name Ad control vs 
Wt control 
Ad treated vs 
Wt treated 
Wt treated vs 
Wt control 
Ad treated vs 
Ad control 
PEB3 +2.4 +2.8 - - 
Cj0294 +2.4 +2.5   
Cj0017c +2.0 +2.0 - - 
Cj0025c -7.6 -5.3 - +5.9 
Cj1608 -6.6 -4.9 - - 
Cj0379c - - +2.4 +2.3 
Cj0874c - -2.2 +2.0 - 
Cj1358c - -2.6 - -5.5 
Cj0982c -3.6 -3.0 - - 
KpsM +2.2 - - +2.4 
Cj1500 +2.2 - - -2.4 
Wt = wild-type C. jejuni NCTC11168, Ad = ‘adapted’ isolate of C. jejuni NCTC11168 
 
 
 
 
 
7.4.5 Microarray Validation via qRT-PCR 
 
As a means of validating the transcriptional differences observed by microarray 
analysis, qRT-PCR was conducted on cDNA samples from the original RNA 
yielded for the microarray experimentation (Figure 7.6). 
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Figure 7.6: Relative fold changes in selected target genes with regards to microarray validation. 
Data values represent means, error bars indicate standard deviation (n = 4). Darker bars indicate 
fold changes in target genes regarding the wild-type treated vs. control samples, whereas lighter 
grey bars indicate targets validating ‘adapted’ treated vs. ‘adapted’ control samples. 
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Figure 7.7: Microarray fold change vs. qRT-PCR fold change regarding wild-type control vs wild-
type treated C. jejuni following 16 hours exposure to 0.0008% chitosan. Data points represent the 
mean of 4 biological replicates.  
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Figure 7.8: Microarray fold change vs. qRT-PCR fold change regarding adapted control vs adapted 
treated C. jejuni following 16 hours exposure to 0.0008% chitosan. Data points represent the 
mean of 4 biological replicates.  
 
 
When comparing the genes up/down regulated in both the microarray and the 
qRT-PCR analysis, a strong correlation was apparent between the selected genes 
chosen for the wild-type control versus the wild-type treated samples (Figure 
7.7) and those involving the control versus the treated chitosan ‘adapted’ 
samples (Figure 7.8). Respective R² values of 0.9284 and 0.9953 were seen to 
show a strong correlation (Woodall et al., 2005). Thus, the qRT-PCR was seen to 
validate the microarray data in the gene tested, meaning that all findings in the 
microarray were therefore accepted to be true. 
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7.5 Discussion 
 
 
Generally, microarray analysis of the wild-type and chitosan ‘adapted’ isolates of 
C. jejuni NCTC11168 revealed multiple transcriptional differences in relation to 
cells exposed to low molecular weight chitosan and those which were not subject 
to chitosan. 
 
7.5.1 Transcriptional differences between wild-type versus ‘adapted’ 
untreated cells 
 
When assessing the differences between  gene expression in control samples 
compared to the chitosan ‘adapted’ isolates against multiple genes were 
indicative of significant up/down regulation (p <0.05). Of the five genes which 
happened to be up regulated in the chitosan ‘adapted’ control, a gene encoding 
a major antigenic peptide (PEB3) was found to have the most substantial 
difference relative to the wild-type control cells.  
 
PEB3 is thought to be one of the most abundant glycoproteins in eukaryotes, 
functioning as a surface protein (Linton et al., 2002; Wacker et al., 2002). The 
structure of PEB3 may also lend itself to have functionality as a transportation 
protein and/or in adhesion, resembling PEB1a which transports both aspartic and 
glutamic acids (Leon-Kempis Mdel et al., 2006.) 
 
The degree of adherence to intestinal epithelial cells may play an important role 
in C. jejuni resistance when in this environment. Other adhesins which are found 
in C. jejuni thought to mediate bacterial cell adherence to host cells include the 
antigens PEB1a and PEB4 (Pei et al., 1998; Asakura et al., 2007). Along with the 
role of adherence in of these two genes, their function seems to be also linked to 
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the in vivo colonisation (Jeon et al., 2010). There have been instances whereby 
mutations in PEB1a and PEB4 resulted in diminishing levels of colonisation in 
mice intestines (Pei et al., 1998; Asakura et al., 2007). A study undertaken by 
Asakura et al. (2007) also found a lower incidence of PEB4 mutant cells that 
undertook stress induced biofilm formation when compared to the wild-type cells 
of C. jejuni. Thus, increases in expression of PEB3 in the ‘adapted’ cells of C. 
jejuni NCTC 11168 as seen in the microarray analysis may raise questions as to 
whether an increased virulence potential can be associated compared to that of 
the wild-type, which typically has a  lower expression of PEB3. The related genes 
which encode the PEB1a and PEB4 proteins mentioned above may suggest that 
the ‘adapted’ isolate is perhaps more able to colonise a given host through 
induction of PEB3. Additionally, it is possible that an up regulation of PEB3 may 
have implications with respect to an increased biofilm formation, if the true 
function is related to adherence. 
 
The kpsM gene encoding an inner membrane protein was also found to be 
significantly up regulated in the ‘adapted’ isolate, compared to the wild-type 
cells of C. jejuni NCTC 11168 under control conditions. The kpsM encoding 
protein belongs to an ATP-binding (ABC) transporter superfamily, which in turn 
are thought to be important in terms of virulence, viability and pathogenicity of 
bacteria though the export of toxic compounds and mediation of numerous 
substrates including polysaccharides, ions, amino acids including others  (Pigeon 
and Silver, 2006; Davidson et al., 2008). It has been seen previously that kpsM 
influences intestinal invasion of epithelial cells in vitro, approximately 10 fold 
decreases in C. jejuni 81-176 was observed with respect to a kpsM mutant when 
compared to that of the wild-type (Bacon et al., 2001). The influence of kpsM 
upon colonisation and subsequent virulence in C. jejuni NCTC11168 was 
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indicated in a study conducted by Jones et al. (2004), with a total absence of 
colonisation in chickens presented in a kpsM mutant in comparison to wild-type 
cells.  
 
However, a study assessing biofilm formation with regards to an isogenic kpsM 
mutant was seen to have an increased pellicle formation in comparison to the 
wild-type C. jejuni strain (Joshua et al., 2006). As well as the observed up 
regulation of PEB3 in the chitosan ‘adapted’ cells of C. jejuni, simultaneous 
increases in kpsM may contribute the of an enhanced tolerance towards low 
molecular weight chitosan, generally observed in the ‘adapted’ cells. 
Interestingly, this coincides with a notable visual increase in pellicle formation 
upon conducting biofilm assays in relation to the ‘adapted’ isolate (data not 
shown). 
 
 The greater expression of these genes seen in the ‘adapted’ cells may also 
explain the enhanced degree of biofilm formation both in the presence and 
absence of chitosan, illustrated in the ‘adapted’ variant when compared to the 
wild-type C. jejuni NCTC11168 (chapter 6). Given that the PEB3 protein is 
thought to be involved in adherence and colonisation, this may potentially be 
linked to the visual increases in pellicle quantity observed in the biofilm 
formation and eradication studies (chapter 6). 
 
 In other bacteria, it has been observed that the extracellular matrix in formed 
biofilms can contain carbohydrate-containing molecules (Solano et al., 2002; 
Sherlock et al., 2005). Therefore, the increased expression of kpsM may be 
partially responsible for mediation of biofilm formation through subsequent 
changes in the extracellular matrix. 
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Gram negative bacteria have the ability to form disulphide bonds which is 
facilitated via the Dsb family of proteins, functioning within the periplasmic 
space. The oxidation pathway, in where some members of the family are related 
to, is responsible for the formation of disulphide bond in proteins which have 
recently undergone synthesis, upon crossing the cytoplasmic membrane 
(Grabowska et al., 2011). Despite expression of membrane-bound 
oxidoreductases such and dsbB and dsbI being dependant on iron 
concentration/availability and interaction with Fur proteins, involved in iron 
regulation, changes in dsb protein levels can lead to the regulation of 
extraplasmic virulence factors (substrates of the dsb system), which in turn is 
controlled by environmental conditions (Grabowska et al., 2011). The dsb family 
has also been associated with intestinal colonisation, as findings in experiments 
conducted by Lasica et al. (2010) found that mutants of both dsbI and dsbB 
illustrated decreased invasion and intracellular survival in human intestinal 
epithelial T84 cells. Also, double mutants of dsbB and dsbI were not recovered 
after 3 hours of invasion into these cells. This suggests that dsbI up regulation 
may contribute to the pathogenicity and survival of C. jejuni as a whole.  
 
Of the genes which were seen to be down regulated in the untreated ‘adapted’ 
cells in comparison to the untreated wild-type C. jejuni cells, the greatest fold 
difference (9.2) was Cj0025c, believed to encode a protein encoding sodium-
dicarboxylate transmembrane symporter.  
 
Generally, divalent anion/sodium symporters (DASSs) are a family of secondary 
active transporters which utilise the energy from the movement of sodium ions 
across the electrochemical gradient, at the same time facilitating the transport of 
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decarboxylases and inorganic anions through the membrane (Pajor, 2006). 
Prokaryotic sodium:dicarboxylate symporter proteins within this DASS family 
have been characterised, one of these being SdcS, originally from 
Staphylococcus aureus (Hall and Pajor, 2005). According to Strickler et al. 
(2009), this symporter occupies similar transport properties to those symporter 
present in mammalian cells. 
 
C. jejuni, similar to all prokaryotic cells can react to environmental stressors via 
utilisation of two-component regulatory systems or TCRSs, which involve 
regulators and sensor kinases responsible for the mediating gene expression 
(Raphael et al., 2005; Mikkelsen et al., 2011). Several TCRSs have currently 
been identified in terms of unique functionality, namely the reduced ability to 
colonise system or RacRS (Bras et al., 1999), Campylobacter planktonic growth 
regulation or CprRS (Svensson et al., 2009), diminished capability to colonise or 
DccRS (MacKichan et al., 2004), FlgRS involved with flagella motility (Wosten et 
al., 2004) and CbrR, linked to colonisation and resistance (Raphael et al., 2005). 
The amount of  translated protein following changes in gene expression involving 
the TCRSs can be altered further by various posttranslational modifications, 
including glycosylation and disulphide bond formation, which in the modify 
structures impacting virulence and accounting for alterations in pathogenesis 
(Heras et al., 2009; Grabowska et al., 2011). With the above in mind, it can be 
suggested that although the exact function of the protein encoded by the Cj1608 
gene has not been established, this two-component regulator may be important 
for an enhanced survival upon exposure to chitosan. 
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7.5.2 Transcriptional differences between wild-type treated versus 
chitosan ‘adapted’ treated cells 
 
Interestingly, when comparing the gene expressional changes in the chitosan 
treated cells of the ‘adapted’ isolate, relative to the wild-type cells of C. jejuni 
NCTC 11168, the genes PEB3 and dbsI were seen to be up regulated, totalling a 
2.8 fold and 2.0 fold change, respectively (p <0.05). These encode a major 
antigenic peptide believed to involve glycosylation and disulphite bond 
formation, respectively. As these same two genes were seen to be up regulated 
in the untreated ‘adapted’ cells versus the wild-type untreated cells of C. jejuni 
(Table 7.14), this supports the potential importance of enhanced expression of 
these genes from a survival aspect. This may contribute to the enhanced growth 
of the ‘adapted’ cells under 0.0008% (w/v) chitosan in comparison to the wild-
type cells over the course of 16 hours under microaerobic conditions (pH 6.0, 
42°C).  
 
A 2.5 fold increase in Cj0294 was also observed when comparing the chitosan 
‘adapted’ cells versus the wild-type cells after having undergone chitosan 
exposure. Again, this proposes that the gene thought to encode MoeB/ThiF 
family proteins may be important in the higher overall tolerance typically 
observed in the generated ‘adapted’ isolate of C. jejuni NCTC11168.  
 
A gene believed to encode a transcriptional regulator (CmeR) was found to be 
significantly upregulated in the ‘adapted’ cells, as oppose to the wild-type cells 
after chitosan treatment (2.1 fold increase). CmeR belongs to a family of 
transcriptional regulators (TetR) and is said to function as a repressor of 
CmeABC operon, which in turn functions as an efflux pump. The three 
components; CmeA, CmeB and CmeC have been shown to contribute to 
202 
 
resistance in Campylobacter spp. with respect to antimicrobials and bile 
components in a hosts intestinal tract (Lin et al., 2002; Lin et al., 2003, Guo et 
al., 2008). A Mutant generated resulting in CmeABC inactivation was found to 
demonstrate an inability to colonise chicken intestines in vivo (Lin et al., 2003).  
 
It is therefore interesting that an up regulation in the ‘adapted’ treated cells was 
observed in comparison to the wild-type, as increases in CmeR would 
theoretically allow for a decrease in efflux. If during exposure, chitosan was able 
to enter the cells, it would be expected that transcriptional repressors such as 
CmeR would be down regulated so that subsequent increases in efflux pumps 
would be seen. However, it may be the case that due to the increase tolerance 
of the ‘adapted’ cells of C. jejuni, they may be more efficient at preventing 
chitosan influx, thus accounting for a lesser need for such mechanisms. 
 
The intermediates in the tricarboxylic acid cycle fumarate, succinate and malate 
can be transported by several C4-dicarboxylate carriers, including DcuA and 
DcuB (Guccione et al., 2008). These carries are restricted to anaerobic and 
facultative anaerobic bacteria species, including C. jejuni (Hofreuter et al., 
2006). 
The DcuA and DcuB transporters may have important roles due to their essential 
aspect of electron donation with respect to fumarate and succinate metabolites 
within C. jejuni (Stahl et al., 2012). It is possible that DcuA may be also be 
involved in subsequent cytoplasmic-periplasmic membrane transport, as the 
succinate and fumarate required for this process is thought to be initiated by the 
DcuA and DcuB transporters (Guccione et al., 2010). 
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This may explain gene expression increases typical of 2.1 fold in Cj0088 (DcuA) 
and a putative periplasmic protein encoding gene (Cj0420), seen to be induced 2 
fold in the chitosan exposed ‘adapted’ cells, compared to the wild-type C. jejuni 
NCTC 11168 cells. Campylobacter relies greatly upon the tricarboxylic acid cycle 
for the energy requirements (Stahl et al., 2012), hence it would make sense that 
the ‘adapted’ cells of C. jejuni would potentially occupy increased energy needs 
for a decreased susceptibility to such stressors as chitosan. 
The greatest down regulations were equal to 6.2 and 3.6 fold for Cj0025c and 
Cj1608, respectively. Interestingly, the same trend was observed in the wild-
type versus the ‘adapted’ untreated cells of C. jejuni. This reinforces the 
potential importance in the regulation of protein-coding genes which function as 
sodium:dicarboxylate transmembrane symporter and two-components 
regulators in the ability to increase survival. It may be possible that the upon 
exposure to 0.0008% (w/v) chitosan, up regulation in these genes may be 
required to enhance the capacity for growth, whereas the more tolerant 
‘adapted’ isolate may theoretically rely less on these genes for survival, resulting 
in relative down regulation. 
 
Additional genes which were found to be down regulated in the ‘adapted’ cells in 
relation to the wild-type included Cj1629 (3.1 fold) and Cj0982c or cjaA (-3.0 
fold). These genes encode proteins perceived to be related to ExbD/TolR family 
transport and amino acid transport mediated through substrate binding, 
respectively. Down regulation in other genes thought to be have similar 
functionality were also apparent, including Cj0753 (TonB3) encoding a TonB 
transport protein and Cj1628 (exbB2) encoding an ExbB/TolQ family transport 
protein.  
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Genes believed to be involved in energy transduction (exbB1–exbD1, exbB2–
exbD2, tonB1, tonB2 and tonB3) are thought to have some bearing upon iron 
acquisition, as they are generally greater expressed under iron limiting 
conditions (Holmes et al., 2005; Miller et al., 2009). Therefore, a down 
regulation in such genes present in the ‘adapted’ cells versus the wild-type cells 
whilst under chitosan exposure (down regulation in tonB3 gene of 2.2 fold) may 
imply that the wild-type cells require more iron for metabolic purposes, in an 
attempt to combat the chitosan stress. Alternatively, the ‘adapted’ isolate upon 
exposure to chitosan, may down regulate various genes related to iron 
transport/acquisition in order to conserve energy needed for other unknown 
processes, accounting for an increased survival potential. Iron uptake in C. jejuni 
is well regulated to avoid reactive oxygen species (ROS) formation through 
combination of iron and oxygen (Masse and Arguin, 2005). 
 
Generally, Gram negative microorganisms such as C. jejuni have iron acquisition 
systems which comprise of outer-membrane receptors, transport via 
TonB/ExbB/ExbD complexes, periplasmic proteins and inner-membrane ABC 
transporters (Holmes et al., 2005). This may clarify simultaneous down 
regulation is other genes encoding periplasmic proteins and inner-membrane 
ABC transporters, namely Cj1358c (putative periplasmic cytochrome c), Cj0876c 
(probable periplasmic protein) and Cj1584c (peptide ABC transporter-substrate 
binding protein). It has been proposed that a fraction of iron uptake could be 
facilitated via the ZupT gene (Cj0263), encoding a transporter predominantly 
responsible for uptake of zinc (Stahl et al., 2012). In E.coli, a ZupT homolog has 
illustrated substrate affinity for various cations, including ferrous ions; however 
the exact function of this gene has not been confirmed in C. jejuni (Grass et al., 
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2005). The gene Cj1659, also found to be down regulated in the ‘adapted’ 
treated cells compare to the wild-type treated cells is a periplasmic membrane 
protein which is potentially involved in iron transport (Holmes et al., 2005).  
 
 
7.5.3 Transcriptional differences between wild-type control versus wild-
type chitosan treated cells 
 
Comparing expressional differences between the wild-type untreated (control) 
cells versus the those treated with 0.0008% (w/v) chitosan, revealed  several 
genes which were significantly up regulated following chitosan exposure, in 
relation to control cells (p <0.05).  
 
Several of these genes were thought to be related to transportation of 
ions/substrates. These included Cj0731 (ABC transporter permease), Cj1560 
(probable permease), Cj0730 (putative ABC transport permease), Cj0967 
(putative periplasmic protein) and Cj1539c, thought to be involved in an anion-
uptake ABC-transport system permease protein (Table 7.15). It would make 
logical sense that upon exposure to antimicrobials including chitosan may 
enhance genes involved in transport to be better able to survive in a less than 
ideal environment. 
 
Other genes perceived to be related to transport, were up regulated in terms of 
the wild-type treated versus respective controls. These included the pseudogene 
Cj0046 (probable transport protein), exbB1 (biopolymer transport) and modB, 
encoding a protein molybdenum transport system permease.  
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Interestingly, a putative efflux protein encoding gene (Cj0035c) was also seen to 
be up regulated in the treated cells of the wild-type C. jejuni cells compared to 
those of which were subject to no chitosan challenge (2.2 fold). It is possible 
that C. jejuni may up regulate such genes in order to remove chitosan which 
may have entered the cell through membrane perturbation, a potential mode of 
action proposed by Helander et al. (2001); Zakrzewska et al., (2005) and Je and 
Kim (2006). 
 
Additional up regulation of both Cj0291c, encoding a glycerol-3-phosphate 
transporter and Cj0379c, possibly involving a sulphite oxidase subunit was 
observed in the treated versus non-treated wild-type cells.  C. jejuni is known to 
convert glycerol-3-phosphate to glyceraldehyde-3-phosphate, which can then be 
utilised in the glycolysis pathway. An enhanced ability in the uptake of glycerol-
3-phophate, as seen in the chitosan treated cells of the wild-type when 
compared to the untreated cells, may result in a metabolic advantage (Hofreuter 
et al., 2006). 
 
The metabolic alterations which seem to be resultant occur in an attempt to 
combat such chitosan exposure may also be associated with the overexpression 
of genes thought to encode cytochrome C proteins (Cj0874c), which facilitate 
transfer of electrons in the electron transport chain. Likewise, this links to other 
genes, for instance the up regulated Cj1530, involving the enzyme dephospho-
CoA kinase, a phosphotransferase which involves catalysis of the de-
phosphorylation of ATP in the tricarboxylic acid cycle. 
 
Interestingly, only two genes were found to be significantly down regulated in 
the chitosan treated wild-type cells compared to those cells which were grown in 
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the absence of chitosan, encoding a cbb3-type cytochrome C oxidase subunit II 
and a cb-type cytochrome C oxidase subunit III (ccoO and ccoP, respectively).  
 
 
7.5.4 Transcriptional differences between ‘adapted’ treated versus 
‘adapted’ untreated cells 
 
When assessing the differences in gene expression with regards to the ‘adapted’ 
chitosan treated cells against those which did not undergo exposure to chitosan 
during the 16 hours of growth, the greatest increase in gene expression was 
typical of the Cj0025c, encoding a putative sodium:dicarboxylate family 
transmembrane symporter (5.2 fold increase). This is contrary to what was 
observed in the comparison of the ‘adapted’ treated cells versus the wild-type 
treated cells and adapted untreated versus wild-type untreated cells. Thus, 
these data suggest an important role of this gene in terms of the degree to 
which C. jejuni is able to survive. Unfortunately, as there is no definitive function 
of this gene in Campylobacter, it is difficult to establish to exact mechanism of 
action of the gene product. 
 
Iron is known to be an essential nutrient for organisms in general due to its 
involvement in enzymes as a cofactor as well as having a prominent role in 
electron transport and redox reactions (Earhart, 1996). Bacteria such as C. 
jejuni have the ability to transfer iron complexes across the outer membrane via 
high affinity receptors. Transportation of the iron complexes over the 
cytoplasmic membrane is mediated by ABC transporters (van Vliet et al., 2002).  
 
Uncontrolled iron uptake may cause iron toxicity and oxidative stress, leading to 
impaired growth characteristics (Litwin and Calderwood, 1993). Thus, the 
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maintenance of iron homeostasis seems to be paramount to survival of 
microorganisms, this regulation of iron is usually controlled via a balance in the 
uptake and storage (van Vliet et al., 2002). Iron homeostasis is associated with 
various mechanisms to protect against oxidative stress and also the formation of 
toxic oxygen intermediates, which in turn is related to iron metabolism (Touati, 
2000; van Vliet et al., 2002). 
 
Although C. jejuni is equipped with an array of enzymes which may facilitate 
oxygen-independent respiration, it has an inability to grow in strictly anaerobic 
conditions (Veron et al., 1981). Thus the pre-requisite for oxygen indicative of 
the microaerobic requirements, brings a disadvantage in that electron transfer of 
a non-specific nature in the respiratory chain can be transferred to oxygen 
molecules, ultimately leading to ROS generation, namely superoxide and 
hydrogen peroxide (Cabiscol et al., 2000; Hofreuter et al., 2014). However, C. 
jejuni possesses a number enzymes involved in ROS-detoxification, thiol 
peroxidase (Tpx) being one of these (Atack et al., 2008). 
 
As study conducted by Atack et al., (2008) revealed that Tpx plays important 
roles in the resistance to a multitude of oxidative and nitrosative agents, 
including molecular oxygen. Studies indicated that Tpx functions as a hydrogen 
peroxide reductase. Moreover, a gene encoding a Tpx protein (Cj0779) was 
found to be up regulated in the treated cells of the ‘adapted’ isolate, as oppose 
to the untreated cells. The build-up of highly reactive species can account for 
damage to vital components within C. jejuni; these include proteins, nucleic 
acids and cell membranes (Atack et al., 2008). The ability of C. jejuni to 
overcome such compounds may contribute to an enhanced survival and 
potentially an increased pathogenesis/virulence (Imlay, 2003).  
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Bacteria have mechanisms to counter such stress, which include cytochrome c 
peroxidases and peroxiredoxins (Atack and Kelly, 2006; Wood and Kelly, 2006). 
Up regulation with regards to the chitosan exposed ‘adapted’ cells was observed 
in the Cj1665 gene, encoding a putative lipoprotein thioredoxin was observed. 
This may suggest that the ‘adapted’ cells which upon exposure to chitosan may 
occupy a greater ability to deal with inevitable ROS toxicity. Excess Iron which is 
not utilised immediately needs to be stored in a non-reactive state, minimising 
the hydroxyl radical formation and thus preventing iron toxicity (van Vliet et al., 
2002). Another advantage of storing iron is that it is available during iron 
shortage in cells. Two classes of bacterial iron storage proteins are known to 
exist, ferritin and bacterioferritins (Andrews, 1998). 
 
Genes which encode bacterioferritins are usually said to be located in the genes 
which code small ferredoxins. A protein associated with E.coli (bacterioferritins-
associated ferredoxin, Bfd) has been shown to have similarity to a region of the 
NifU protein. This NifU protein is encoded for in a number of genes which are 
thought to be responsible for the biosynthesis of iron-sulphur [Fe-S] centres in 
terms of the nitrogen-fixation proteins (Crichton, 2001). 
 
Additionally, homologs of nitrogen-fixation protein, for example IscS homolog of 
NifS, encodes a cysteine desulphurase, involves the catalysis of sulphur from 
cysteine, allowing for [Fe-S] cluster synthesis (Zheng al.,1998; Agar et al., 
2000). Genes of this nature were found to up regulated in the ‘adapted’ 
treated cells when compared to those which were untreated included Cj0240c 
(IscS) and Cj0239c (NifU), encoding proteins cysteine desulphurase and 
nitrogen-fixation, respectively.  
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Thus up regulations of a putative ABC transporter (Cj1663) and gene encoding a 
periplasmic protein (Cj1637c) with regards to the ‘adapted’ treated cells over 
those not subjected to chitosan addition may well contribute to iron acquisition. 
Iron acquisition may be an important attribute contributing to the increased 
survival following chitosan treatment. The greatest decreases in gene expression 
with respect to the ‘adapted’ treated cells compared to the non-treated controls 
were present in Cj1586, encoding a single domain haemoglobin (Cgb) and 
Cj0465c, encoding a truncated haemoglobin protein (Ctb). 
 
C. jejuni is often exposed to nitric oxide (NO), which is produced by the host 
upon transmission. C. jejuni is thought to express two haemoglobins which may 
account for an increase tolerance of such nitrosative stress conditions (Tinajero-
Trejo and Poole, 2012). Surprisingly, these two haemoglobins were those found 
to be down regulated, as indicated by the microarray analysis. The Cgb 
haemoglobin is believed to be involved in the detoxification of NO, whilst the Ctb 
has been associated with cytochrome c peroxidase catalysis and also oxygen 
delivery (Lu et al., 2007; Wainwright et al., 2006), as oppose to aspect of NO 
protection (Tinajero-Trejo and Poole, 2012). 
 
In a study conducted by Monk et al. (2008) a Ctb mutant was not compromised 
in its ability to tolerant nitrosative stress related agents, implying that the Ctb 
protein is not directly involved in combatting nitrosative stress. However, since 
the functions of the Ctb and Cgb haemoglobins are thought to be intimately 
related somewhat, this may explain previously observed co-regulation 
(Wainwright et al., 2005).  
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The down regulation in the bacterial haemoglobin related genes mentioned 
above may link to the down regulation in genes which are speculated to encode 
a cytochrome c peroxidase (Cj0358) and also two genes, Cj1358c (nrfH) and 
Cj0783, encoding a putative cytochrome c nitrite reductase and a cytochrome c-
type protein periplasmic nitrate reductase small subunit, respectively. It can be 
suggested that with increases in expression of thioredoxin functionality (Cj1665) 
and thiol peroxidase activity (Cj0779, Tpx), may facilitate the down regulation in 
the cytochrome c peroxidases as this involves the catalysis of hydrogen peroxide 
to water. Thus, if increases in genes related to reducing ROS are accounted for, 
down regulation in cytochrome c peroxidases may follow potentially due to a 
decreased likelihood ROS development, such as hydrogen peroxide. This may 
also account for decreases in genes responsible for nitrosative stress (e.g. 
Cj1358c and Cj0783) due to co-regulation between these types of stresses 
commonly faced by C .jejuni. This in turn may explain down regulation in the 
Ctb gene, if its role in mediation of oxygen is correct. The observed down 
regulation in the Ctb gene present in the treated ‘adapted’ cells as opposed to 
the untreated cells may be present to reduce oxygen flux into the cytoplasm. It 
is known that iron, along with oxygen molecules can form ROS such as hydrogen 
peroxide (Holmes et al., 2005). A decrease in oxygen intake could theoretically 
limit the possibility of subsequent ROS generation. This especially links to the 
apparent iron acquisition and storage in which genes thought to be related to 
this were up regulated in the ‘adapted’ treated cells compared to those cells 
which were untreated. As co-regulation was apparent in terms of the genes 
involved in oxidative and nitrosative stress, it is not surprising that co-regulation 
in the two bacterial haemoglobins was observed. 
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A previous study found an over expression of genes encoding enzymes involved 
in oxidative stress are often in accordance with expression of iron transport 
systems, presumably owing to the anticipation of iron influx into the cell (Holmes 
et al., 2005). Transcript levels in non-essential iron-containing proteins have 
been shown to decrease in relation to iron depletion, seemingly as a mechanism 
to allow for iron to become more readily available for more vital processes within 
the cell. Genes encoding non-haem protein (Cj0012c), ferredoxin (Cj0333c), 
cytochrome c peroxidase (Cj1358) and members of the succinate dehydrogenase 
operon (Cj0437-0438) were all found to show a down regulation (Holmes et al., 
2005).  
 
This is somewhat in accordance to findings highlighted in Table 7.17, with down 
regulations being apparent in Cj1358, Cj1358c (nrfH), Cj0437, Cj0438 and 
Cj0439 (a putative succinate dehydrogenase subunit C). In this case, it may be 
that the genes Cj0465c and Cj1586 (encoding the bacterial haemoglobins), are 
subject to a related down regulated in chitosan treated ‘adapted’ isolate when 
compared to the control, potentially resultant from a greater need for iron 
acquisition in more important cell activities elsewhere. 
 
 
7.5.5 Overlapping genes between comparisons tested 
 
Of the genes which we seen to overlap between initial comparisons (Table 7.18), 
it is clear that protein-coding PEB3 and Cj0017c were both over expressed with 
regards to the ‘adapted’ isolate in relation to the wild-type, both in response to 
and in the absence of chitosan. As TCRSs can be altered by posttranslational 
modifications, namely glycosylation and disulphide bond formation, this may 
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suggest a close relationship between an up regulation in PEB3 and Cj0017c, 
believed to encode protein functioning in glycosylation and disulphide bond 
formation, respectively, with a simultaneous down regulation in the putative 
two-component regulator (Cj1608) observed in both instances (table 7.18).  
 
 
7.5.6 Conclusions 
 
To date, there appears to be no previously documented data regarding the 
transcriptional differences following C. jejuni exposure to chitosan. The results in 
this chapter highlight differences in gene expression not only in response to 
chitosan treatment but also between C. jejuni isolates.  
 
Generally, genes encoding proteins believed to be associated with energy 
metabolism, solute/ion uptake/acquisition and efflux systems, were seen to be 
differentially regulated when growth in the presence of low molecular weight 
chitosan. Differences were also present when comparing the wild-type and 
‘adapted’ cells of C. jejuni when grown in the presence of chitosan and also in 
the absence of chitosan challenge.  
 
A number of genes were found to be of particular interest, an example includes 
the observed co-expression of PEB3 and Cj0017c, exclusively found to be over 
expressed in the ‘adapted’ isolate under in the presence and absence of 
chitosan, potentially highlighting major roles towards development an enhanced 
phenotype, established in previous findings.  
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Consistent over expression observed in the ‘adapted’ control versus the wild-
type control and ‘adapted’ chitosan treated relative to the control in the protein-
coding gene KpsM, thought to involved capsule polysaccharide export, may 
contribute to aspects such as enhanced biofilm formation phenotype, in the 
‘adapted’ isolate, compared to the wild-type C. jejuni cells (chapter 6).  
 
An increased expression in the genes, encoding a putative efflux protein 
(Cj0035c) and a probable multidrug efflux transporter (Cj1375) in response to 
chitosan treatment, seen in the wild-type treated and ‘adapted’ isolates when 
compared to their respective untreated controls, may also highlight potential 
mechanisms involved in efflux, are likely to be important in combatting the 
antimicrobial effects of chitosan.  
 
Findings also strongly suggest that the mediation of the putative two-component 
regulator (Cj1608) and/or sodium:dicarboxylate symporter (Cj0025c) may be 
important for mediation of numerous processes concerning transport, following 
chitosan exposure. For instance, the wild-type treated cells accounted for an up 
regulation in protein-encoding genes relating to amino acid, iron and ion 
transportation. It is possible that because of the greater susceptibility to 
chitosan with regards to the ‘adapted’ isolate, increases in a number of these 
genes, alongside co-expression in CJ1608 and Cj0025c, may facilitate such up 
regulations. 
With particular respect to the observed increases in expression in these efflux 
related genes, it can be suggested that exposure to chitosan may disrupt the 
bacterial membrane to some extent. In the possibility of chitosan being able to 
interfere with cell permeability and membrane function, cell death could be 
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prevented by metabolic imbalances and alterations in ionic homeostasis (Raafat 
et al., 2008). It has also been suggested that chitosan may bind to cell wall 
polymers, which could account for destabilisation and/or disruption of the 
bacterial membrane. This may consequently lead to cellular leakage of key 
components with the cells (Raafat et al., 2008). 
There are limited studies which have investigated the effect of chitosan exposure 
from a transcriptional perspective. However, the findings presented in this 
chapter support some of the previous findings observed in a study undertaken 
by Mellegard et al. (2011). Results indicated numerous transcriptional 
differences were observed when comparing Bacillus cereus exposed to chitosan 
in relation to the non-treated cells. An up regulation in genes involved iron 
uptake and transport were typical with regards to the chitosan cells, as oppose 
to the control samples. Other genes also found to be upregulated included 
encoded proteins involved in alkali metal ion binding, potassium ion binding and 
ion transmembrane transportation (Mellegard et al., 2011). Related down 
regulations in genes involving nitrate metabolic pathways and oxidoreductase 
activity with respect to nitrogenous compounds were also observed, which is in 
accordance with findings in this chapter. 
 
Some similarity to previous transcriptional analysis undertaken by Raafat et al. 
(2008) was also apparent. This study investigated the transcriptional alterations 
resulting from chitosan exposure with respect to S. aureus SG511 cells relative 
to untreated control cells. Chitosan treatment was speculated to interfere with 
cellular energy metabolism. This was based on an increased expression of genes 
which are normally preferentially expressed in response to oxygen depletion. 
Transcriptional increase in the chitosan treated cells, typical of genes encoding 
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proteins involved in nitrite reduction, anaerobic respiration and NADH 
dehydrogenase, were presumed by the authors to be a result of uncoupling of 
the electron transport chain, resulting in an impairment of oxygen consumption. 
This also may explain the seemingly odd results with respect to the ‘adapted’ 
chitosan treated cells compared to control cells, typical of a down regulation in 
two bacterial haemoglobin related genes.  
 
Several possible modes of action have been proposed with respect to chitosan. 
The binding of chitosan to anionic compounds has been proposed as a mode of 
action, which has previously been observed on the surface of Gram negative 
bacteria (Helander et al., 2001). It has also been found that the presence of 
divalent cations has been shown to impair the antimicrobial effect of chitosan via 
binding to chitosan targets (Helander et al., 2001). This has been reinforced by 
the observed interaction between chitosan and negatively charged surface 
components of bacteria, namely phospholipids (Liu et al., 2004). 
Moreover, the interaction of chitosan with negatively charged surface 
components may perhaps cause cell surface alterations, consequently impairing 
important bacterial activities and thus general functionality (Je and Kim, 2006). 
It has been found that Salmonella typhimurium mutants with a reduced overall 
negative cell surface charge in comparison the parental strain was less 
susceptible to the antimicrobial effects of chitosan (Helander et al., 2001). 
Another study assessing Staphylococcal mutants, which displayed different cell 
overall surface charges found that a highly negative cell surface enhanced the 
activity of chitosan (Raafat et al., 2008). 
In addition, the Chelating ability of chitosan has also been speculated to be 
involved in terms of mode of action (Rabea et al. (2003), which may explain 
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observed over expression in acquisition/uptake related genes, as chitosan limit 
available metal ions which could be transported into the cell for metabolic 
purposes.  
To conclude, although the exact mode of action of chitosan remains to be 
established definitively, the findings in this chapter support the theory that 
chitosan may affect metabolic processes, probably through initial membrane 
perturbation. It is also likely that the mechanism of action with regards to 
chitosan is multifactorial, with an occurrence of several events compared to a 
single molecular system. Especially in the case of the gene with putative 
function, there is a requirement for additional gene characterisation. Gene 
inactivation studies may also been required to reveal the association between 
the certain gene targets which are thought to be of particular importance and in 
an attempt to decipher their role in response to chitosan. 
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Chapter 8 – General conclusions and future 
work 
 
 
 
8.1 Conclusions 
 
This study set out to establish the phenotypic and molecular mechanisms which 
facilitate C. jejuni to adapt and survive exposure to low molecular weight 
chitosan. C. jejuni is a leading cause of gastroenteritis, primarily resultant from 
the consumption of contaminated foodstuffs. Although C. jejuni is renowned for 
its fastidious nature, this microorganism continues to cause problems from a 
health perspective.  
 
At present, there remains a high demand for novel and naturally derived 
antimicrobials which can be utilised to combat pathogens. This has been 
strengthened by consumer demands which detract from the more traditional 
preservation methods. Chitosan, a naturally derived from the deacetylation of 
chitin, has been seen to possess antimicrobial properties in a number of 
microorganisms, and has been shown to be particularly effective against C. 
jejuni (Ganan et al., 2009). This antimicrobial has received increasing interest 
due to the GRAS nature (FDA, 2001) and variety of potential applications.  
 
Exposure of bacteria species to non-optimal environmental conditions can induce 
an adaptive tolerance response (ATR), which can aid the survival to further 
homologous and/or heterologous stress (Murphy et al., 2003; Kumar-Phillips et 
al., 2013). An adaptive response of C. jejuni towards repeated sub-lethal 
exposure through step-wise increases of commonly used biocides has been 
previously documented, resulting in a non-permanent tolerance (Mavri and 
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Možina, 2012). These phenomenon pose problems in terms of a public health 
risk, as unwanted persistence may result from this (Mavri and Možina, 2012).  
 
It has been suggested that resistant sub-populations can also exist alongside 
wild-type populations and that repeated the same sub-lethal treatment to 
stressors can also lead to the potential for a proportion of cells which occupy an 
enhanced resistance (Rajkovic et al., 2009). Thus, the exploration of such stress 
responses is encouraged in an attempt to understand the mechanisms which can 
lead to this enhanced survival, which is also driven by industrial and safety 
concerns within the food industry (Scheyhing et al., 2004).   
 
There appears to be no literature which has previously demonstrated the 
generation of adaptive response towards low molecular weight chitosan. Thus, 
chapter 4 aimed to address the effect of exposure to low molecular weight 
chitosan towards C. jejuni NCTC11168, and to establish if this strain of C. jejuni 
was able to become stress hardened following increasing sub-lethal 
concentrations of chitosan. 
 
After defining the intensities required needed for at least a 1 log CFU/ml 
reduction in cell count, no decreases in susceptibility was apparent after 
repeated challenge to 0.02% (w/v) and 0.03% (w/v) chitosan, when applying 
methods modified from Rajkovic et al. (2009). This was indicated by the lack of 
deviation of recovered cells after each treatment over the course of 20 days. 
Several attempts were made in order to generate an adaptive sub-population 
through step-wise training typical of increasing increments of chitosan exposure. 
Despite the inability to produce adaptive responses following methods adapted 
from Mavri and Možina (2012) in MH broth, when applying an agar-based 
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alternative using similar step-wise incremental increases, an adaptive response 
was identified, possessing an increased tolerance to low molecular weight 
chitosan. Serial passaging onto non-chitosan containing media revealed a non-
stable adaptation of the newly generated isolate, referred to as the chitosan 
‘adapted’ C. jejuni NCTC11168. After 12-13 passages onto non-chitosan 
containing agar with simultaneous plating onto 0.044% (w/v) chitosan 
containing agar accounted for no cell recovery after incubation for 72 hours 
under conditions mentioned previous. This complies with the study conducted by 
Mavri and Možina (2012), which also found a non-permanent resistance in C. 
jejuni to several biocides. 
 
Whilst a chitosan ‘adapted’ isolate of C. jejuni NCTC11168 was successfully 
generated, presenting an enhanced tolerance to chitosan, these findings are 
limited to this well characterised genome strain. It can be assumed that if C. 
jejuni NCTC11168 is able to present an adaptive tolerance response towards 
chitosan, other bacteria species which harbour more widespread mechanisms 
can also development of antimicrobial resistance.  
 
This chapter presented what was assumed to be the first documented case of an 
ATR resultant from sub-lethal exposure to low molecular weight chitosan. 
Understanding how sub-lethal treatments to stressors may allow for enhanced 
survival properties of C. jejuni is necessary when evaluation current food 
preservation methods, as these may well have undesirable effects on aspects 
such as virulence and alteration in gene expression (Ma et al., 2009).   
 
Chapter 5 aimed to establish the differences in terms of susceptibility of several 
C. jejuni strain/isolates towards low molecular weight chitosan under varying 
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conditions. Briefly, results indicated that the antimicrobial activity of chitosan 
was highly dependent on pH, with greater MIC and MBC values following an 
increase in pH in all C. jejuni strains/isolates tested. This is in accordance with 
other previous research, thought to be resulting from a higher solubility and 
protonation under more acidic conditions (Aider et al., 2010). 
 
Overall, the wild-type C. jejuni NCTC11168 strain was found to harbour the 
greatest susceptibility towards chitosan when compared to the other C. jejuni 
strains/isolates tested. Whilst the previously developed ‘adapted’ isolate of C. 
jejuni NCTC11168 was found to possess the lowest susceptibility of all 
strains/isolates tested, as revealed by the MIC agar dilution results (pH 6.0). 
 
Additionally, time kill assays also reinforced differences between C. jejuni 
strain/isolate susceptibility when challenged for a total of 6 hours under both 
nutrient rich (MH broth) and limited (PBS) conditions. Generally speaking, under 
nutrient limitation, subsequent recovery was found to be lower, which was 
dependant on both exposure time and chitosan concentration utilised. The wild-
type NCTC11168 and RM1221 strains of C. jejuni were found to occupy the 
lowest degree of total recovery in nutrient rich conditions. A similar trend was 
observed in both strains with respect to the same concentrations of chitosan 
under nutrient depleted conditions. Whereas, in the chitosan ‘adapted’ isolate of 
C. jejuni NCTC11168, 81116 strain and NCTC11168CH isolate, cell viability was 
identified even after 6 hour exposure following exposure to 0.01% (w/v) in 
nutrient rich conditions. 
 
Growth inhibition studies also complemented previous findings with particular 
respect to the wild-type versus the chitosan ‘adapted’ isolate of C. jejuni 
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NCTC11168. To summarise, growth inhibition was more apparent in the wild-
type C. jejuni NCTC11168 compared to the ‘adapted’ isolate previously 
generated through step-wise exposure to chitosan. This was especially 
noticeable when cells were grown in the presence of 0.0016% (w/v) chitosan. 
The findings in chapter 5 highlight not only that C. jejuni strains/isolates tested 
are sensitive to low molecular weight chitosan, when compared to other species 
as previously illustrated by Ganan et al. (2009), but also express strain/isolate 
dependant antimicrobial efficacy. The enhanced tolerance found in the ‘adapted’ 
isolate of C. jejuni NCTC11168 in relation to the wild-type may explain how this 
microorganism, through step-wise training exposure to antimicrobial stresses, 
can lead to enhanced persistence which allow for phenotypic and genotypic 
alterations. 
 
Aspects such as biofilm formation, motility and chemotaxis are all thought to 
provide C. jejuni with an improved capability in which to survival environmental 
stresses. Aspects such as motility of C. jejuni, for instance are said to have a 
direct influence on the ability for colonising the host through migration through 
gastrointestinal mucus (Lertsethtakarn et al., 2011). Additionally, it has been 
suggested that flagella may also be required in order for biofilm development 
and maturation (Reeser et al., 2007). The process of biofilm formation is known 
to be of great importance to survival particularly in unfavourable conditions. In 
the event of an enhanced biofilm formation occurring in vivo for instance, has 
seen suggested to not only account for an increased protection from high levels 
of bile in the gall bladder, but may also lead to a limitation in antibiotic 
effectiveness (Begley et al., 2005). 
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The goal of chapter 6 aimed to establish any phenotypical differences between 
the C. jejuni strains/isolates with particular attention to biofilm development, 
motility and chemotaxis. Overall, the degree of motility was found to be 
strain/isolate dependant and increased in all strains/isolates tested from 24-72 
hours, as expected. After 72 hours incubation at 42°C under microaerobic 
conditions, the greatest degree of motility was observed in the RM1221, followed 
by the ‘adapted’ C. jejuni NCTC11168 cells. Conversely, the lowest degree of 
motility was typical of the wild-type C. jejuni NCTC11168. This implies that 
through the development of an ‘adapted’ isolate under a step-wise training 
regime, phenotypic alterations can result and may account for advantages in 
terms of survival.  
 
All strain/isolates tested were able to form biofilms after 2 and 3 days incubation 
under control conditions (chapter 6).With respect to the ‘adapted’ isolate of C. 
jejuni NCTC11168, an increase in biofilm formation was apparent after 3 days 
incubation, when compared to the wild-type C. jejuni NCTC11168 strain. Biofilm 
formation was also evident under chitosan conditions. Therefore, although 
chitosan illustrated a strong antimicrobial activity towards C. jejuni in general, 
especially when compared to other bacterial species, as indicated in a study 
conducted by Ganan et al., (2009), the ability of C. jejuni to form biofilms even 
in concentrations which would not permit growth in a planktonic state, is likely to 
be of great also be of importance in terms of persistence. Findings also indicated 
not only that pre-formed biofilms appear to be less susceptible to chitosan 
exposure than planktonic cells, but that the ‘adapted’ isolate, with particular in 
particular relation to the wild-type C. jejuni NCTC11168 occupies an altered 
biofilm phenotype, which can facilitate survival and potentially virulence. It is 
interesting that the isolate previously subjected to passage through a chicken 
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was similarly able to tolerate chitosan in a pre-formed biofilm state. It can be 
speculated that previous entry into the gastrointestinal tract may contribute to 
an enhanced phenotype, which may impact biofilm formation. However, other 
assays involving cell adherence and invasion may establish to true extent of the 
’adapted’ isolates tolerance to host stress. These findings in chapter 6 suggest 
that step-wise training of C. jejuni leading to an adaptive tolerance response to 
chitosan may contribute to alterations in key aspects such as biofilm formation 
and motility.  
 
As discussed previously, upon exposure to unfavourable stresses, 
microorganisms such as C. jejuni can adaptive responses which can alter the 
phenotype which can have implication towards enhanced survival. This was 
observed to be the case in terms of the ‘adapted’ isolate of C. jejuni NCTC11168, 
which exerted a decrease in susceptibility towards chitosan exposure.  
 
 In order to understand the transcriptional changes which may be responsible for 
these phenotypic changes in the ‘adapted’ isolate of C. jejuni NCTC 11168, 
relative to the wild-type strain, microarray analysis was conducted (chapter 7). 
Many genes were found to be altered in terms of gene expression in response to 
sub-lethal chitosan. To summarise, protein-coding genes associated with efflux 
systems, energy metabolism and solute/ion transport/acquisition were found to 
be differentially expressed following sub-inhibitory exposure to chitosan. Several 
genes were also found to overlap between the initial comparisons tested. 
Examples included significant up regulation of PEB3 (major antigenic peptide), 
Cj0017c (disulphide bond) and Cj0294 (potentially involved in thiamine 
biosynthesis) were found to be up regulated in ‘adapted’ C. jejuni cells both 
when compared to the wild-type both in the presence and absence of chitosan. 
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The exclusive over expression of these genes was therefore deemed important 
for an increased phenotype associated with the ‘adapted’ isolate. Overlapping 
down regulation was found in genes thought to be involved in a putative 
sodium:dicarboxylate symporter and two-component regulator (Cj1608) with 
respect to the same comparisons. It can also be speculated that these genes are 
therefore of some importance for dealing with chitosan challenge. 
 
Owing to the wild-type isolate being notably more susceptible to chitosan 
exposure, any up regulation in genes may enable increased survival. 
Interestingly, the putative sodium:dicarboxylate symporter gene-encoding 
protein (Cj0025c) was also up regulated in the ‘adapted’ treated cells relative to 
the respective control (untreated). This also implies that this putative gene is 
important towards survival.  
 
Perhaps the most surprising findings with regards to microarray analysis were 
apparent when cells of the ‘adapted’ isolate of C. jejuni NCTC11168 were 
exposed to chitosan, an observed down regulation of two bacterial 
haemoglobins, ctb and cgb, related genes, thought to be involved in oxygen 
metabolism and nitrosative stress respectively. A possible explanation for this 
surprising observation may be that upon chitosan treatment, there is a shift in 
metabolic activity, potentially due to an inhibition of oxygen consumption in an 
attempt to preserve energy needed for more important stress responses. This 
may be a mechanism which leads to an increased chance of survival potential. 
Dufour et al. (2010) found similar decreases in expression of genes thought to 
allow for an impaired oxygen consumption of C. jejuni when challenged to the 
naturally derived antimicrobial, benzyl isothiocyanate. This switching from 
oxygenic respiration in C. jejuni to an alternative electron transport pathway 
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may also prevent the amount of ROS formed by components of the electron 
transport chain. This may also explain the down regulation of two oxygen-
accepting cytochrome C oxidase subunits (ccoP and ccoO) with respect to the 
wild-type when challenged with chitosan. These findings correlate to the 
probable electron transport chain uncoupling, suggested by Raafat et al. (2008) 
involving S. aureus challenged to chitosan. In this study, several genes usually 
preferentially expressed under oxygen depleted conditions, were upregulated 
upon treatment. Thus, it can be speculated that chitosan exposure can lead to 
oxygen impairment and interferes with cellular energy metabolism (Raafat et al., 
2008). 
 
In summary, this study has revealed some important phenotypic and 
transcriptional responses of C. jejuni in response to low molecular weight 
chitosan. This study has demonstrated that C. jejuni can illustrate an adaptive 
response through repeated exposure of increasing concentrations of chitosan, 
resulting in an isolate with an altered phenotype, through molecular 
mechanisms. In a general sense, these findings demonstrate that although C. 
jejuni is thought to be limited to an extent with regards to its limited growth 
conditions, specific nutrient requirements  and some general stress response 
genes (Gaynor and Wells, 2005), this microorganism is able to efficiently adapt 
to the chitosan, which can have a profound effect on virulence potential. 
 
From this study, it can be suggested that when using antimicrobials such as 
chitosan, there is a necessity to make logical decisions in terms of application 
such as to limit the virulence potential of the contaminating microorganisms. In 
controlling the given pathogen effectively through these means, there is a 
decreased the chance of future food-borne outbreaks, which can result through 
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persistence. Understanding how sub-lethal exposure to antimicrobials such as 
chitosan, may further promote the survival of C. jejuni, is required for evaluating 
food preservation strategies, as there may be unwanted effects on virulence 
through transcriptional changes (Ma et al., 2009).  
 
 
8.2 Future Work 
 
 
While the antimicrobial effects of chitosan have been demonstrated in this study, 
the effects in combination with additional hurdles such as low temperature and 
oxygen limitation which are encountered during food processing/storage and the 
host upon infection, may provide some additional information as to how C. jejuni 
is able to survive. With respect to the ‘adapted’ isolate, the assessment of cross 
protection to other antimicrobials through susceptibility assays could be 
undertaken to reveal whether this altered phenotype associated with this isolate 
may contribute to resistance on a grander scale. 
 
The findings in this study highlight some interesting stress responses to 
chitosan, both at a phenotypic and transcriptional level. In order to provide more 
information as to the individual effects that certain genes such as KpsM and the 
two-component regulator (Cj1608), gene inactivation studies of these genes 
could be undertaken. This may establish why these genes are differentially 
regulated following chitosan exposure and what specific role they may have in 
combatting chitosan stress. If functions are effectively defined in candidate 
genes, this may reinforce current theories with respect to the aspects such as 
the mode of action(s) involving chitosan. 
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Additional gene expression studies on different strains of C. jejuni may also be 
worthwhile, as this study was limited to wild-type C. jejuni NCTC11168 and the 
subsequently generated ‘adapted’ isolate. Therefore, to generalise the findings in 
this study, the use of additional strains of C. jejuni, especially from a variety of 
sources of origin, would likely be necessary.  
 
 Other experiments could also include other aspects involved in virulence such as 
adherence, invasion and quorum sensing which could potentially allow for some 
interesting comparisons to be established between the strains/isolates tested. 
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